id	sid	tid	token	lemma	pos
dpc-4246	1	1	dermatology	dermatology	NOUN
dpc-4246	1	2	:	:	PUNCT
dpc-4246	1	3	practical	practical	ADJ
dpc-4246	1	4	and	and	CCONJ
dpc-4246	1	5	conceptual	conceptual	ADJ
dpc-4246	1	6	original	original	ADJ
dpc-4246	1	7	article	article	NOUN
dpc-4246	1	8	|	|	ADV
dpc-4246	1	9	dermatol	dermatol	ADJ
dpc-4246	1	10	pract	pract	NOUN
dpc-4246	1	11	concept	concept	NOUN
dpc-4246	1	12	.	.	PUNCT
dpc-4246	2	1	2024;14(3):e2024193	2024;14(3):e2024193	NUM
dpc-4246	2	2	1	1	NUM
dpc-4246	2	3	evaluation	evaluation	NOUN
dpc-4246	2	4	of	of	ADP
dpc-4246	2	5	serum	serum	NOUN
dpc-4246	2	6	inflammatory	inflammatory	ADJ
dpc-4246	2	7	markers	marker	NOUN
dpc-4246	2	8	and	and	CCONJ
dpc-4246	2	9	their	their	PRON
dpc-4246	2	10	relationship	relationship	NOUN
dpc-4246	2	11	to	to	ADP
dpc-4246	2	12	treatment	treatment	NOUN
dpc-4246	2	13	response	response	NOUN
dpc-4246	2	14	in	in	ADP
dpc-4246	2	15	alopecia	alopecia	NOUN
dpc-4246	2	16	areata	areata	ADJ
dpc-4246	2	17	patients	patient	NOUN
dpc-4246	2	18	icim	icim	PROPN
dpc-4246	2	19	komurcugil1	komurcugil1	PROPN
dpc-4246	2	20	,	,	PUNCT
dpc-4246	2	21	nermin	nermin	ADJ
dpc-4246	2	22	karaosmanoglu1	karaosmanoglu1	PROPN
dpc-4246	2	23	1	1	NUM
dpc-4246	2	24	health	health	PROPN
dpc-4246	2	25	sciences	sciences	PROPN
dpc-4246	2	26	university	university	PROPN
dpc-4246	2	27	,	,	PUNCT
dpc-4246	2	28	ankara	ankara	PROPN
dpc-4246	2	29	training	training	NOUN
dpc-4246	2	30	and	and	CCONJ
dpc-4246	2	31	research	research	NOUN
dpc-4246	2	32	hospital	hospital	NOUN
dpc-4246	2	33	,	,	PUNCT
dpc-4246	2	34	ankara	ankara	PROPN
dpc-4246	2	35	,	,	PUNCT
dpc-4246	2	36	turkey	turkey	PROPN
dpc-4246	2	37	key	key	ADJ
dpc-4246	2	38	words	word	NOUN
dpc-4246	2	39	:	:	PUNCT
dpc-4246	2	40	alopecia	alopecia	NOUN
dpc-4246	2	41	areata	areata	NOUN
dpc-4246	2	42	,	,	PUNCT
dpc-4246	2	43	serum	serum	VERB
dpc-4246	2	44	inflammatory	inflammatory	ADJ
dpc-4246	2	45	markers	marker	NOUN
dpc-4246	2	46	,	,	PUNCT
dpc-4246	2	47	systemic	systemic	ADJ
dpc-4246	2	48	immune	immune	ADJ
dpc-4246	2	49	inflammation	inflammation	NOUN
dpc-4246	2	50	index	index	NOUN
dpc-4246	2	51	citation	citation	NOUN
dpc-4246	2	52	:	:	PUNCT
dpc-4246	2	53	komurcugil	komurcugil	PROPN
dpc-4246	2	54	i	i	PROPN
dpc-4246	2	55	,	,	PUNCT
dpc-4246	2	56	karaosmanoglu	karaosmanoglu	PROPN
dpc-4246	2	57	n.	n.	NOUN
dpc-4246	2	58	evaluation	evaluation	NOUN
dpc-4246	2	59	of	of	ADP
dpc-4246	2	60	serum	serum	NOUN
dpc-4246	2	61	inflammatory	inflammatory	ADJ
dpc-4246	2	62	markers	marker	NOUN
dpc-4246	2	63	and	and	CCONJ
dpc-4246	2	64	their	their	PRON
dpc-4246	2	65	relationship	relationship	NOUN
dpc-4246	2	66	to	to	ADP
dpc-4246	2	67	treatment	treatment	NOUN
dpc-4246	2	68	response	response	NOUN
dpc-4246	2	69	in	in	ADP
dpc-4246	2	70	alopecia	alopecia	NOUN
dpc-4246	2	71	areata	areata	ADJ
dpc-4246	2	72	patients	patient	NOUN
dpc-4246	2	73	.	.	PUNCT
dpc-4246	3	1	dermatol	dermatol	NOUN
dpc-4246	3	2	pract	pract	PROPN
dpc-4246	3	3	concept	concept	NOUN
dpc-4246	3	4	.	.	PUNCT
dpc-4246	4	1	2024;14(3):e2024193	2024;14(3):e2024193	X
dpc-4246	4	2	.	.	X
dpc-4246	4	3	doi	doi	PROPN
dpc-4246	4	4	:	:	PUNCT
dpc-4246	4	5	https://doi.org/10.5826/dpc.1403a193	https://doi.org/10.5826/dpc.1403a193	PROPN
dpc-4246	4	6	accepted	accept	VERB
dpc-4246	4	7	:	:	PUNCT
dpc-4246	4	8	march	march	PROPN
dpc-4246	4	9	27	27	NUM
dpc-4246	4	10	,	,	PUNCT
dpc-4246	4	11	2024	2024	NUM
dpc-4246	4	12	;	;	PUNCT
dpc-4246	4	13	published	publish	VERB
dpc-4246	4	14	:	:	PUNCT
dpc-4246	5	1	july	july	PROPN
dpc-4246	5	2	2024	2024	NUM
dpc-4246	5	3	copyright	copyright	NOUN
dpc-4246	5	4	:	:	PUNCT
dpc-4246	5	5	©	©	PROPN
dpc-4246	5	6	2024	2024	NUM
dpc-4246	5	7	komurcugil	komurcugil	NOUN
dpc-4246	5	8	et	et	PROPN
dpc-4246	5	9	al	al	PROPN
dpc-4246	5	10	.	.	PUNCT
dpc-4246	6	1	this	this	PRON
dpc-4246	6	2	is	be	AUX
dpc-4246	6	3	an	an	DET
dpc-4246	6	4	open	open	ADJ
dpc-4246	6	5	-	-	PUNCT
dpc-4246	6	6	access	access	NOUN
dpc-4246	6	7	article	article	NOUN
dpc-4246	6	8	distributed	distribute	VERB
dpc-4246	6	9	under	under	ADP
dpc-4246	6	10	the	the	DET
dpc-4246	6	11	terms	term	NOUN
dpc-4246	6	12	of	of	ADP
dpc-4246	6	13	the	the	DET
dpc-4246	6	14	creative	creative	ADJ
dpc-4246	6	15	commons	common	NOUN
dpc-4246	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4246	6	17	license	license	NOUN
dpc-4246	6	18	(	(	PUNCT
dpc-4246	6	19	by	by	ADP
dpc-4246	6	20	-	-	PUNCT
dpc-4246	6	21	nc-4.0	nc-4.0	NOUN
dpc-4246	6	22	)	)	PUNCT
dpc-4246	6	23	,	,	PUNCT
dpc-4246	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4246	6	25	,	,	PUNCT
dpc-4246	6	26	which	which	PRON
dpc-4246	6	27	permits	permit	VERB
dpc-4246	6	28	unrestricted	unrestricted	ADJ
dpc-4246	6	29	noncommercial	noncommercial	ADJ
dpc-4246	6	30	use	use	NOUN
dpc-4246	6	31	,	,	PUNCT
dpc-4246	6	32	distribution	distribution	NOUN
dpc-4246	6	33	,	,	PUNCT
dpc-4246	6	34	and	and	CCONJ
dpc-4246	6	35	reproduction	reproduction	NOUN
dpc-4246	6	36	in	in	ADP
dpc-4246	6	37	any	any	DET
dpc-4246	6	38	medium	medium	NOUN
dpc-4246	6	39	,	,	PUNCT
dpc-4246	6	40	provided	provide	VERB
dpc-4246	6	41	the	the	DET
dpc-4246	6	42	original	original	ADJ
dpc-4246	6	43	authors	author	NOUN
dpc-4246	6	44	and	and	CCONJ
dpc-4246	6	45	source	source	NOUN
dpc-4246	6	46	are	be	AUX
dpc-4246	6	47	credited	credit	VERB
dpc-4246	6	48	.	.	PUNCT
dpc-4246	7	1	funding	funding	NOUN
dpc-4246	7	2	:	:	PUNCT
dpc-4246	7	3	none	none	NOUN
dpc-4246	7	4	.	.	PUNCT
dpc-4246	8	1	competing	compete	VERB
dpc-4246	8	2	interests	interest	NOUN
dpc-4246	8	3	:	:	PUNCT
dpc-4246	8	4	none	none	NOUN
dpc-4246	8	5	.	.	PUNCT
dpc-4246	9	1	authorship	authorship	NOUN
dpc-4246	9	2	:	:	PUNCT
dpc-4246	9	3	all	all	DET
dpc-4246	9	4	authors	author	NOUN
dpc-4246	9	5	have	have	AUX
dpc-4246	9	6	contributed	contribute	VERB
dpc-4246	9	7	significantly	significantly	ADV
dpc-4246	9	8	to	to	ADP
dpc-4246	9	9	this	this	DET
dpc-4246	9	10	publication	publication	NOUN
dpc-4246	9	11	.	.	PUNCT
dpc-4246	10	1	corresponding	correspond	VERB
dpc-4246	10	2	author	author	NOUN
dpc-4246	10	3	:	:	PUNCT
dpc-4246	10	4	icim	icim	PROPN
dpc-4246	10	5	komurcugil	komurcugil	PROPN
dpc-4246	10	6	,	,	PUNCT
dpc-4246	10	7	hacettepe	hacettepe	ADV
dpc-4246	10	8	,	,	PUNCT
dpc-4246	10	9	hamamönü	hamamönü	NOUN
dpc-4246	10	10	,	,	PUNCT
dpc-4246	10	11	talatpaşa	talatpaşa	PROPN
dpc-4246	10	12	boulevard	boulevard	NOUN
dpc-4246	10	13	,	,	PUNCT
dpc-4246	10	14	no:128	no:128	PROPN
dpc-4246	10	15	,	,	PUNCT
dpc-4246	10	16	altındağ	altındağ	NOUN
dpc-4246	10	17	/	/	SYM
dpc-4246	10	18	ankara	ankara	PROPN
dpc-4246	10	19	.	.	PUNCT
dpc-4246	11	1	telephone	telephone	NOUN
dpc-4246	11	2	:	:	PUNCT
dpc-4246	12	1	+90	+90	NOUN
dpc-4246	12	2	552	552	NUM
dpc-4246	12	3	454	454	NUM
dpc-4246	12	4	23	23	NUM
dpc-4246	12	5	31	31	NUM
dpc-4246	12	6	e	e	NOUN
dpc-4246	12	7	-	-	NOUN
dpc-4246	12	8	mail	mail	NOUN
dpc-4246	12	9	:	:	PUNCT
dpc-4246	12	10	icim.komurcugil@yahoo.com	icim.komurcugil@yahoo.com	X
dpc-4246	12	11	introduction	introduction	NOUN
dpc-4246	12	12	:	:	PUNCT
dpc-4246	12	13	alopecia	alopecia	NOUN
dpc-4246	12	14	areata	areata	NOUN
dpc-4246	12	15	is	be	AUX
dpc-4246	12	16	a	a	DET
dpc-4246	12	17	type	type	NOUN
dpc-4246	12	18	of	of	ADP
dpc-4246	12	19	non	non	ADJ
dpc-4246	12	20	-	-	ADJ
dpc-4246	12	21	scarring	scar	VERB
dpc-4246	12	22	alopecia	alopecia	NOUN
dpc-4246	12	23	which	which	PRON
dpc-4246	12	24	is	be	AUX
dpc-4246	12	25	thought	think	VERB
dpc-4246	12	26	to	to	PART
dpc-4246	12	27	be	be	AUX
dpc-4246	12	28	associated	associate	VERB
dpc-4246	12	29	with	with	ADP
dpc-4246	12	30	t	t	NOUN
dpc-4246	12	31	-	-	PUNCT
dpc-4246	12	32	cell	cell	NOUN
dpc-4246	12	33	mediated	mediate	VERB
dpc-4246	12	34	immune	immune	ADJ
dpc-4246	12	35	response	response	NOUN
dpc-4246	12	36	.	.	PUNCT
dpc-4246	13	1	objective	objective	NOUN
dpc-4246	13	2	:	:	PUNCT
dpc-4246	13	3	this	this	DET
dpc-4246	13	4	study	study	NOUN
dpc-4246	13	5	aimed	aim	VERB
dpc-4246	13	6	to	to	PART
dpc-4246	13	7	compare	compare	VERB
dpc-4246	13	8	the	the	DET
dpc-4246	13	9	levels	level	NOUN
dpc-4246	13	10	of	of	ADP
dpc-4246	13	11	serum	serum	NOUN
dpc-4246	13	12	inflammatory	inflammatory	ADJ
dpc-4246	13	13	markers	marker	NOUN
dpc-4246	13	14	before	before	ADV
dpc-4246	13	15	and	and	CCONJ
dpc-4246	13	16	after	after	ADP
dpc-4246	13	17	treatment	treatment	NOUN
dpc-4246	13	18	in	in	ADP
dpc-4246	13	19	patients	patient	NOUN
dpc-4246	13	20	with	with	ADP
dpc-4246	13	21	alopecia	alopecia	NOUN
dpc-4246	13	22	areata	areata	ADJ
dpc-4246	13	23	.	.	PUNCT
dpc-4246	14	1	the	the	DET
dpc-4246	14	2	study	study	NOUN
dpc-4246	14	3	explored	explore	VERB
dpc-4246	14	4	the	the	DET
dpc-4246	14	5	utility	utility	NOUN
dpc-4246	14	6	of	of	ADP
dpc-4246	14	7	the	the	DET
dpc-4246	14	8	systemic	systemic	ADJ
dpc-4246	14	9	immuneinflammation	immuneinflammation	NOUN
dpc-4246	14	10	index	index	NOUN
dpc-4246	14	11	(	(	PUNCT
dpc-4246	14	12	sii	sii	PROPN
dpc-4246	14	13	)	)	PUNCT
dpc-4246	14	14	in	in	ADP
dpc-4246	14	15	assessing	assess	VERB
dpc-4246	14	16	the	the	DET
dpc-4246	14	17	severity	severity	NOUN
dpc-4246	14	18	and	and	CCONJ
dpc-4246	14	19	treatment	treatment	NOUN
dpc-4246	14	20	response	response	NOUN
dpc-4246	14	21	in	in	ADP
dpc-4246	14	22	alopecia	alopecia	NOUN
dpc-4246	14	23	areata	areata	ADJ
dpc-4246	14	24	patients	patient	NOUN
dpc-4246	14	25	.	.	PUNCT
dpc-4246	15	1	methods	method	NOUN
dpc-4246	15	2	:	:	PUNCT
dpc-4246	15	3	the	the	DET
dpc-4246	15	4	study	study	NOUN
dpc-4246	15	5	included	include	VERB
dpc-4246	15	6	60	60	NUM
dpc-4246	15	7	alopecia	alopecia	NOUN
dpc-4246	15	8	areata	areata	ADJ
dpc-4246	15	9	patients	patient	NOUN
dpc-4246	15	10	and	and	CCONJ
dpc-4246	15	11	40	40	NUM
dpc-4246	15	12	control	control	NOUN
dpc-4246	15	13	patients	patient	NOUN
dpc-4246	15	14	diagnosed	diagnose	VERB
dpc-4246	15	15	with	with	ADP
dpc-4246	15	16	tinea	tinea	PROPN
dpc-4246	15	17	unguium	unguium	NOUN
dpc-4246	15	18	,	,	PUNCT
dpc-4246	15	19	aged	age	VERB
dpc-4246	15	20	between	between	ADP
dpc-4246	15	21	18	18	NUM
dpc-4246	15	22	and	and	CCONJ
dpc-4246	15	23	65	65	NUM
dpc-4246	15	24	years	year	NOUN
dpc-4246	15	25	.	.	PUNCT
dpc-4246	16	1	sociodemographic	sociodemographic	ADJ
dpc-4246	16	2	characteristics	characteristic	NOUN
dpc-4246	16	3	such	such	ADJ
dpc-4246	16	4	as	as	ADP
dpc-4246	16	5	age	age	NOUN
dpc-4246	16	6	,	,	PUNCT
dpc-4246	16	7	sex	sex	NOUN
dpc-4246	16	8	,	,	PUNCT
dpc-4246	16	9	and	and	CCONJ
dpc-4246	16	10	medical	medical	ADJ
dpc-4246	16	11	history	history	NOUN
dpc-4246	16	12	were	be	AUX
dpc-4246	16	13	recorded	record	VERB
dpc-4246	16	14	for	for	ADP
dpc-4246	16	15	both	both	DET
dpc-4246	16	16	groups	group	NOUN
dpc-4246	16	17	.	.	PUNCT
dpc-4246	17	1	for	for	ADP
dpc-4246	17	2	alopecia	alopecia	NOUN
dpc-4246	17	3	areata	areata	ADJ
dpc-4246	17	4	patients	patient	NOUN
dpc-4246	17	5	,	,	PUNCT
dpc-4246	17	6	serum	serum	VERB
dpc-4246	17	7	inflammatory	inflammatory	ADJ
dpc-4246	17	8	markers	marker	NOUN
dpc-4246	17	9	were	be	AUX
dpc-4246	17	10	recorded	record	VERB
dpc-4246	17	11	before	before	ADV
dpc-4246	17	12	and	and	CCONJ
dpc-4246	17	13	at	at	ADP
dpc-4246	17	14	the	the	DET
dpc-4246	17	15	third	third	ADJ
dpc-4246	17	16	month	month	NOUN
dpc-4246	17	17	of	of	ADP
dpc-4246	17	18	treatment	treatment	NOUN
dpc-4246	17	19	.	.	PUNCT
dpc-4246	18	1	serum	serum	VERB
dpc-4246	18	2	inflammatory	inflammatory	ADJ
dpc-4246	18	3	markers	marker	NOUN
dpc-4246	18	4	for	for	ADP
dpc-4246	18	5	the	the	DET
dpc-4246	18	6	control	control	NOUN
dpc-4246	18	7	group	group	NOUN
dpc-4246	18	8	were	be	AUX
dpc-4246	18	9	also	also	ADV
dpc-4246	18	10	recorded	record	VERB
dpc-4246	18	11	.	.	PUNCT
dpc-4246	19	1	furthermore	furthermore	ADV
dpc-4246	19	2	,	,	PUNCT
dpc-4246	19	3	the	the	DET
dpc-4246	19	4	severity	severity	NOUN
dpc-4246	19	5	of	of	ADP
dpc-4246	19	6	alopecia	alopecia	NOUN
dpc-4246	19	7	tool	tool	NOUN
dpc-4246	19	8	(	(	PUNCT
dpc-4246	19	9	salt	salt	NOUN
dpc-4246	19	10	)	)	PUNCT
dpc-4246	19	11	score	score	NOUN
dpc-4246	19	12	was	be	AUX
dpc-4246	19	13	calculated	calculate	VERB
dpc-4246	19	14	for	for	ADP
dpc-4246	19	15	alopecia	alopecia	NOUN
dpc-4246	19	16	areata	areata	ADJ
dpc-4246	19	17	patients	patient	NOUN
dpc-4246	19	18	before	before	ADP
dpc-4246	19	19	and	and	CCONJ
dpc-4246	19	20	at	at	ADP
dpc-4246	19	21	the	the	DET
dpc-4246	19	22	third	third	ADJ
dpc-4246	19	23	month	month	NOUN
dpc-4246	19	24	of	of	ADP
dpc-4246	19	25	treatment	treatment	NOUN
dpc-4246	19	26	.	.	PUNCT
dpc-4246	20	1	results	result	NOUN
dpc-4246	20	2	:	:	PUNCT
dpc-4246	20	3	the	the	DET
dpc-4246	20	4	alopecia	alopecia	NOUN
dpc-4246	20	5	areata	areata	ADJ
dpc-4246	20	6	group	group	NOUN
dpc-4246	20	7	had	have	AUX
dpc-4246	20	8	a	a	DET
dpc-4246	20	9	significantly	significantly	ADV
dpc-4246	20	10	higher	high	ADJ
dpc-4246	20	11	neutrophil	neutrophil	ADJ
dpc-4246	20	12	-	-	PUNCT
dpc-4246	20	13	lymphocyte	lymphocyte	NOUN
dpc-4246	20	14	ratio	ratio	NOUN
dpc-4246	20	15	,	,	PUNCT
dpc-4246	20	16	mean	mean	VERB
dpc-4246	20	17	platelet	platelet	NOUN
dpc-4246	20	18	volume	volume	NOUN
dpc-4246	20	19	,	,	PUNCT
dpc-4246	20	20	and	and	CCONJ
dpc-4246	20	21	sii	sii	ADJ
dpc-4246	20	22	values	value	NOUN
dpc-4246	20	23	compared	compare	VERB
dpc-4246	20	24	to	to	ADP
dpc-4246	20	25	the	the	DET
dpc-4246	20	26	control	control	NOUN
dpc-4246	20	27	group	group	NOUN
dpc-4246	20	28	,	,	PUNCT
dpc-4246	20	29	while	while	SCONJ
dpc-4246	20	30	high	high	ADJ
dpc-4246	20	31	-	-	PUNCT
dpc-4246	20	32	density	density	NOUN
dpc-4246	20	33	lipoprotein	lipoprotein	ADJ
dpc-4246	20	34	(	(	PUNCT
dpc-4246	20	35	hdl	hdl	NOUN
dpc-4246	20	36	)	)	PUNCT
dpc-4246	20	37	values	value	NOUN
dpc-4246	20	38	were	be	AUX
dpc-4246	20	39	significantly	significantly	ADV
dpc-4246	20	40	lower	low	ADJ
dpc-4246	20	41	.	.	PUNCT
dpc-4246	21	1	serum	serum	VERB
dpc-4246	21	2	inflammatory	inflammatory	ADJ
dpc-4246	21	3	markers	marker	NOUN
dpc-4246	21	4	,	,	PUNCT
dpc-4246	21	5	assessed	assess	VERB
dpc-4246	21	6	at	at	ADP
dpc-4246	21	7	the	the	DET
dpc-4246	21	8	third	third	ADJ
dpc-4246	21	9	month	month	NOUN
dpc-4246	21	10	of	of	ADP
dpc-4246	21	11	treatment	treatment	NOUN
dpc-4246	21	12	in	in	ADP
dpc-4246	21	13	the	the	DET
dpc-4246	21	14	alopecia	alopecia	NOUN
dpc-4246	21	15	areata	areata	ADJ
dpc-4246	21	16	group	group	NOUN
dpc-4246	21	17	,	,	PUNCT
dpc-4246	21	18	were	be	AUX
dpc-4246	21	19	lower	low	ADJ
dpc-4246	21	20	,	,	PUNCT
dpc-4246	21	21	and	and	CCONJ
dpc-4246	21	22	hdl	hdl	PROPN
dpc-4246	21	23	values	value	NOUN
dpc-4246	21	24	were	be	AUX
dpc-4246	21	25	significantly	significantly	ADV
dpc-4246	21	26	higher	high	ADJ
dpc-4246	21	27	compared	compare	VERB
dpc-4246	21	28	to	to	ADP
dpc-4246	21	29	pretreatment	pretreatment	NOUN
dpc-4246	21	30	levels	level	NOUN
dpc-4246	21	31	.	.	PUNCT
dpc-4246	22	1	a	a	DET
dpc-4246	22	2	statistically	statistically	ADV
dpc-4246	22	3	significant	significant	ADJ
dpc-4246	22	4	correlation	correlation	NOUN
dpc-4246	22	5	was	be	AUX
dpc-4246	22	6	observed	observe	VERB
dpc-4246	22	7	between	between	ADP
dpc-4246	22	8	disease	disease	NOUN
dpc-4246	22	9	severity	severity	NOUN
dpc-4246	22	10	and	and	CCONJ
dpc-4246	22	11	the	the	DET
dpc-4246	22	12	sii	sii	PROPN
dpc-4246	22	13	.	.	PUNCT
dpc-4246	22	14	conclusion	conclusion	NOUN
dpc-4246	22	15	:	:	PUNCT
dpc-4246	22	16	the	the	DET
dpc-4246	22	17	sii	sii	PROPN
dpc-4246	22	18	is	be	AUX
dpc-4246	22	19	a	a	DET
dpc-4246	22	20	cost	cost	NOUN
dpc-4246	22	21	-	-	PUNCT
dpc-4246	22	22	effective	effective	ADJ
dpc-4246	22	23	marker	marker	NOUN
dpc-4246	22	24	that	that	PRON
dpc-4246	22	25	can	can	AUX
dpc-4246	22	26	be	be	AUX
dpc-4246	22	27	utilized	utilize	VERB
dpc-4246	22	28	in	in	ADP
dpc-4246	22	29	assessing	assess	VERB
dpc-4246	22	30	the	the	DET
dpc-4246	22	31	severity	severity	NOUN
dpc-4246	22	32	of	of	ADP
dpc-4246	22	33	alopecia	alopecia	NOUN
dpc-4246	22	34	areata	areata	ADJ
dpc-4246	22	35	and	and	CCONJ
dpc-4246	22	36	treatment	treatment	NOUN
dpc-4246	22	37	response	response	NOUN
dpc-4246	22	38	.	.	PUNCT
dpc-4246	23	1	abstract	abstract	ADJ
dpc-4246	23	2	2	2	NUM
dpc-4246	23	3	original	original	ADJ
dpc-4246	23	4	article	article	NOUN
dpc-4246	23	5	|	|	ADV
dpc-4246	23	6	dermatol	dermatol	ADJ
dpc-4246	23	7	pract	pract	NOUN
dpc-4246	23	8	concept	concept	NOUN
dpc-4246	23	9	.	.	PUNCT
dpc-4246	24	1	2024;14(3):e2024193	2024;14(3):e2024193	NUM
dpc-4246	24	2	introduction	introduction	NOUN
dpc-4246	24	3	alopecia	alopecia	NOUN
dpc-4246	24	4	areata	areata	NOUN
dpc-4246	24	5	(	(	PUNCT
dpc-4246	24	6	aa	aa	NOUN
dpc-4246	24	7	)	)	PUNCT
dpc-4246	24	8	is	be	AUX
dpc-4246	24	9	a	a	DET
dpc-4246	24	10	chronic	chronic	ADJ
dpc-4246	24	11	autoimmune	autoimmune	ADJ
dpc-4246	24	12	disease	disease	NOUN
dpc-4246	24	13	that	that	PRON
dpc-4246	24	14	results	result	VERB
dpc-4246	24	15	in	in	ADP
dpc-4246	24	16	non	non	ADJ
dpc-4246	24	17	-	-	ADJ
dpc-4246	24	18	scarring	scarring	ADJ
dpc-4246	24	19	hair	hair	NOUN
dpc-4246	24	20	loss	loss	NOUN
dpc-4246	24	21	.	.	PUNCT
dpc-4246	25	1	the	the	DET
dpc-4246	25	2	scalp	scalp	NOUN
dpc-4246	25	3	is	be	AUX
dpc-4246	25	4	the	the	DET
dpc-4246	25	5	most	most	ADV
dpc-4246	25	6	commonly	commonly	ADV
dpc-4246	25	7	affected	affect	VERB
dpc-4246	25	8	area	area	NOUN
dpc-4246	25	9	,	,	PUNCT
dpc-4246	25	10	but	but	CCONJ
dpc-4246	25	11	eyebrows	eyebrow	NOUN
dpc-4246	25	12	,	,	PUNCT
dpc-4246	25	13	eyelashes	eyelash	NOUN
dpc-4246	25	14	,	,	PUNCT
dpc-4246	25	15	and	and	CCONJ
dpc-4246	25	16	body	body	NOUN
dpc-4246	25	17	hair	hair	NOUN
dpc-4246	25	18	can	can	AUX
dpc-4246	25	19	also	also	ADV
dpc-4246	25	20	be	be	AUX
dpc-4246	25	21	involved	involve	VERB
dpc-4246	25	22	[	[	PUNCT
dpc-4246	25	23	1	1	NUM
dpc-4246	25	24	]	]	PUNCT
dpc-4246	25	25	.	.	PUNCT
dpc-4246	26	1	aa	aa	PROPN
dpc-4246	26	2	is	be	AUX
dpc-4246	26	3	classified	classify	VERB
dpc-4246	26	4	based	base	VERB
dpc-4246	26	5	on	on	ADP
dpc-4246	26	6	disease	disease	NOUN
dpc-4246	26	7	severity	severity	NOUN
dpc-4246	26	8	and	and	CCONJ
dpc-4246	26	9	clinical	clinical	ADJ
dpc-4246	26	10	presentation	presentation	NOUN
dpc-4246	26	11	.	.	PUNCT
dpc-4246	27	1	patchy	patchy	ADJ
dpc-4246	27	2	aa	aa	NOUN
dpc-4246	27	3	is	be	AUX
dpc-4246	27	4	characterized	characterize	VERB
dpc-4246	27	5	by	by	ADP
dpc-4246	27	6	well	well	ADV
dpc-4246	27	7	-	-	PUNCT
dpc-4246	27	8	defined	define	VERB
dpc-4246	27	9	,	,	PUNCT
dpc-4246	27	10	oval	oval	NOUN
dpc-4246	27	11	,	,	PUNCT
dpc-4246	27	12	or	or	CCONJ
dpc-4246	27	13	circular	circular	ADJ
dpc-4246	27	14	alopecic	alopecic	NOUN
dpc-4246	27	15	patches	patch	NOUN
dpc-4246	27	16	,	,	PUNCT
dpc-4246	27	17	occasionally	occasionally	ADV
dpc-4246	27	18	extending	extend	VERB
dpc-4246	27	19	to	to	ADP
dpc-4246	27	20	total	total	ADJ
dpc-4246	27	21	scalp	scalp	NOUN
dpc-4246	27	22	hair	hair	NOUN
dpc-4246	27	23	loss	loss	NOUN
dpc-4246	27	24	(	(	PUNCT
dpc-4246	27	25	alopecia	alopecia	NOUN
dpc-4246	27	26	totalis	totalis	PROPN
dpc-4246	27	27	)	)	PUNCT
dpc-4246	27	28	or	or	CCONJ
dpc-4246	27	29	complete	complete	ADJ
dpc-4246	27	30	body	body	NOUN
dpc-4246	27	31	hair	hair	NOUN
dpc-4246	27	32	loss	loss	NOUN
dpc-4246	27	33	(	(	PUNCT
dpc-4246	27	34	alopecia	alopecia	NOUN
dpc-4246	27	35	universalis	universali	VERB
dpc-4246	27	36	)	)	PUNCT
dpc-4246	27	37	.	.	PUNCT
dpc-4246	28	1	other	other	ADJ
dpc-4246	28	2	atypical	atypical	ADJ
dpc-4246	28	3	variants	variant	NOUN
dpc-4246	28	4	include	include	VERB
dpc-4246	28	5	ophiasis	ophiasis	NOUN
dpc-4246	28	6	,	,	PUNCT
dpc-4246	28	7	characterized	characterize	VERB
dpc-4246	28	8	by	by	ADP
dpc-4246	28	9	occipital	occipital	NOUN
dpc-4246	28	10	and	and	CCONJ
dpc-4246	28	11	retroauricular	retroauricular	ADJ
dpc-4246	28	12	alopecia	alopecia	NOUN
dpc-4246	28	13	,	,	PUNCT
dpc-4246	28	14	inverse	inverse	NOUN
dpc-4246	28	15	ophiasis	ophiasis	NOUN
dpc-4246	28	16	which	which	PRON
dpc-4246	28	17	is	be	AUX
dpc-4246	28	18	marked	mark	VERB
dpc-4246	28	19	by	by	ADP
dpc-4246	28	20	hair	hair	NOUN
dpc-4246	28	21	loss	loss	NOUN
dpc-4246	28	22	in	in	ADP
dpc-4246	28	23	vertex	vertex	NOUN
dpc-4246	28	24	as	as	ADV
dpc-4246	28	25	well	well	ADV
dpc-4246	28	26	as	as	ADP
dpc-4246	28	27	diffuse	diffuse	ADJ
dpc-4246	28	28	,	,	PUNCT
dpc-4246	28	29	reticular	reticular	ADJ
dpc-4246	28	30	,	,	PUNCT
dpc-4246	28	31	and	and	CCONJ
dpc-4246	28	32	perinevoid	perinevoid	PROPN
dpc-4246	28	33	forms	form	NOUN
dpc-4246	28	34	[	[	X
dpc-4246	28	35	2	2	NUM
dpc-4246	28	36	]	]	PUNCT
dpc-4246	28	37	.	.	PUNCT
dpc-4246	29	1	the	the	DET
dpc-4246	29	2	estimated	estimate	VERB
dpc-4246	29	3	prevalence	prevalence	NOUN
dpc-4246	29	4	is	be	AUX
dpc-4246	29	5	0.1	0.1	NUM
dpc-4246	29	6	%	%	NOUN
dpc-4246	29	7	,	,	PUNCT
dpc-4246	29	8	with	with	ADP
dpc-4246	29	9	a	a	DET
dpc-4246	29	10	lifelong	lifelong	ADJ
dpc-4246	29	11	risk	risk	NOUN
dpc-4246	29	12	of	of	ADP
dpc-4246	29	13	2	2	NUM
dpc-4246	29	14	%	%	NOUN
dpc-4246	29	15	.	.	PUNCT
dpc-4246	30	1	aa	aa	PROPN
dpc-4246	30	2	can	can	AUX
dpc-4246	30	3	be	be	AUX
dpc-4246	30	4	associated	associate	VERB
dpc-4246	30	5	with	with	ADP
dpc-4246	30	6	autoimmune	autoimmune	ADJ
dpc-4246	30	7	disorders	disorder	NOUN
dpc-4246	30	8	such	such	ADJ
dpc-4246	30	9	as	as	ADP
dpc-4246	30	10	vitiligo	vitiligo	NOUN
dpc-4246	30	11	,	,	PUNCT
dpc-4246	30	12	diabetes	diabetes	NOUN
dpc-4246	30	13	mellitus	mellitus	NOUN
dpc-4246	30	14	,	,	PUNCT
dpc-4246	30	15	pernicious	pernicious	ADJ
dpc-4246	30	16	anemia	anemia	NOUN
dpc-4246	30	17	,	,	PUNCT
dpc-4246	30	18	and	and	CCONJ
dpc-4246	30	19	hypothyroidism	hypothyroidism	NOUN
dpc-4246	30	20	[	[	X
dpc-4246	30	21	1	1	NUM
dpc-4246	30	22	]	]	PUNCT
dpc-4246	30	23	.	.	PUNCT
dpc-4246	31	1	the	the	DET
dpc-4246	31	2	exact	exact	ADJ
dpc-4246	31	3	etiology	etiology	NOUN
dpc-4246	31	4	of	of	ADP
dpc-4246	31	5	aa	aa	NOUN
dpc-4246	31	6	is	be	AUX
dpc-4246	31	7	not	not	PART
dpc-4246	31	8	fully	fully	ADV
dpc-4246	31	9	understood	understand	VERB
dpc-4246	31	10	;	;	PUNCT
dpc-4246	31	11	it	it	PRON
dpc-4246	31	12	is	be	AUX
dpc-4246	31	13	thought	think	VERB
dpc-4246	31	14	to	to	PART
dpc-4246	31	15	be	be	AUX
dpc-4246	31	16	associated	associate	VERB
dpc-4246	31	17	with	with	ADP
dpc-4246	31	18	genetic	genetic	ADJ
dpc-4246	31	19	predisposition	predisposition	NOUN
dpc-4246	31	20	and	and	CCONJ
dpc-4246	31	21	t	t	NOUN
dpc-4246	31	22	-	-	PUNCT
dpc-4246	31	23	cell	cell	NOUN
dpc-4246	31	24	-	-	PUNCT
dpc-4246	31	25	mediated	mediate	VERB
dpc-4246	31	26	autoimmunity	autoimmunity	NOUN
dpc-4246	31	27	[	[	X
dpc-4246	31	28	2	2	NUM
dpc-4246	31	29	]	]	PUNCT
dpc-4246	31	30	.	.	PUNCT
dpc-4246	32	1	cd4	cd4	PROPN
dpc-4246	32	2	+	+	PROPN
dpc-4246	32	3	and	and	CCONJ
dpc-4246	32	4	cd8	cd8	PROPN
dpc-4246	32	5	+	+	PROPN
dpc-4246	32	6	t	t	PROPN
dpc-4246	32	7	-	-	PUNCT
dpc-4246	32	8	cells	cell	NOUN
dpc-4246	32	9	,	,	PUNCT
dpc-4246	32	10	along	along	ADP
dpc-4246	32	11	with	with	ADP
dpc-4246	32	12	natural	natural	ADJ
dpc-4246	32	13	killer	killer	NOUN
dpc-4246	32	14	cells	cell	NOUN
dpc-4246	32	15	and	and	CCONJ
dpc-4246	32	16	dendritic	dendritic	ADJ
dpc-4246	32	17	cells	cell	NOUN
dpc-4246	32	18	,	,	PUNCT
dpc-4246	32	19	form	form	VERB
dpc-4246	32	20	an	an	DET
dpc-4246	32	21	infiltrate	infiltrate	NOUN
dpc-4246	32	22	around	around	ADP
dpc-4246	32	23	the	the	DET
dpc-4246	32	24	anagen	anagen	NOUN
dpc-4246	32	25	hair	hair	NOUN
dpc-4246	32	26	bulb	bulb	NOUN
dpc-4246	32	27	,	,	PUNCT
dpc-4246	32	28	producing	produce	VERB
dpc-4246	32	29	interferon	interferon	ADJ
dpc-4246	32	30	-	-	PUNCT
dpc-4246	32	31	gamma	gamma	NOUN
dpc-4246	32	32	,	,	PUNCT
dpc-4246	32	33	tumor	tumor	NOUN
dpc-4246	32	34	necrosis	necrosis	NOUN
dpc-4246	32	35	factor	factor	NOUN
dpc-4246	32	36	-	-	PUNCT
dpc-4246	32	37	α	α	NOUN
dpc-4246	32	38	,	,	PUNCT
dpc-4246	32	39	and	and	CCONJ
dpc-4246	32	40	interleukin	interleukin	NOUN
dpc-4246	32	41	(	(	PUNCT
dpc-4246	32	42	il	il	PROPN
dpc-4246	32	43	)	)	PUNCT
dpc-4246	32	44	12/23	12/23	NUM
dpc-4246	32	45	.	.	PUNCT
dpc-4246	33	1	consequently	consequently	ADV
dpc-4246	33	2	,	,	PUNCT
dpc-4246	33	3	the	the	DET
dpc-4246	33	4	hair	hair	NOUN
dpc-4246	33	5	growth	growth	NOUN
dpc-4246	33	6	cycle	cycle	NOUN
dpc-4246	33	7	is	be	AUX
dpc-4246	33	8	disrupted	disrupt	VERB
dpc-4246	33	9	,	,	PUNCT
dpc-4246	33	10	resulting	result	VERB
dpc-4246	33	11	in	in	ADP
dpc-4246	33	12	premature	premature	ADJ
dpc-4246	33	13	hair	hair	NOUN
dpc-4246	33	14	loss	loss	NOUN
dpc-4246	33	15	and	and	CCONJ
dpc-4246	33	16	alopecia	alopecia	NOUN
dpc-4246	33	17	.	.	PUNCT
dpc-4246	34	1	the	the	DET
dpc-4246	34	2	systemic	systemic	ADJ
dpc-4246	34	3	immune	immune	ADJ
dpc-4246	34	4	-	-	PUNCT
dpc-4246	34	5	inflammation	inflammation	NOUN
dpc-4246	34	6	index	index	NOUN
dpc-4246	34	7	(	(	PUNCT
dpc-4246	34	8	sii	sii	ADJ
dpc-4246	34	9	:	:	PUNCT
dpc-4246	34	10	platelet	platelet	NOUN
dpc-4246	34	11	count	count	NOUN
dpc-4246	34	12	×	×	NOUN
dpc-4246	34	13	neutrophil	neutrophil	ADJ
dpc-4246	34	14	-	-	PUNCT
dpc-4246	34	15	lymphocyte	lymphocyte	NOUN
dpc-4246	34	16	ratio	ratio	NOUN
dpc-4246	34	17	)	)	PUNCT
dpc-4246	34	18	is	be	AUX
dpc-4246	34	19	a	a	DET
dpc-4246	34	20	novel	novel	ADJ
dpc-4246	34	21	marker	marker	NOUN
dpc-4246	34	22	,	,	PUNCT
dpc-4246	34	23	developed	develop	VERB
dpc-4246	34	24	in	in	ADP
dpc-4246	34	25	2014	2014	NUM
dpc-4246	34	26	by	by	ADP
dpc-4246	34	27	hu	hu	PROPN
dpc-4246	34	28	and	and	CCONJ
dpc-4246	34	29	colleagues	colleague	NOUN
dpc-4246	34	30	to	to	PART
dpc-4246	34	31	evaluate	evaluate	VERB
dpc-4246	34	32	hepatocellular	hepatocellular	ADJ
dpc-4246	34	33	cancer	cancer	NOUN
dpc-4246	34	34	severity	severity	NOUN
dpc-4246	34	35	.	.	PUNCT
dpc-4246	35	1	sii	sii	PROPN
dpc-4246	35	2	has	have	AUX
dpc-4246	35	3	been	be	AUX
dpc-4246	35	4	used	use	VERB
dpc-4246	35	5	to	to	PART
dpc-4246	35	6	assess	assess	VERB
dpc-4246	35	7	the	the	DET
dpc-4246	35	8	severity	severity	NOUN
dpc-4246	35	9	of	of	ADP
dpc-4246	35	10	various	various	ADJ
dpc-4246	35	11	inflammatory	inflammatory	ADJ
dpc-4246	35	12	conditions	condition	NOUN
dpc-4246	35	13	,	,	PUNCT
dpc-4246	35	14	including	include	VERB
dpc-4246	35	15	acne	acne	NOUN
dpc-4246	35	16	vulgaris	vulgaris	NOUN
dpc-4246	35	17	,	,	PUNCT
dpc-4246	35	18	rosacea	rosacea	NOUN
dpc-4246	35	19	,	,	PUNCT
dpc-4246	35	20	psoriasis	psoriasis	NOUN
dpc-4246	35	21	,	,	PUNCT
dpc-4246	35	22	psoriatic	psoriatic	ADJ
dpc-4246	35	23	arthritis	arthritis	NOUN
dpc-4246	35	24	,	,	PUNCT
dpc-4246	35	25	and	and	CCONJ
dpc-4246	35	26	behçet	behçet	ADJ
dpc-4246	35	27	disease	disease	NOUN
dpc-4246	35	28	[	[	X
dpc-4246	35	29	3	3	NUM
dpc-4246	35	30	-	-	SYM
dpc-4246	35	31	5	5	NUM
dpc-4246	35	32	]	]	PUNCT
dpc-4246	35	33	.	.	PUNCT
dpc-4246	36	1	moreover	moreover	ADV
dpc-4246	36	2	,	,	PUNCT
dpc-4246	36	3	mean	mean	ADJ
dpc-4246	36	4	platelet	platelet	NOUN
dpc-4246	36	5	volume	volume	NOUN
dpc-4246	36	6	(	(	PUNCT
dpc-4246	36	7	mpv	mpv	PROPN
dpc-4246	36	8	)	)	PUNCT
dpc-4246	36	9	,	,	PUNCT
dpc-4246	36	10	monocyte	monocyte	PROPN
dpc-4246	36	11	-	-	PUNCT
dpc-4246	36	12	hdl	hdl	NOUN
dpc-4246	36	13	ratio	ratio	NOUN
dpc-4246	36	14	(	(	PUNCT
dpc-4246	36	15	mhr	mhr	PROPN
dpc-4246	36	16	)	)	PUNCT
dpc-4246	36	17	,	,	PUNCT
dpc-4246	36	18	monocyte	monocyte	ADJ
dpc-4246	36	19	-	-	PUNCT
dpc-4246	36	20	lymphocyte	lymphocyte	ADJ
dpc-4246	36	21	ratio	ratio	NOUN
dpc-4246	36	22	(	(	PUNCT
dpc-4246	36	23	mlr	mlr	NOUN
dpc-4246	36	24	)	)	PUNCT
dpc-4246	36	25	,	,	PUNCT
dpc-4246	36	26	and	and	CCONJ
dpc-4246	36	27	neutrophil	neutrophil	ADJ
dpc-4246	36	28	-	-	PUNCT
dpc-4246	36	29	lymphocyte	lymphocyte	ADJ
dpc-4246	36	30	ratio	ratio	NOUN
dpc-4246	36	31	(	(	PUNCT
dpc-4246	36	32	nlr	nlr	PROPN
dpc-4246	36	33	)	)	PUNCT
dpc-4246	36	34	are	be	AUX
dpc-4246	36	35	hematologic	hematologic	ADJ
dpc-4246	36	36	markers	marker	NOUN
dpc-4246	36	37	that	that	PRON
dpc-4246	36	38	have	have	AUX
dpc-4246	36	39	been	be	AUX
dpc-4246	36	40	shown	show	VERB
dpc-4246	36	41	to	to	PART
dpc-4246	36	42	increase	increase	VERB
dpc-4246	36	43	in	in	ADP
dpc-4246	36	44	inflammatory	inflammatory	ADJ
dpc-4246	36	45	diseases	disease	NOUN
dpc-4246	36	46	like	like	ADP
dpc-4246	36	47	psoriasis	psoriasis	NOUN
dpc-4246	36	48	and	and	CCONJ
dpc-4246	36	49	acne	acne	NOUN
dpc-4246	36	50	vulgaris	vulgaris	NOUN
dpc-4246	36	51	,	,	PUNCT
dpc-4246	36	52	serving	serve	VERB
dpc-4246	36	53	as	as	ADP
dpc-4246	36	54	indicators	indicator	NOUN
dpc-4246	36	55	of	of	ADP
dpc-4246	36	56	disease	disease	NOUN
dpc-4246	36	57	severity	severity	NOUN
dpc-4246	36	58	[	[	X
dpc-4246	36	59	5,6	5,6	NUM
dpc-4246	36	60	]	]	X
dpc-4246	36	61	.	.	PUNCT
dpc-4246	37	1	the	the	DET
dpc-4246	37	2	objective	objective	NOUN
dpc-4246	37	3	of	of	ADP
dpc-4246	37	4	this	this	DET
dpc-4246	37	5	study	study	NOUN
dpc-4246	37	6	was	be	AUX
dpc-4246	37	7	to	to	PART
dpc-4246	37	8	compare	compare	VERB
dpc-4246	37	9	the	the	DET
dpc-4246	37	10	levels	level	NOUN
dpc-4246	37	11	of	of	ADP
dpc-4246	37	12	inflammatory	inflammatory	ADJ
dpc-4246	37	13	markers	marker	NOUN
dpc-4246	37	14	before	before	ADV
dpc-4246	37	15	and	and	CCONJ
dpc-4246	37	16	at	at	ADP
dpc-4246	37	17	the	the	DET
dpc-4246	37	18	third	third	ADJ
dpc-4246	37	19	month	month	NOUN
dpc-4246	37	20	of	of	ADP
dpc-4246	37	21	treatment	treatment	NOUN
dpc-4246	37	22	of	of	ADP
dpc-4246	37	23	aa	aa	NOUN
dpc-4246	37	24	patients	patient	NOUN
dpc-4246	37	25	.	.	PUNCT
dpc-4246	38	1	this	this	DET
dpc-4246	38	2	study	study	NOUN
dpc-4246	38	3	also	also	ADV
dpc-4246	38	4	aimed	aim	VERB
dpc-4246	38	5	to	to	PART
dpc-4246	38	6	investigate	investigate	VERB
dpc-4246	38	7	the	the	DET
dpc-4246	38	8	utility	utility	NOUN
dpc-4246	38	9	of	of	ADP
dpc-4246	38	10	sii	sii	PROPN
dpc-4246	38	11	in	in	ADP
dpc-4246	38	12	assessing	assess	VERB
dpc-4246	38	13	disease	disease	NOUN
dpc-4246	38	14	severity	severity	NOUN
dpc-4246	38	15	and	and	CCONJ
dpc-4246	38	16	treatment	treatment	NOUN
dpc-4246	38	17	response	response	NOUN
dpc-4246	38	18	in	in	ADP
dpc-4246	38	19	aa	aa	PROPN
dpc-4246	38	20	patients	patient	NOUN
dpc-4246	38	21	.	.	PUNCT
dpc-4246	39	1	methods	method	NOUN
dpc-4246	39	2	the	the	DET
dpc-4246	39	3	institutional	institutional	ADJ
dpc-4246	39	4	ethics	ethic	NOUN
dpc-4246	39	5	committee	committee	PROPN
dpc-4246	39	6	of	of	ADP
dpc-4246	39	7	ankara	ankara	PROPN
dpc-4246	39	8	training	training	NOUN
dpc-4246	39	9	and	and	CCONJ
dpc-4246	39	10	research	research	NOUN
dpc-4246	39	11	hospital	hospital	NOUN
dpc-4246	39	12	approved	approve	VERB
dpc-4246	39	13	the	the	DET
dpc-4246	39	14	study	study	NOUN
dpc-4246	39	15	(	(	PUNCT
dpc-4246	39	16	23	23	NUM
dpc-4246	39	17	-	-	SYM
dpc-4246	39	18	1187	1187	NUM
dpc-4246	39	19	)	)	PUNCT
dpc-4246	39	20	.	.	PUNCT
dpc-4246	40	1	the	the	DET
dpc-4246	40	2	study	study	NOUN
dpc-4246	40	3	included	include	VERB
dpc-4246	40	4	60	60	NUM
dpc-4246	40	5	aa	aa	NOUN
dpc-4246	40	6	patients	patient	NOUN
dpc-4246	40	7	,	,	PUNCT
dpc-4246	40	8	aged	aged	ADJ
dpc-4246	40	9	18–65	18–65	NUM
dpc-4246	40	10	,	,	PUNCT
dpc-4246	40	11	who	who	PRON
dpc-4246	40	12	presented	present	VERB
dpc-4246	40	13	to	to	ADP
dpc-4246	40	14	the	the	DET
dpc-4246	40	15	dermatology	dermatology	NOUN
dpc-4246	40	16	outpatient	outpatient	NOUN
dpc-4246	40	17	clinic	clinic	NOUN
dpc-4246	40	18	of	of	ADP
dpc-4246	40	19	the	the	DET
dpc-4246	40	20	ankara	ankara	PROPN
dpc-4246	40	21	training	training	NOUN
dpc-4246	40	22	and	and	CCONJ
dpc-4246	40	23	research	research	NOUN
dpc-4246	40	24	hospital	hospital	NOUN
dpc-4246	40	25	between	between	ADP
dpc-4246	40	26	november	november	PROPN
dpc-4246	40	27	2022	2022	NUM
dpc-4246	40	28	and	and	CCONJ
dpc-4246	40	29	april	april	PROPN
dpc-4246	40	30	2023	2023	NUM
dpc-4246	40	31	.	.	PUNCT
dpc-4246	41	1	additionally	additionally	ADV
dpc-4246	41	2	,	,	PUNCT
dpc-4246	41	3	40	40	NUM
dpc-4246	41	4	control	control	NOUN
dpc-4246	41	5	patients	patient	NOUN
dpc-4246	41	6	,	,	PUNCT
dpc-4246	41	7	matched	match	VERB
dpc-4246	41	8	for	for	ADP
dpc-4246	41	9	age	age	NOUN
dpc-4246	41	10	and	and	CCONJ
dpc-4246	41	11	sex	sex	NOUN
dpc-4246	41	12	,	,	PUNCT
dpc-4246	41	13	were	be	AUX
dpc-4246	41	14	included	include	VERB
dpc-4246	41	15	.	.	PUNCT
dpc-4246	42	1	exclusion	exclusion	NOUN
dpc-4246	42	2	criteria	criterion	NOUN
dpc-4246	42	3	included	include	VERB
dpc-4246	42	4	patients	patient	NOUN
dpc-4246	42	5	with	with	ADP
dpc-4246	42	6	systemic	systemic	ADJ
dpc-4246	42	7	diseases	disease	NOUN
dpc-4246	42	8	,	,	PUNCT
dpc-4246	42	9	active	active	ADJ
dpc-4246	42	10	infections	infection	NOUN
dpc-4246	42	11	,	,	PUNCT
dpc-4246	42	12	malignancies	malignancy	NOUN
dpc-4246	42	13	,	,	PUNCT
dpc-4246	42	14	hematological	hematological	ADJ
dpc-4246	42	15	disorders	disorder	NOUN
dpc-4246	42	16	,	,	PUNCT
dpc-4246	42	17	pregnancy	pregnancy	NOUN
dpc-4246	42	18	,	,	PUNCT
dpc-4246	42	19	and	and	CCONJ
dpc-4246	42	20	breastfeeding	breastfeed	VERB
dpc-4246	42	21	.	.	PUNCT
dpc-4246	43	1	in	in	ADP
dpc-4246	43	2	the	the	DET
dpc-4246	43	3	aa	aa	PROPN
dpc-4246	43	4	group	group	NOUN
dpc-4246	43	5	,	,	PUNCT
dpc-4246	43	6	serum	serum	VERB
dpc-4246	43	7	inflammatory	inflammatory	ADJ
dpc-4246	43	8	markers	marker	NOUN
dpc-4246	43	9	were	be	AUX
dpc-4246	43	10	recorded	record	VERB
dpc-4246	43	11	before	before	ADV
dpc-4246	43	12	and	and	CCONJ
dpc-4246	43	13	at	at	ADP
dpc-4246	43	14	the	the	DET
dpc-4246	43	15	third	third	ADJ
dpc-4246	43	16	month	month	NOUN
dpc-4246	43	17	of	of	ADP
dpc-4246	43	18	intralesional	intralesional	ADJ
dpc-4246	43	19	triamcinolone	triamcinolone	NOUN
dpc-4246	43	20	acetonide	acetonide	ADJ
dpc-4246	43	21	treatment	treatment	NOUN
dpc-4246	43	22	.	.	PUNCT
dpc-4246	44	1	the	the	DET
dpc-4246	44	2	severity	severity	NOUN
dpc-4246	44	3	of	of	ADP
dpc-4246	44	4	alopecia	alopecia	NOUN
dpc-4246	44	5	tool	tool	NOUN
dpc-4246	44	6	(	(	PUNCT
dpc-4246	44	7	salt	salt	NOUN
dpc-4246	44	8	)	)	PUNCT
dpc-4246	44	9	score	score	NOUN
dpc-4246	44	10	was	be	AUX
dpc-4246	44	11	calculated	calculate	VERB
dpc-4246	44	12	for	for	ADP
dpc-4246	44	13	aa	aa	PROPN
dpc-4246	44	14	patients	patient	NOUN
dpc-4246	44	15	before	before	ADP
dpc-4246	44	16	and	and	CCONJ
dpc-4246	44	17	at	at	ADP
dpc-4246	44	18	the	the	DET
dpc-4246	44	19	third	third	ADJ
dpc-4246	44	20	month	month	NOUN
dpc-4246	44	21	of	of	ADP
dpc-4246	44	22	treatment	treatment	NOUN
dpc-4246	44	23	.	.	PUNCT
dpc-4246	45	1	all	all	DET
dpc-4246	45	2	data	datum	NOUN
dpc-4246	45	3	were	be	AUX
dpc-4246	45	4	analyzed	analyze	VERB
dpc-4246	45	5	by	by	ADP
dpc-4246	45	6	using	use	VERB
dpc-4246	45	7	spss	spss	PROPN
dpc-4246	45	8	(	(	PUNCT
dpc-4246	45	9	statistical	statistical	ADJ
dpc-4246	45	10	package	package	NOUN
dpc-4246	45	11	for	for	ADP
dpc-4246	45	12	social	social	ADJ
dpc-4246	45	13	sciences	science	NOUN
dpc-4246	45	14	)	)	PUNCT
dpc-4246	45	15	for	for	ADP
dpc-4246	45	16	windows	window	NOUN
dpc-4246	45	17	22.0	22.0	NUM
dpc-4246	45	18	.	.	PUNCT
dpc-4246	46	1	students	student	NOUN
dpc-4246	46	2	t	t	NOUN
dpc-4246	46	3	-	-	PUNCT
dpc-4246	46	4	test	test	NOUN
dpc-4246	46	5	and	and	CCONJ
dpc-4246	46	6	mann	mann	PROPN
dpc-4246	46	7	-	-	PUNCT
dpc-4246	46	8	whitney	whitney	PROPN
dpc-4246	46	9	u	u	NOUN
dpc-4246	46	10	-	-	NOUN
dpc-4246	46	11	test	test	NOUN
dpc-4246	46	12	were	be	AUX
dpc-4246	46	13	used	use	VERB
dpc-4246	46	14	to	to	PART
dpc-4246	46	15	compare	compare	VERB
dpc-4246	46	16	the	the	DET
dpc-4246	46	17	data	datum	NOUN
dpc-4246	46	18	of	of	ADP
dpc-4246	46	19	the	the	DET
dpc-4246	46	20	two	two	NUM
dpc-4246	46	21	groups	group	NOUN
dpc-4246	46	22	.	.	PUNCT
dpc-4246	47	1	spearman	spearman	NOUN
dpc-4246	47	2	rho	rho	ADJ
dpc-4246	47	3	correlation	correlation	NOUN
dpc-4246	47	4	analysis	analysis	NOUN
dpc-4246	47	5	was	be	AUX
dpc-4246	47	6	used	use	VERB
dpc-4246	47	7	to	to	PART
dpc-4246	47	8	examine	examine	VERB
dpc-4246	47	9	relationships	relationship	NOUN
dpc-4246	47	10	.	.	PUNCT
dpc-4246	48	1	significance	significance	NOUN
dpc-4246	48	2	was	be	AUX
dpc-4246	48	3	evaluated	evaluate	VERB
dpc-4246	48	4	at	at	ADP
dpc-4246	48	5	the	the	DET
dpc-4246	48	6	p	p	X
dpc-4246	48	7	<	<	X
dpc-4246	48	8	0.05	0.05	NUM
dpc-4246	48	9	level	level	NOUN
dpc-4246	48	10	.	.	PUNCT
dpc-4246	49	1	all	all	DET
dpc-4246	49	2	participants	participant	NOUN
dpc-4246	49	3	were	be	AUX
dpc-4246	49	4	informed	inform	VERB
dpc-4246	49	5	about	about	ADP
dpc-4246	49	6	the	the	DET
dpc-4246	49	7	study	study	NOUN
dpc-4246	49	8	,	,	PUNCT
dpc-4246	49	9	and	and	CCONJ
dpc-4246	49	10	written	write	VERB
dpc-4246	49	11	informed	informed	ADJ
dpc-4246	49	12	consent	consent	NOUN
dpc-4246	49	13	was	be	AUX
dpc-4246	49	14	obtained	obtain	VERB
dpc-4246	49	15	.	.	PUNCT
dpc-4246	50	1	the	the	DET
dpc-4246	50	2	study	study	NOUN
dpc-4246	50	3	was	be	AUX
dpc-4246	50	4	performed	perform	VERB
dpc-4246	50	5	following	follow	VERB
dpc-4246	50	6	the	the	DET
dpc-4246	50	7	latest	late	ADJ
dpc-4246	50	8	version	version	NOUN
dpc-4246	50	9	of	of	ADP
dpc-4246	50	10	the	the	DET
dpc-4246	50	11	helsinki	helsinki	PROPN
dpc-4246	50	12	declaration	declaration	PROPN
dpc-4246	50	13	and	and	CCONJ
dpc-4246	50	14	guidelines	guideline	NOUN
dpc-4246	50	15	for	for	ADP
dpc-4246	50	16	good	good	ADJ
dpc-4246	50	17	clinical	clinical	ADJ
dpc-4246	50	18	practice	practice	NOUN
dpc-4246	50	19	.	.	PUNCT
dpc-4246	51	1	results	result	VERB
dpc-4246	51	2	this	this	DET
dpc-4246	51	3	study	study	NOUN
dpc-4246	51	4	included	include	VERB
dpc-4246	51	5	100	100	NUM
dpc-4246	51	6	patients	patient	NOUN
dpc-4246	51	7	,	,	PUNCT
dpc-4246	51	8	consisting	consist	VERB
dpc-4246	51	9	of	of	ADP
dpc-4246	51	10	60	60	NUM
dpc-4246	51	11	aa	aa	NOUN
dpc-4246	51	12	patients	patient	NOUN
dpc-4246	51	13	(	(	PUNCT
dpc-4246	51	14	58.3	58.3	NUM
dpc-4246	51	15	%	%	NOUN
dpc-4246	51	16	male	male	NOUN
dpc-4246	51	17	,	,	PUNCT
dpc-4246	51	18	41.7	41.7	NUM
dpc-4246	51	19	%	%	NOUN
dpc-4246	51	20	female	female	NOUN
dpc-4246	51	21	)	)	PUNCT
dpc-4246	51	22	and	and	CCONJ
dpc-4246	51	23	40	40	NUM
dpc-4246	51	24	patients	patient	NOUN
dpc-4246	51	25	for	for	ADP
dpc-4246	51	26	the	the	DET
dpc-4246	51	27	control	control	NOUN
dpc-4246	51	28	group	group	NOUN
dpc-4246	51	29	(	(	PUNCT
dpc-4246	51	30	45	45	NUM
dpc-4246	51	31	%	%	NOUN
dpc-4246	51	32	male	male	NOUN
dpc-4246	51	33	,	,	PUNCT
dpc-4246	51	34	55	55	NUM
dpc-4246	51	35	%	%	NOUN
dpc-4246	51	36	female	female	NOUN
dpc-4246	51	37	)	)	PUNCT
dpc-4246	51	38	.	.	PUNCT
dpc-4246	52	1	the	the	DET
dpc-4246	52	2	average	average	ADJ
dpc-4246	52	3	ages	age	NOUN
dpc-4246	52	4	of	of	ADP
dpc-4246	52	5	the	the	DET
dpc-4246	52	6	aa	aa	PROPN
dpc-4246	52	7	group	group	PROPN
dpc-4246	52	8	and	and	CCONJ
dpc-4246	52	9	control	control	PROPN
dpc-4246	52	10	group	group	NOUN
dpc-4246	52	11	were	be	AUX
dpc-4246	52	12	28.93	28.93	NUM
dpc-4246	52	13	and	and	CCONJ
dpc-4246	52	14	40.85	40.85	NUM
dpc-4246	52	15	,	,	PUNCT
dpc-4246	52	16	respectively	respectively	ADV
dpc-4246	52	17	.	.	PUNCT
dpc-4246	53	1	the	the	DET
dpc-4246	53	2	mean	mean	ADJ
dpc-4246	53	3	age	age	NOUN
dpc-4246	53	4	of	of	ADP
dpc-4246	53	5	the	the	DET
dpc-4246	53	6	aa	aa	PROPN
dpc-4246	53	7	group	group	NOUN
dpc-4246	53	8	was	be	AUX
dpc-4246	53	9	significantly	significantly	ADV
dpc-4246	53	10	lower	low	ADJ
dpc-4246	53	11	than	than	ADP
dpc-4246	53	12	that	that	PRON
dpc-4246	53	13	of	of	ADP
dpc-4246	53	14	the	the	DET
dpc-4246	53	15	control	control	NOUN
dpc-4246	53	16	group	group	NOUN
dpc-4246	53	17	(	(	PUNCT
dpc-4246	53	18	p	p	X
dpc-4246	53	19	:	:	PUNCT
dpc-4246	53	20	0.001	0.001	NUM
dpc-4246	53	21	;	;	PUNCT
dpc-4246	53	22	p	p	X
dpc-4246	53	23	<	<	X
dpc-4246	53	24	0.05	0.05	NUM
dpc-4246	53	25	)	)	PUNCT
dpc-4246	53	26	.	.	PUNCT
dpc-4246	54	1	there	there	PRON
dpc-4246	54	2	was	be	VERB
dpc-4246	54	3	no	no	DET
dpc-4246	54	4	statistically	statistically	ADV
dpc-4246	54	5	significant	significant	ADJ
dpc-4246	54	6	difference	difference	NOUN
dpc-4246	54	7	in	in	ADP
dpc-4246	54	8	terms	term	NOUN
dpc-4246	54	9	of	of	ADP
dpc-4246	54	10	sex	sex	NOUN
dpc-4246	54	11	distribution	distribution	NOUN
dpc-4246	54	12	between	between	ADP
dpc-4246	54	13	the	the	DET
dpc-4246	54	14	two	two	NUM
dpc-4246	54	15	groups	group	NOUN
dpc-4246	54	16	(	(	PUNCT
dpc-4246	54	17	p	p	X
dpc-4246	54	18	>	>	X
dpc-4246	54	19	0.05	0.05	NUM
dpc-4246	54	20	)	)	PUNCT
dpc-4246	54	21	.	.	PUNCT
dpc-4246	55	1	among	among	ADP
dpc-4246	55	2	the	the	DET
dpc-4246	55	3	60	60	NUM
dpc-4246	55	4	aa	aa	NOUN
dpc-4246	55	5	patients	patient	NOUN
dpc-4246	55	6	,	,	PUNCT
dpc-4246	55	7	six	six	NUM
dpc-4246	55	8	individuals	individual	NOUN
dpc-4246	55	9	(	(	PUNCT
dpc-4246	55	10	10	10	NUM
dpc-4246	55	11	%	%	NOUN
dpc-4246	55	12	)	)	PUNCT
dpc-4246	55	13	had	have	AUX
dpc-4246	55	14	coexisting	coexist	VERB
dpc-4246	55	15	diseases	disease	NOUN
dpc-4246	55	16	and	and	CCONJ
dpc-4246	55	17	were	be	AUX
dpc-4246	55	18	taking	take	VERB
dpc-4246	55	19	medications	medication	NOUN
dpc-4246	55	20	(	(	PUNCT
dpc-4246	55	21	table	table	NOUN
dpc-4246	55	22	1	1	NUM
dpc-4246	55	23	)	)	PUNCT
dpc-4246	55	24	.	.	PUNCT
dpc-4246	56	1	the	the	DET
dpc-4246	56	2	pre	pre	ADJ
dpc-4246	56	3	-	-	ADJ
dpc-4246	56	4	treatment	treatment	ADJ
dpc-4246	56	5	parameters	parameter	NOUN
dpc-4246	56	6	of	of	ADP
dpc-4246	56	7	the	the	DET
dpc-4246	56	8	aa	aa	PROPN
dpc-4246	56	9	patient	patient	PROPN
dpc-4246	56	10	group	group	NOUN
dpc-4246	56	11	were	be	AUX
dpc-4246	56	12	compared	compare	VERB
dpc-4246	56	13	with	with	ADP
dpc-4246	56	14	the	the	DET
dpc-4246	56	15	control	control	NOUN
dpc-4246	56	16	group	group	NOUN
dpc-4246	56	17	.	.	PUNCT
dpc-4246	57	1	neutrophil	neutrophil	ADJ
dpc-4246	57	2	lymphocyte	lymphocyte	ADJ
dpc-4246	57	3	ratio	ratio	NOUN
dpc-4246	57	4	(	(	PUNCT
dpc-4246	57	5	nlr	nlr	PROPN
dpc-4246	57	6	)	)	PUNCT
dpc-4246	57	7	in	in	ADP
dpc-4246	57	8	the	the	DET
dpc-4246	57	9	patient	patient	NOUN
dpc-4246	57	10	group	group	NOUN
dpc-4246	57	11	was	be	AUX
dpc-4246	57	12	2.09	2.09	NUM
dpc-4246	57	13	,	,	PUNCT
dpc-4246	57	14	while	while	SCONJ
dpc-4246	57	15	it	it	PRON
dpc-4246	57	16	was	be	AUX
dpc-4246	57	17	1.73	1.73	NUM
dpc-4246	57	18	in	in	ADP
dpc-4246	57	19	the	the	DET
dpc-4246	57	20	control	control	NOUN
dpc-4246	57	21	group	group	NOUN
dpc-4246	57	22	.	.	PUNCT
dpc-4246	58	1	the	the	DET
dpc-4246	58	2	mpv	mpv	PROPN
dpc-4246	58	3	for	for	ADP
dpc-4246	58	4	the	the	DET
dpc-4246	58	5	patient	patient	NOUN
dpc-4246	58	6	group	group	NOUN
dpc-4246	58	7	was	be	AUX
dpc-4246	58	8	10.31	10.31	NUM
dpc-4246	58	9	,	,	PUNCT
dpc-4246	58	10	while	while	SCONJ
dpc-4246	58	11	in	in	ADP
dpc-4246	58	12	the	the	DET
dpc-4246	58	13	control	control	NOUN
dpc-4246	58	14	group	group	NOUN
dpc-4246	58	15	,	,	PUNCT
dpc-4246	58	16	it	it	PRON
dpc-4246	58	17	was	be	AUX
dpc-4246	58	18	9.65	9.65	NUM
dpc-4246	58	19	.	.	PUNCT
dpc-4246	59	1	the	the	DET
dpc-4246	59	2	sii	sii	PROPN
dpc-4246	59	3	for	for	ADP
dpc-4246	59	4	the	the	DET
dpc-4246	59	5	patient	patient	NOUN
dpc-4246	59	6	group	group	NOUN
dpc-4246	59	7	was	be	AUX
dpc-4246	59	8	562	562	NUM
dpc-4246	59	9	,	,	PUNCT
dpc-4246	59	10	whereas	whereas	SCONJ
dpc-4246	59	11	it	it	PRON
dpc-4246	59	12	was	be	AUX
dpc-4246	59	13	455	455	NUM
dpc-4246	59	14	in	in	ADP
dpc-4246	59	15	the	the	DET
dpc-4246	59	16	control	control	NOUN
dpc-4246	59	17	group	group	NOUN
dpc-4246	59	18	.	.	PUNCT
dpc-4246	60	1	the	the	DET
dpc-4246	60	2	nlr	nlr	PROPN
dpc-4246	60	3	,	,	PUNCT
dpc-4246	60	4	mpv	mpv	PROPN
dpc-4246	60	5	,	,	PUNCT
dpc-4246	60	6	and	and	CCONJ
dpc-4246	60	7	sii	sii	ADV
dpc-4246	60	8	in	in	ADP
dpc-4246	60	9	the	the	DET
dpc-4246	60	10	patient	patient	NOUN
dpc-4246	60	11	group	group	NOUN
dpc-4246	60	12	were	be	AUX
dpc-4246	60	13	statistically	statistically	ADV
dpc-4246	60	14	significantly	significantly	ADV
dpc-4246	60	15	higher	high	ADJ
dpc-4246	60	16	than	than	ADP
dpc-4246	60	17	those	those	PRON
dpc-4246	60	18	in	in	ADP
dpc-4246	60	19	the	the	DET
dpc-4246	60	20	control	control	NOUN
dpc-4246	60	21	group	group	NOUN
dpc-4246	60	22	(	(	PUNCT
dpc-4246	60	23	p	p	X
dpc-4246	60	24	<	<	X
dpc-4246	60	25	0.05	0.05	NUM
dpc-4246	60	26	)	)	PUNCT
dpc-4246	60	27	.	.	PUNCT
dpc-4246	61	1	the	the	DET
dpc-4246	61	2	hdl	hdl	PROPN
dpc-4246	61	3	for	for	ADP
dpc-4246	61	4	the	the	DET
dpc-4246	61	5	patient	patient	ADJ
dpc-4246	61	6	and	and	CCONJ
dpc-4246	61	7	control	control	NOUN
dpc-4246	61	8	groups	group	NOUN
dpc-4246	61	9	were	be	AUX
dpc-4246	61	10	50.4	50.4	NUM
dpc-4246	61	11	and	and	CCONJ
dpc-4246	61	12	55.88	55.88	NUM
dpc-4246	61	13	,	,	PUNCT
dpc-4246	61	14	respectively	respectively	ADV
dpc-4246	61	15	.	.	PUNCT
dpc-4246	62	1	the	the	DET
dpc-4246	62	2	hdl	hdl	NOUN
dpc-4246	62	3	in	in	ADP
dpc-4246	62	4	the	the	DET
dpc-4246	62	5	patient	patient	NOUN
dpc-4246	62	6	group	group	NOUN
dpc-4246	62	7	was	be	AUX
dpc-4246	62	8	statistically	statistically	ADV
dpc-4246	62	9	significantly	significantly	ADV
dpc-4246	62	10	lower	low	ADJ
dpc-4246	62	11	than	than	ADP
dpc-4246	62	12	that	that	PRON
dpc-4246	62	13	in	in	ADP
dpc-4246	62	14	the	the	DET
dpc-4246	62	15	control	control	NOUN
dpc-4246	62	16	group	group	NOUN
dpc-4246	62	17	(	(	PUNCT
dpc-4246	62	18	p	p	X
dpc-4246	62	19	:	:	PUNCT
dpc-4246	62	20	0.015	0.015	NUM
dpc-4246	62	21	;	;	PUNCT
dpc-4246	62	22	p	p	X
dpc-4246	62	23	<	<	X
dpc-4246	62	24	0.05	0.05	NUM
dpc-4246	62	25	)	)	PUNCT
dpc-4246	62	26	.	.	PUNCT
dpc-4246	63	1	there	there	PRON
dpc-4246	63	2	were	be	VERB
dpc-4246	63	3	no	no	DET
dpc-4246	63	4	statistically	statistically	ADV
dpc-4246	63	5	significant	significant	ADJ
dpc-4246	63	6	differences	difference	NOUN
dpc-4246	63	7	between	between	ADP
dpc-4246	63	8	the	the	DET
dpc-4246	63	9	two	two	NUM
dpc-4246	63	10	groups	group	NOUN
dpc-4246	63	11	in	in	ADP
dpc-4246	63	12	terms	term	NOUN
dpc-4246	63	13	of	of	ADP
dpc-4246	63	14	other	other	ADJ
dpc-4246	63	15	hematologic	hematologic	NOUN
dpc-4246	63	16	parameters	parameter	NOUN
dpc-4246	63	17	(	(	PUNCT
dpc-4246	63	18	p	p	X
dpc-4246	63	19	>	>	X
dpc-4246	63	20	0.05	0.05	NUM
dpc-4246	63	21	)	)	PUNCT
dpc-4246	63	22	(	(	PUNCT
dpc-4246	63	23	table	table	NOUN
dpc-4246	63	24	1	1	NUM
dpc-4246	63	25	)	)	PUNCT
dpc-4246	63	26	.	.	PUNCT
dpc-4246	64	1	parameters	parameter	NOUN
dpc-4246	64	2	before	before	ADP
dpc-4246	64	3	and	and	CCONJ
dpc-4246	64	4	at	at	ADP
dpc-4246	64	5	the	the	DET
dpc-4246	64	6	third	third	ADJ
dpc-4246	64	7	month	month	NOUN
dpc-4246	64	8	of	of	ADP
dpc-4246	64	9	treatment	treatment	NOUN
dpc-4246	64	10	in	in	ADP
dpc-4246	64	11	the	the	DET
dpc-4246	64	12	aa	aa	PROPN
dpc-4246	64	13	group	group	NOUN
dpc-4246	64	14	were	be	AUX
dpc-4246	64	15	compared	compare	VERB
dpc-4246	64	16	.	.	PUNCT
dpc-4246	65	1	before	before	ADP
dpc-4246	65	2	treatment	treatment	NOUN
dpc-4246	65	3	,	,	PUNCT
dpc-4246	65	4	the	the	DET
dpc-4246	65	5	average	average	ADJ
dpc-4246	65	6	erythrocyte	erythrocyte	NOUN
dpc-4246	65	7	sedimentation	sedimentation	NOUN
dpc-4246	65	8	rate	rate	NOUN
dpc-4246	65	9	(	(	PUNCT
dpc-4246	65	10	esr	esr	PROPN
dpc-4246	65	11	)	)	PUNCT
dpc-4246	65	12	was	be	AUX
dpc-4246	65	13	7.27	7.27	NUM
dpc-4246	65	14	,	,	PUNCT
dpc-4246	65	15	which	which	PRON
dpc-4246	65	16	decreased	decrease	VERB
dpc-4246	65	17	to	to	ADP
dpc-4246	65	18	4.63	4.63	NUM
dpc-4246	65	19	in	in	ADP
dpc-4246	65	20	the	the	DET
dpc-4246	65	21	third	third	ADJ
dpc-4246	65	22	month	month	NOUN
dpc-4246	65	23	of	of	ADP
dpc-4246	65	24	treatment	treatment	NOUN
dpc-4246	65	25	.	.	PUNCT
dpc-4246	66	1	the	the	DET
dpc-4246	66	2	average	average	ADJ
dpc-4246	66	3	c	c	NOUN
dpc-4246	66	4	-	-	ADJ
dpc-4246	66	5	reactive	reactive	ADJ
dpc-4246	66	6	protein	protein	NOUN
dpc-4246	66	7	(	(	PUNCT
dpc-4246	66	8	crp	crp	NOUN
dpc-4246	66	9	)	)	PUNCT
dpc-4246	66	10	before	before	ADP
dpc-4246	66	11	treatment	treatment	NOUN
dpc-4246	66	12	was	be	AUX
dpc-4246	66	13	4.31	4.31	NUM
dpc-4246	66	14	,	,	PUNCT
dpc-4246	66	15	which	which	PRON
dpc-4246	66	16	decreased	decrease	VERB
dpc-4246	66	17	to	to	ADP
dpc-4246	66	18	1.6	1.6	NUM
dpc-4246	66	19	in	in	ADP
dpc-4246	66	20	the	the	DET
dpc-4246	66	21	third	third	ADJ
dpc-4246	66	22	month	month	NOUN
dpc-4246	66	23	of	of	ADP
dpc-4246	66	24	treatment	treatment	NOUN
dpc-4246	66	25	.	.	PUNCT
dpc-4246	67	1	the	the	DET
dpc-4246	67	2	decline	decline	NOUN
dpc-4246	67	3	observed	observe	VERB
dpc-4246	67	4	in	in	ADP
dpc-4246	67	5	esr	esr	PROPN
dpc-4246	67	6	and	and	CCONJ
dpc-4246	67	7	crp	crp	PROPN
dpc-4246	67	8	values	value	NOUN
dpc-4246	67	9	in	in	ADP
dpc-4246	67	10	the	the	DET
dpc-4246	67	11	third	third	ADJ
dpc-4246	67	12	month	month	NOUN
dpc-4246	67	13	of	of	ADP
dpc-4246	67	14	treatment	treatment	NOUN
dpc-4246	67	15	was	be	AUX
dpc-4246	67	16	found	find	VERB
dpc-4246	67	17	to	to	PART
dpc-4246	67	18	be	be	AUX
dpc-4246	67	19	statistically	statistically	ADV
dpc-4246	67	20	significant	significant	ADJ
dpc-4246	67	21	(	(	PUNCT
dpc-4246	67	22	p	p	X
dpc-4246	67	23	:	:	PUNCT
dpc-4246	67	24	0.001	0.001	NUM
dpc-4246	67	25	;	;	PUNCT
dpc-4246	67	26	p	p	X
dpc-4246	67	27	<	<	X
dpc-4246	67	28	0.05	0.05	NUM
dpc-4246	67	29	)	)	PUNCT
dpc-4246	67	30	.	.	PUNCT
dpc-4246	68	1	the	the	DET
dpc-4246	68	2	average	average	ADJ
dpc-4246	68	3	monocyte	monocyte	NOUN
dpc-4246	68	4	counts	count	VERB
dpc-4246	68	5	before	before	ADV
dpc-4246	68	6	and	and	CCONJ
dpc-4246	68	7	at	at	ADP
dpc-4246	68	8	the	the	DET
dpc-4246	68	9	third	third	ADJ
dpc-4246	68	10	month	month	NOUN
dpc-4246	68	11	of	of	ADP
dpc-4246	68	12	treatment	treatment	NOUN
dpc-4246	68	13	were	be	AUX
dpc-4246	68	14	0.58	0.58	NUM
dpc-4246	68	15	and	and	CCONJ
dpc-4246	68	16	0.52	0.52	NUM
dpc-4246	68	17	,	,	PUNCT
dpc-4246	68	18	respectively	respectively	ADV
dpc-4246	68	19	.	.	PUNCT
dpc-4246	69	1	the	the	DET
dpc-4246	69	2	mhr	mhr	PROPN
dpc-4246	69	3	was	be	AUX
dpc-4246	69	4	0.013	0.013	NUM
dpc-4246	69	5	before	before	ADP
dpc-4246	69	6	treatment	treatment	NOUN
dpc-4246	69	7	and	and	CCONJ
dpc-4246	69	8	decreased	decrease	VERB
dpc-4246	69	9	to	to	ADP
dpc-4246	69	10	0.010	0.010	NUM
dpc-4246	69	11	in	in	ADP
dpc-4246	69	12	the	the	DET
dpc-4246	69	13	third	third	ADJ
dpc-4246	69	14	month	month	NOUN
dpc-4246	69	15	of	of	ADP
dpc-4246	69	16	treatment	treatment	NOUN
dpc-4246	69	17	.	.	PUNCT
dpc-4246	70	1	the	the	DET
dpc-4246	70	2	decrease	decrease	NOUN
dpc-4246	70	3	observed	observe	VERB
dpc-4246	70	4	original	original	ADJ
dpc-4246	70	5	article	article	NOUN
dpc-4246	70	6	|	|	ADV
dpc-4246	70	7	dermatol	dermatol	ADJ
dpc-4246	70	8	pract	pract	NOUN
dpc-4246	70	9	concept	concept	NOUN
dpc-4246	70	10	.	.	PUNCT
dpc-4246	71	1	2024;14(3):e2024193	2024;14(3):e2024193	NUM
dpc-4246	71	2	3	3	NUM
dpc-4246	71	3	table	table	NOUN
dpc-4246	71	4	1	1	NUM
dpc-4246	71	5	.	.	PUNCT
dpc-4246	71	6	coexisting	coexist	VERB
dpc-4246	71	7	diseases	disease	NOUN
dpc-4246	71	8	,	,	PUNCT
dpc-4246	71	9	pre	pre	ADJ
dpc-4246	71	10	-	-	ADJ
dpc-4246	71	11	treatment	treatment	ADJ
dpc-4246	71	12	blood	blood	NOUN
dpc-4246	71	13	values	value	NOUN
dpc-4246	71	14	in	in	ADP
dpc-4246	71	15	alopecia	alopecia	NOUN
dpc-4246	71	16	areata	areata	ADJ
dpc-4246	71	17	(	(	PUNCT
dpc-4246	71	18	aa	aa	NOUN
dpc-4246	71	19	)	)	PUNCT
dpc-4246	71	20	group	group	NOUN
dpc-4246	71	21	and	and	CCONJ
dpc-4246	71	22	control	control	NOUN
dpc-4246	71	23	group	group	NOUN
dpc-4246	71	24	,	,	PUNCT
dpc-4246	71	25	blood	blood	NOUN
dpc-4246	71	26	values	value	NOUN
dpc-4246	71	27	before	before	ADV
dpc-4246	71	28	and	and	CCONJ
dpc-4246	71	29	at	at	ADP
dpc-4246	71	30	the	the	DET
dpc-4246	71	31	third	third	ADJ
dpc-4246	71	32	month	month	NOUN
dpc-4246	71	33	of	of	ADP
dpc-4246	71	34	treatment	treatment	NOUN
dpc-4246	71	35	in	in	ADP
dpc-4246	71	36	aa	aa	PROPN
dpc-4246	71	37	group	group	NOUN
dpc-4246	71	38	coexisting	coexist	VERB
dpc-4246	71	39	diseases	disease	NOUN
dpc-4246	71	40	and	and	CCONJ
dpc-4246	71	41	medications	medication	NOUN
dpc-4246	71	42	used	use	VERB
dpc-4246	71	43	in	in	ADP
dpc-4246	71	44	aa	aa	PROPN
dpc-4246	71	45	patient	patient	NOUN
dpc-4246	71	46	group	group	NOUN
dpc-4246	71	47	coexisting	coexist	VERB
dpc-4246	71	48	disease	disease	NOUN
dpc-4246	71	49	medication	medication	NOUN
dpc-4246	71	50	used	use	VERB
dpc-4246	71	51	n	n	NUM
dpc-4246	71	52	hypercholesterolemia	hypercholesterolemia	NOUN
dpc-4246	71	53	atorvastatin	atorvastatin	NOUN
dpc-4246	71	54	1	1	NUM
dpc-4246	71	55	pyelonephritis	pyelonephritis	PROPN
dpc-4246	71	56	nitrofurantoin	nitrofurantoin	NOUN
dpc-4246	71	57	1	1	NUM
dpc-4246	71	58	hypothyroidism	hypothyroidism	NOUN
dpc-4246	71	59	levothyroxine	levothyroxine	NOUN
dpc-4246	71	60	,	,	PUNCT
dpc-4246	71	61	fluoxetine	fluoxetine	VERB
dpc-4246	71	62	1	1	NUM
dpc-4246	71	63	diabetes	diabete	NOUN
dpc-4246	71	64	,	,	PUNCT
dpc-4246	71	65	hypertension	hypertension	NOUN
dpc-4246	71	66	metformin	metformin	NOUN
dpc-4246	71	67	,	,	PUNCT
dpc-4246	71	68	metoprolol	metoprolol	PROPN
dpc-4246	71	69	1	1	NUM
dpc-4246	71	70	hashimoto	hashimoto	NOUN
dpc-4246	71	71	thyroiditis	thyroiditis	NOUN
dpc-4246	71	72	levothyroxine	levothyroxine	NOUN
dpc-4246	71	73	1	1	NUM
dpc-4246	71	74	iron	iron	NOUN
dpc-4246	71	75	deficiency	deficiency	NOUN
dpc-4246	71	76	anemia	anemia	NOUN
dpc-4246	71	77	iron	iron	NOUN
dpc-4246	71	78	(	(	PUNCT
dpc-4246	71	79	iii	iii	NOUN
dpc-4246	71	80	)	)	PUNCT
dpc-4246	71	81	hydroxide	hydroxide	NOUN
dpc-4246	71	82	1	1	NUM
dpc-4246	71	83	assessment	assessment	NOUN
dpc-4246	71	84	of	of	ADP
dpc-4246	71	85	pre	pre	ADJ
dpc-4246	71	86	-	-	ADJ
dpc-4246	71	87	treatment	treatment	ADJ
dpc-4246	71	88	blood	blood	NOUN
dpc-4246	71	89	values	value	NOUN
dpc-4246	71	90	in	in	ADP
dpc-4246	71	91	aa	aa	PROPN
dpc-4246	71	92	patient	patient	NOUN
dpc-4246	71	93	group	group	NOUN
dpc-4246	71	94	and	and	CCONJ
dpc-4246	71	95	control	control	NOUN
dpc-4246	71	96	group	group	NOUN
dpc-4246	71	97	pre	pre	ADJ
dpc-4246	71	98	-	-	ADJ
dpc-4246	71	99	treatment	treatment	ADJ
dpc-4246	71	100	patient	patient	NOUN
dpc-4246	71	101	control	control	NOUN
dpc-4246	71	102	pmin	pmin	PROPN
dpc-4246	71	103	-	-	PUNCT
dpc-4246	71	104	max	max	PROPN
dpc-4246	71	105	mean±sd	mean±sd	PROPN
dpc-4246	71	106	(	(	PUNCT
dpc-4246	71	107	median	median	PROPN
dpc-4246	71	108	)	)	PUNCT
dpc-4246	71	109	min	min	PROPN
dpc-4246	71	110	-	-	PUNCT
dpc-4246	71	111	max	max	PROPN
dpc-4246	71	112	mean±sd	mean±sd	PROPN
dpc-4246	71	113	(	(	PUNCT
dpc-4246	71	114	median	median	PROPN
dpc-4246	71	115	)	)	PUNCT
dpc-4246	71	116	esr	esr	PROPN
dpc-4246	71	117	(	(	PUNCT
dpc-4246	71	118	mm	mm	PROPN
dpc-4246	71	119	/	/	SYM
dpc-4246	71	120	h	h	NOUN
dpc-4246	71	121	)	)	PUNCT
dpc-4246	71	122	2	2	NUM
dpc-4246	71	123	-	-	SYM
dpc-4246	71	124	40	40	NUM
dpc-4246	71	125	7.27±8.04	7.27±8.04	NOUN
dpc-4246	71	126	(	(	PUNCT
dpc-4246	71	127	4	4	NUM
dpc-4246	71	128	)	)	PUNCT
dpc-4246	71	129	0.2	0.2	NUM
dpc-4246	71	130	-	-	SYM
dpc-4246	71	131	18	18	NUM
dpc-4246	71	132	4.36±2.88	4.36±2.88	NUM
dpc-4246	71	133	(	(	PUNCT
dpc-4246	71	134	4.5	4.5	NUM
dpc-4246	71	135	)	)	PUNCT
dpc-4246	71	136	0.343	0.343	NUM
dpc-4246	71	137	crp	crp	NOUN
dpc-4246	71	138	(	(	PUNCT
dpc-4246	71	139	mg	mg	PROPN
dpc-4246	71	140	/	/	SYM
dpc-4246	71	141	l	l	NOUN
dpc-4246	71	142	)	)	PUNCT
dpc-4246	71	143	0.1	0.1	NUM
dpc-4246	71	144	-	-	SYM
dpc-4246	71	145	87	87	NUM
dpc-4246	71	146	4.31±12.41	4.31±12.41	NUM
dpc-4246	71	147	(	(	PUNCT
dpc-4246	71	148	1.3	1.3	NUM
dpc-4246	71	149	)	)	PUNCT
dpc-4246	71	150	0.1	0.1	NUM
dpc-4246	71	151	-	-	SYM
dpc-4246	71	152	5	5	NUM
dpc-4246	71	153	1.6±1.32	1.6±1.32	NUM
dpc-4246	71	154	(	(	PUNCT
dpc-4246	71	155	1.3	1.3	NUM
dpc-4246	71	156	)	)	PUNCT
dpc-4246	71	157	0.624	0.624	NUM
dpc-4246	71	158	monocyte	monocyte	NOUN
dpc-4246	71	159	(	(	PUNCT
dpc-4246	71	160	109	109	NUM
dpc-4246	71	161	/	/	SYM
dpc-4246	71	162	l	l	NOUN
dpc-4246	71	163	)	)	PUNCT
dpc-4246	71	164	0.29	0.29	NUM
dpc-4246	71	165	-	-	SYM
dpc-4246	71	166	1.48	1.48	NUM
dpc-4246	71	167	0.58±0.22	0.58±0.22	NOUN
dpc-4246	71	168	(	(	PUNCT
dpc-4246	71	169	0.5	0.5	NUM
dpc-4246	71	170	)	)	PUNCT
dpc-4246	71	171	0.32	0.32	NUM
dpc-4246	71	172	-	-	SYM
dpc-4246	71	173	0.9	0.9	NUM
dpc-4246	71	174	0.58±0.14	0.58±0.14	NOUN
dpc-4246	71	175	(	(	PUNCT
dpc-4246	71	176	0.6	0.6	NUM
dpc-4246	71	177	)	)	PUNCT
dpc-4246	71	178	0.398	0.398	NUM
dpc-4246	71	179	neutrophil	neutrophil	ADJ
dpc-4246	71	180	(	(	PUNCT
dpc-4246	71	181	109	109	NUM
dpc-4246	71	182	/	/	SYM
dpc-4246	71	183	l	l	NOUN
dpc-4246	71	184	)	)	PUNCT
dpc-4246	71	185	1.41	1.41	NUM
dpc-4246	71	186	-	-	SYM
dpc-4246	71	187	9.31	9.31	NUM
dpc-4246	71	188	4.26±1.48	4.26±1.48	NOUN
dpc-4246	71	189	(	(	PUNCT
dpc-4246	71	190	4	4	NUM
dpc-4246	71	191	)	)	PUNCT
dpc-4246	71	192	2.66	2.66	NUM
dpc-4246	71	193	-	-	SYM
dpc-4246	71	194	6.69	6.69	NUM
dpc-4246	71	195	3.86±0.84	3.86±0.84	NOUN
dpc-4246	71	196	(	(	PUNCT
dpc-4246	71	197	3.8	3.8	NUM
dpc-4246	71	198	)	)	PUNCT
dpc-4246	71	199	0.147	0.147	NUM
dpc-4246	71	200	lymphocyte	lymphocyte	NOUN
dpc-4246	71	201	(	(	PUNCT
dpc-4246	71	202	109	109	NUM
dpc-4246	71	203	/	/	SYM
dpc-4246	71	204	l	l	NOUN
dpc-4246	71	205	)	)	PUNCT
dpc-4246	71	206	1.09	1.09	NUM
dpc-4246	71	207	-	-	SYM
dpc-4246	71	208	4.5	4.5	NUM
dpc-4246	71	209	2.18±0.76	2.18±0.76	NUM
dpc-4246	71	210	(	(	PUNCT
dpc-4246	71	211	2.1	2.1	NUM
dpc-4246	71	212	)	)	PUNCT
dpc-4246	71	213	1.14	1.14	NUM
dpc-4246	71	214	-	-	SYM
dpc-4246	71	215	4.37	4.37	NUM
dpc-4246	71	216	2.45±0.82	2.45±0.82	NOUN
dpc-4246	71	217	(	(	PUNCT
dpc-4246	71	218	2.3	2.3	NUM
dpc-4246	71	219	)	)	PUNCT
dpc-4246	71	220	0.087	0.087	NUM
dpc-4246	71	221	mlr	mlr	NOUN
dpc-4246	71	222	0.11	0.11	NUM
dpc-4246	71	223	-	-	SYM
dpc-4246	71	224	0.65	0.65	NUM
dpc-4246	71	225	0.28±0.1	0.28±0.1	NOUN
dpc-4246	71	226	(	(	PUNCT
dpc-4246	71	227	0.3	0.3	NUM
dpc-4246	71	228	)	)	PUNCT
dpc-4246	71	229	0.12	0.12	NUM
dpc-4246	71	230	-	-	SYM
dpc-4246	71	231	0.53	0.53	NUM
dpc-4246	71	232	0.26±0.09	0.26±0.09	NOUN
dpc-4246	71	233	(	(	PUNCT
dpc-4246	71	234	0.2	0.2	NUM
dpc-4246	71	235	)	)	PUNCT
dpc-4246	71	236	0.316	0.316	NUM
dpc-4246	71	237	nlr	nlr	PROPN
dpc-4246	71	238	0.85	0.85	NUM
dpc-4246	71	239	-	-	SYM
dpc-4246	71	240	4.85	4.85	NUM
dpc-4246	71	241	2.09±0.84	2.09±0.84	NUM
dpc-4246	71	242	(	(	PUNCT
dpc-4246	71	243	1.9	1.9	NUM
dpc-4246	71	244	)	)	PUNCT
dpc-4246	71	245	0.83	0.83	NUM
dpc-4246	71	246	-	-	SYM
dpc-4246	71	247	3.14	3.14	NUM
dpc-4246	71	248	1.73±0.61	1.73±0.61	NOUN
dpc-4246	71	249	(	(	PUNCT
dpc-4246	71	250	1.6	1.6	NUM
dpc-4246	71	251	)	)	PUNCT
dpc-4246	71	252	0.035	0.035	NUM
dpc-4246	71	253	*	*	PUNCT
dpc-4246	71	254	hdl	hdl	X
dpc-4246	71	255	(	(	PUNCT
dpc-4246	71	256	mg	mg	PROPN
dpc-4246	71	257	/	/	SYM
dpc-4246	71	258	dl	dl	NOUN
dpc-4246	71	259	)	)	PUNCT
dpc-4246	71	260	26	26	NUM
dpc-4246	71	261	-	-	SYM
dpc-4246	71	262	80	80	NUM
dpc-4246	71	263	50.4±11.74	50.4±11.74	NOUN
dpc-4246	71	264	(	(	PUNCT
dpc-4246	71	265	50.5	50.5	NUM
dpc-4246	71	266	)	)	PUNCT
dpc-4246	71	267	35	35	NUM
dpc-4246	71	268	-	-	SYM
dpc-4246	71	269	83	83	NUM
dpc-4246	71	270	55.88±9.41	55.88±9.41	NUM
dpc-4246	71	271	(	(	PUNCT
dpc-4246	71	272	55.5	55.5	NUM
dpc-4246	71	273	)	)	PUNCT
dpc-4246	71	274	+0.015	+0.015	PROPN
dpc-4246	71	275	*	*	PUNCT
dpc-4246	71	276	mhr	mhr	PROPN
dpc-4246	71	277	0	0	NUM
dpc-4246	71	278	-	-	SYM
dpc-4246	71	279	0.04	0.04	NUM
dpc-4246	71	280	0.01±0.01	0.01±0.01	NOUN
dpc-4246	71	281	(	(	PUNCT
dpc-4246	71	282	0	0	NUM
dpc-4246	71	283	)	)	PUNCT
dpc-4246	71	284	0	0	NUM
dpc-4246	71	285	-	-	SYM
dpc-4246	71	286	0.02	0.02	NUM
dpc-4246	71	287	0.01±0	0.01±0	NOUN
dpc-4246	71	288	(	(	PUNCT
dpc-4246	71	289	0	0	NUM
dpc-4246	71	290	)	)	PUNCT
dpc-4246	71	291	0.253	0.253	NUM
dpc-4246	71	292	mpv	mpv	PROPN
dpc-4246	71	293	(	(	PUNCT
dpc-4246	71	294	fl	fl	PROPN
dpc-4246	71	295	)	)	PUNCT
dpc-4246	71	296	8.8	8.8	NUM
dpc-4246	71	297	-	-	SYM
dpc-4246	71	298	12.9	12.9	NUM
dpc-4246	71	299	10.31±0.84	10.31±0.84	NUM
dpc-4246	71	300	(	(	PUNCT
dpc-4246	71	301	10.2	10.2	NUM
dpc-4246	71	302	)	)	PUNCT
dpc-4246	71	303	8.1	8.1	NUM
dpc-4246	71	304	-	-	SYM
dpc-4246	71	305	11.2	11.2	NUM
dpc-4246	71	306	9.65±0.66	9.65±0.66	NUM
dpc-4246	71	307	(	(	PUNCT
dpc-4246	71	308	9.7	9.7	NUM
dpc-4246	71	309	)	)	PUNCT
dpc-4246	71	310	+0.001	+0.001	NOUN
dpc-4246	71	311	*	*	PUNCT
dpc-4246	72	1	platelet	platelet	NOUN
dpc-4246	72	2	(	(	PUNCT
dpc-4246	72	3	109	109	NUM
dpc-4246	72	4	/	/	SYM
dpc-4246	72	5	l	l	NOUN
dpc-4246	72	6	)	)	PUNCT
dpc-4246	72	7	162	162	NUM
dpc-4246	72	8	-	-	SYM
dpc-4246	72	9	465	465	NUM
dpc-4246	72	10	269.62±59.18	269.62±59.18	NUM
dpc-4246	72	11	(	(	PUNCT
dpc-4246	72	12	262.5	262.5	NUM
dpc-4246	72	13	)	)	PUNCT
dpc-4246	72	14	158	158	NUM
dpc-4246	72	15	-	-	SYM
dpc-4246	72	16	358	358	NUM
dpc-4246	72	17	265.7±44.75	265.7±44.75	NUM
dpc-4246	72	18	(	(	PUNCT
dpc-4246	72	19	265.5	265.5	NUM
dpc-4246	72	20	)	)	PUNCT
dpc-4246	72	21	+0.723	+0.723	NOUN
dpc-4246	72	22	sii	sii	PROPN
dpc-4246	72	23	187	187	NUM
dpc-4246	72	24	-	-	SYM
dpc-4246	72	25	1644	1644	NUM
dpc-4246	72	26	562.43±264.27	562.43±264.27	NUM
dpc-4246	72	27	(	(	PUNCT
dpc-4246	72	28	480.5	480.5	NUM
dpc-4246	72	29	)	)	PUNCT
dpc-4246	72	30	204.86	204.86	NUM
dpc-4246	72	31	-	-	SYM
dpc-4246	72	32	943.4	943.4	NUM
dpc-4246	72	33	454.77±164.62	454.77±164.62	NUM
dpc-4246	72	34	(	(	PUNCT
dpc-4246	72	35	427.7	427.7	NUM
dpc-4246	72	36	)	)	PUNCT
dpc-4246	72	37	0.035	0.035	NUM
dpc-4246	72	38	*	*	PUNCT
dpc-4246	72	39	assessment	assessment	NOUN
dpc-4246	72	40	of	of	ADP
dpc-4246	72	41	blood	blood	NOUN
dpc-4246	72	42	values	value	NOUN
dpc-4246	72	43	before	before	ADP
dpc-4246	72	44	and	and	CCONJ
dpc-4246	72	45	at	at	ADP
dpc-4246	72	46	the	the	DET
dpc-4246	72	47	third	third	ADJ
dpc-4246	72	48	month	month	NOUN
dpc-4246	72	49	of	of	ADP
dpc-4246	72	50	treatment	treatment	NOUN
dpc-4246	72	51	in	in	ADP
dpc-4246	72	52	aa	aa	PROPN
dpc-4246	72	53	patient	patient	PROPN
dpc-4246	72	54	group	group	NOUN
dpc-4246	72	55	aa	aa	PROPN
dpc-4246	72	56	patient	patient	PROPN
dpc-4246	72	57	group	group	NOUN
dpc-4246	72	58	before	before	ADP
dpc-4246	72	59	treatment	treatment	NOUN
dpc-4246	72	60	month	month	NOUN
dpc-4246	72	61	3	3	NUM
dpc-4246	72	62	of	of	ADP
dpc-4246	72	63	treatment	treatment	NOUN
dpc-4246	72	64	min	min	PROPN
dpc-4246	72	65	-	-	PROPN
dpc-4246	72	66	max	max	PROPN
dpc-4246	72	67	mean±sd	mean±sd	PROPN
dpc-4246	72	68	(	(	PUNCT
dpc-4246	72	69	median	median	PROPN
dpc-4246	72	70	)	)	PUNCT
dpc-4246	72	71	min	min	PROPN
dpc-4246	72	72	-	-	PUNCT
dpc-4246	72	73	max	max	PROPN
dpc-4246	72	74	mean±sd	mean±sd	PROPN
dpc-4246	72	75	(	(	PUNCT
dpc-4246	72	76	median	median	PROPN
dpc-4246	72	77	)	)	PUNCT
dpc-4246	72	78	esr	esr	PROPN
dpc-4246	72	79	(	(	PUNCT
dpc-4246	72	80	mm	mm	PROPN
dpc-4246	72	81	/	/	SYM
dpc-4246	72	82	h	h	NOUN
dpc-4246	72	83	)	)	PUNCT
dpc-4246	72	84	2	2	NUM
dpc-4246	72	85	-	-	SYM
dpc-4246	72	86	40	40	NUM
dpc-4246	72	87	7.27±8.04	7.27±8.04	NOUN
dpc-4246	72	88	(	(	PUNCT
dpc-4246	72	89	4	4	NUM
dpc-4246	72	90	)	)	PUNCT
dpc-4246	72	91	1	1	NUM
dpc-4246	72	92	-	-	SYM
dpc-4246	72	93	34	34	NUM
dpc-4246	72	94	4.63±5.07	4.63±5.07	NOUN
dpc-4246	72	95	(	(	PUNCT
dpc-4246	72	96	3	3	NUM
dpc-4246	72	97	)	)	PUNCT
dpc-4246	72	98	0.001	0.001	NUM
dpc-4246	72	99	*	*	SYM
dpc-4246	72	100	crp	crp	X
dpc-4246	72	101	(	(	PUNCT
dpc-4246	72	102	mg	mg	PROPN
dpc-4246	72	103	/	/	SYM
dpc-4246	72	104	l	l	NOUN
dpc-4246	72	105	)	)	PUNCT
dpc-4246	72	106	0.1	0.1	NUM
dpc-4246	72	107	-	-	SYM
dpc-4246	72	108	87	87	NUM
dpc-4246	72	109	4.31±12.41	4.31±12.41	NUM
dpc-4246	72	110	(	(	PUNCT
dpc-4246	72	111	1.3	1.3	NUM
dpc-4246	72	112	)	)	SYM
dpc-4246	72	113	0.1	0.1	NUM
dpc-4246	72	114	-	-	SYM
dpc-4246	72	115	11	11	NUM
dpc-4246	72	116	1.53±2.28	1.53±2.28	NOUN
dpc-4246	72	117	(	(	PUNCT
dpc-4246	72	118	0.5	0.5	NUM
dpc-4246	72	119	)	)	PUNCT
dpc-4246	72	120	0.001	0.001	NUM
dpc-4246	72	121	*	*	NOUN
dpc-4246	72	122	monocyte	monocyte	NOUN
dpc-4246	72	123	(	(	PUNCT
dpc-4246	72	124	109	109	NUM
dpc-4246	72	125	/	/	SYM
dpc-4246	72	126	l	l	NOUN
dpc-4246	72	127	)	)	PUNCT
dpc-4246	72	128	0.29	0.29	NUM
dpc-4246	72	129	-	-	SYM
dpc-4246	72	130	1.48	1.48	NUM
dpc-4246	72	131	0.58±0.22	0.58±0.22	NOUN
dpc-4246	72	132	(	(	PUNCT
dpc-4246	72	133	0.5	0.5	NUM
dpc-4246	72	134	)	)	PUNCT
dpc-4246	72	135	0.2	0.2	NUM
dpc-4246	72	136	-	-	PUNCT
dpc-4246	72	137	1.07	1.07	NUM
dpc-4246	72	138	0.52±0.16	0.52±0.16	NOUN
dpc-4246	72	139	(	(	PUNCT
dpc-4246	72	140	0.5	0.5	NUM
dpc-4246	72	141	)	)	PUNCT
dpc-4246	72	142	0.029	0.029	NUM
dpc-4246	72	143	*	*	VERB
dpc-4246	72	144	neutrophil	neutrophil	ADJ
dpc-4246	72	145	(	(	PUNCT
dpc-4246	72	146	109	109	NUM
dpc-4246	72	147	/	/	SYM
dpc-4246	72	148	l	l	NOUN
dpc-4246	72	149	)	)	PUNCT
dpc-4246	72	150	1.41	1.41	NUM
dpc-4246	72	151	-	-	SYM
dpc-4246	72	152	9.31	9.31	NUM
dpc-4246	72	153	4.26±1.48	4.26±1.48	NOUN
dpc-4246	72	154	(	(	PUNCT
dpc-4246	72	155	4	4	NUM
dpc-4246	72	156	)	)	PUNCT
dpc-4246	72	157	1.4	1.4	NUM
dpc-4246	72	158	-	-	SYM
dpc-4246	72	159	8.38	8.38	NUM
dpc-4246	72	160	4.09±1.65	4.09±1.65	PROPN
dpc-4246	72	161	(	(	PUNCT
dpc-4246	72	162	3.6	3.6	NUM
dpc-4246	72	163	)	)	PUNCT
dpc-4246	72	164	0.173	0.173	NUM
dpc-4246	72	165	lymphocyte	lymphocyte	NOUN
dpc-4246	72	166	(	(	PUNCT
dpc-4246	72	167	109	109	NUM
dpc-4246	72	168	/	/	SYM
dpc-4246	72	169	l	l	NOUN
dpc-4246	72	170	)	)	PUNCT
dpc-4246	72	171	1.09	1.09	NUM
dpc-4246	72	172	-	-	SYM
dpc-4246	72	173	4.5	4.5	NUM
dpc-4246	72	174	2.18±0.76	2.18±0.76	NUM
dpc-4246	72	175	(	(	PUNCT
dpc-4246	72	176	2.1	2.1	NUM
dpc-4246	72	177	)	)	PUNCT
dpc-4246	72	178	0.91	0.91	NUM
dpc-4246	72	179	-	-	SYM
dpc-4246	72	180	5.7	5.7	NUM
dpc-4246	72	181	2.21±0.81	2.21±0.81	NOUN
dpc-4246	72	182	(	(	PUNCT
dpc-4246	72	183	2	2	NUM
dpc-4246	72	184	)	)	PUNCT
dpc-4246	72	185	0.673	0.673	NUM
dpc-4246	72	186	mlr	mlr	NOUN
dpc-4246	72	187	0.11	0.11	NUM
dpc-4246	72	188	-	-	SYM
dpc-4246	72	189	0.65	0.65	NUM
dpc-4246	72	190	0.28±0.1	0.28±0.1	NOUN
dpc-4246	72	191	(	(	PUNCT
dpc-4246	72	192	0.3	0.3	NUM
dpc-4246	72	193	)	)	PUNCT
dpc-4246	72	194	0.06	0.06	NUM
dpc-4246	72	195	-	-	SYM
dpc-4246	72	196	0.96	0.96	NUM
dpc-4246	72	197	0.26±0.14	0.26±0.14	NOUN
dpc-4246	72	198	(	(	PUNCT
dpc-4246	72	199	0.2	0.2	NUM
dpc-4246	72	200	)	)	PUNCT
dpc-4246	72	201	0.110	0.110	NUM
dpc-4246	72	202	nlr	nlr	PROPN
dpc-4246	72	203	0.85	0.85	NUM
dpc-4246	72	204	-	-	SYM
dpc-4246	72	205	4.85	4.85	NUM
dpc-4246	72	206	2.09±0.84	2.09±0.84	NUM
dpc-4246	72	207	(	(	PUNCT
dpc-4246	72	208	1.9	1.9	NUM
dpc-4246	72	209	)	)	PUNCT
dpc-4246	72	210	0.67	0.67	NUM
dpc-4246	72	211	-	-	SYM
dpc-4246	72	212	5.53	5.53	NUM
dpc-4246	72	213	2.11±1.25	2.11±1.25	NUM
dpc-4246	72	214	(	(	PUNCT
dpc-4246	72	215	1.8	1.8	NUM
dpc-4246	72	216	)	)	PUNCT
dpc-4246	72	217	0.749	0.749	NUM
dpc-4246	72	218	hdl	hdl	NOUN
dpc-4246	72	219	(	(	PUNCT
dpc-4246	72	220	mg	mg	PROPN
dpc-4246	72	221	/	/	SYM
dpc-4246	72	222	dl	dl	NOUN
dpc-4246	72	223	)	)	PUNCT
dpc-4246	72	224	26	26	NUM
dpc-4246	72	225	-	-	SYM
dpc-4246	72	226	80	80	NUM
dpc-4246	72	227	50.4±11.74	50.4±11.74	NOUN
dpc-4246	72	228	(	(	PUNCT
dpc-4246	72	229	50.5	50.5	NUM
dpc-4246	72	230	)	)	SYM
dpc-4246	72	231	30	30	NUM
dpc-4246	72	232	-	-	SYM
dpc-4246	72	233	95	95	NUM
dpc-4246	72	234	57.17±13.32	57.17±13.32	NUM
dpc-4246	72	235	(	(	PUNCT
dpc-4246	72	236	59.5	59.5	NUM
dpc-4246	72	237	)	)	PUNCT
dpc-4246	72	238	+0.001	+0.001	PROPN
dpc-4246	72	239	*	*	PUNCT
dpc-4246	72	240	mhr	mhr	PROPN
dpc-4246	72	241	0	0	NUM
dpc-4246	72	242	-	-	SYM
dpc-4246	72	243	0.04	0.04	NUM
dpc-4246	72	244	0.013±0.01	0.013±0.01	NUM
dpc-4246	72	245	(	(	PUNCT
dpc-4246	72	246	0	0	NUM
dpc-4246	72	247	)	)	PUNCT
dpc-4246	72	248	0	0	NUM
dpc-4246	72	249	-	-	SYM
dpc-4246	72	250	0.03	0.03	NUM
dpc-4246	72	251	0.010±0.01	0.010±0.01	PRON
dpc-4246	72	252	(	(	PUNCT
dpc-4246	72	253	0	0	NUM
dpc-4246	72	254	)	)	PUNCT
dpc-4246	72	255	0.002	0.002	NUM
dpc-4246	72	256	*	*	SYM
dpc-4246	72	257	mpv	mpv	PROPN
dpc-4246	72	258	(	(	PUNCT
dpc-4246	72	259	fl	fl	PROPN
dpc-4246	72	260	)	)	PUNCT
dpc-4246	72	261	8.8	8.8	NUM
dpc-4246	72	262	-	-	SYM
dpc-4246	72	263	12.9	12.9	NUM
dpc-4246	72	264	10.31±0.84	10.31±0.84	NUM
dpc-4246	72	265	(	(	PUNCT
dpc-4246	72	266	10.2	10.2	NUM
dpc-4246	72	267	)	)	PUNCT
dpc-4246	72	268	7.9	7.9	NUM
dpc-4246	72	269	-	-	SYM
dpc-4246	72	270	12.1	12.1	NUM
dpc-4246	72	271	9.89±0.89	9.89±0.89	NUM
dpc-4246	72	272	(	(	PUNCT
dpc-4246	72	273	10.1	10.1	NUM
dpc-4246	72	274	)	)	PUNCT
dpc-4246	72	275	+0.001	+0.001	NOUN
dpc-4246	72	276	*	*	PUNCT
dpc-4246	72	277	platelet	platelet	NOUN
dpc-4246	72	278	(	(	PUNCT
dpc-4246	72	279	109	109	NUM
dpc-4246	72	280	/	/	SYM
dpc-4246	72	281	l	l	NOUN
dpc-4246	72	282	)	)	PUNCT
dpc-4246	72	283	162	162	NUM
dpc-4246	72	284	-	-	SYM
dpc-4246	72	285	465	465	NUM
dpc-4246	72	286	269.62±59.18	269.62±59.18	NUM
dpc-4246	72	287	(	(	PUNCT
dpc-4246	72	288	262.5	262.5	NUM
dpc-4246	72	289	)	)	PUNCT
dpc-4246	72	290	160	160	NUM
dpc-4246	72	291	-	-	SYM
dpc-4246	72	292	504	504	NUM
dpc-4246	72	293	258.17±60.18	258.17±60.18	NUM
dpc-4246	72	294	(	(	PUNCT
dpc-4246	72	295	250	250	NUM
dpc-4246	72	296	)	)	PUNCT
dpc-4246	72	297	+0.005	+0.005	PROPN
dpc-4246	72	298	*	*	PROPN
dpc-4246	72	299	sii	sii	NUM
dpc-4246	72	300	187	187	NUM
dpc-4246	72	301	-	-	SYM
dpc-4246	72	302	1644	1644	NUM
dpc-4246	72	303	562.43±264.27	562.43±264.27	NUM
dpc-4246	72	304	(	(	PUNCT
dpc-4246	72	305	480.5	480.5	NUM
dpc-4246	72	306	)	)	PUNCT
dpc-4246	72	307	147	147	NUM
dpc-4246	72	308	-	-	SYM
dpc-4246	72	309	1809	1809	NUM
dpc-4246	72	310	553.48±377.09	553.48±377.09	NUM
dpc-4246	72	311	(	(	PUNCT
dpc-4246	72	312	490.5	490.5	NUM
dpc-4246	72	313	)	)	PUNCT
dpc-4246	72	314	0.387	0.387	NUM
dpc-4246	72	315	salt	salt	NOUN
dpc-4246	72	316	1	1	NUM
dpc-4246	72	317	-	-	SYM
dpc-4246	72	318	20	20	NUM
dpc-4246	72	319	6.73±5.02	6.73±5.02	NOUN
dpc-4246	72	320	(	(	PUNCT
dpc-4246	72	321	5	5	NUM
dpc-4246	72	322	)	)	PUNCT
dpc-4246	72	323	0	0	NUM
dpc-4246	72	324	-	-	SYM
dpc-4246	72	325	12	12	NUM
dpc-4246	72	326	3.55±3.73	3.55±3.73	NUM
dpc-4246	72	327	(	(	PUNCT
dpc-4246	72	328	2	2	NUM
dpc-4246	72	329	)	)	PUNCT
dpc-4246	72	330	0.001	0.001	NUM
dpc-4246	72	331	*	*	SYM
dpc-4246	72	332	n	n	NOUN
dpc-4246	72	333	=	=	NOUN
dpc-4246	72	334	number	number	NOUN
dpc-4246	72	335	of	of	ADP
dpc-4246	72	336	patients	patient	NOUN
dpc-4246	72	337	,	,	PUNCT
dpc-4246	72	338	esr	esr	PROPN
dpc-4246	72	339	:	:	PUNCT
dpc-4246	72	340	erythrocyte	erythrocyte	PROPN
dpc-4246	72	341	sedimentation	sedimentation	NOUN
dpc-4246	72	342	rate	rate	NOUN
dpc-4246	72	343	,	,	PUNCT
dpc-4246	72	344	crp	crp	PROPN
dpc-4246	72	345	:	:	PUNCT
dpc-4246	72	346	c	c	X
dpc-4246	72	347	-	-	PUNCT
dpc-4246	72	348	reactive	reactive	ADJ
dpc-4246	72	349	protein	protein	NOUN
dpc-4246	72	350	,	,	PUNCT
dpc-4246	72	351	mlr	mlr	NOUN
dpc-4246	72	352	:	:	PUNCT
dpc-4246	72	353	monocyte	monocyte	ADJ
dpc-4246	72	354	-	-	PUNCT
dpc-4246	72	355	lymphocyte	lymphocyte	NOUN
dpc-4246	72	356	ratio	ratio	NOUN
dpc-4246	72	357	,	,	PUNCT
dpc-4246	72	358	nlr	nlr	PROPN
dpc-4246	72	359	:	:	PUNCT
dpc-4246	72	360	neutrophil	neutrophil	ADJ
dpc-4246	72	361	-	-	PUNCT
dpc-4246	72	362	lymphocyte	lymphocyte	NOUN
dpc-4246	72	363	ratio	ratio	NOUN
dpc-4246	72	364	,	,	PUNCT
dpc-4246	72	365	hdl	hdl	PROPN
dpc-4246	72	366	:	:	PUNCT
dpc-4246	72	367	high	high	ADJ
dpc-4246	72	368	density	density	NOUN
dpc-4246	72	369	lipoprotein	lipoprotein	ADJ
dpc-4246	72	370	,	,	PUNCT
dpc-4246	72	371	mhr	mhr	ADJ
dpc-4246	72	372	:	:	PUNCT
dpc-4246	72	373	monocyte	monocyte	ADJ
dpc-4246	72	374	-	-	PUNCT
dpc-4246	72	375	hdl	hdl	NOUN
dpc-4246	72	376	ratio	ratio	NOUN
dpc-4246	72	377	,	,	PUNCT
dpc-4246	72	378	mpv	mpv	PROPN
dpc-4246	72	379	:	:	PUNCT
dpc-4246	72	380	mean	mean	ADJ
dpc-4246	72	381	platelet	platelet	NOUN
dpc-4246	72	382	volume	volume	NOUN
dpc-4246	72	383	,	,	PUNCT
dpc-4246	72	384	sii	sii	ADJ
dpc-4246	72	385	:	:	PUNCT
dpc-4246	72	386	systemic	systemic	ADJ
dpc-4246	72	387	immune	immune	ADJ
dpc-4246	72	388	-	-	PUNCT
dpc-4246	72	389	inflammation	inflammation	NOUN
dpc-4246	72	390	index	index	NOUN
dpc-4246	72	391	;	;	PUNCT
dpc-4246	72	392	sd	sd	NOUN
dpc-4246	72	393	=	=	SYM
dpc-4246	72	394	standard	standard	ADJ
dpc-4246	72	395	deviation	deviation	NOUN
dpc-4246	72	396	,	,	PUNCT
dpc-4246	72	397	salt	salt	NOUN
dpc-4246	72	398	:	:	PUNCT
dpc-4246	72	399	severity	severity	NOUN
dpc-4246	72	400	of	of	ADP
dpc-4246	72	401	alopecia	alopecia	NOUN
dpc-4246	72	402	tool	tool	NOUN
dpc-4246	72	403	in	in	ADP
dpc-4246	72	404	the	the	DET
dpc-4246	72	405	monocyte	monocyte	NOUN
dpc-4246	72	406	count	count	NOUN
dpc-4246	72	407	and	and	CCONJ
dpc-4246	72	408	mhr	mhr	PROPN
dpc-4246	72	409	after	after	SCONJ
dpc-4246	72	410	treatment	treatment	NOUN
dpc-4246	72	411	was	be	AUX
dpc-4246	72	412	statistically	statistically	ADV
dpc-4246	72	413	significant	significant	ADJ
dpc-4246	72	414	(	(	PUNCT
dpc-4246	72	415	p	p	X
dpc-4246	72	416	:	:	PUNCT
dpc-4246	72	417	0.029	0.029	NUM
dpc-4246	72	418	,	,	PUNCT
dpc-4246	72	419	p	p	X
dpc-4246	72	420	:	:	PUNCT
dpc-4246	72	421	0.001	0.001	NUM
dpc-4246	72	422	;	;	PUNCT
dpc-4246	72	423	p	p	X
dpc-4246	72	424	<	<	X
dpc-4246	72	425	0.05	0.05	NUM
dpc-4246	72	426	)	)	PUNCT
dpc-4246	72	427	.	.	PUNCT
dpc-4246	73	1	before	before	ADP
dpc-4246	73	2	treatment	treatment	NOUN
dpc-4246	73	3	,	,	PUNCT
dpc-4246	73	4	the	the	DET
dpc-4246	73	5	average	average	ADJ
dpc-4246	73	6	platelet	platelet	NOUN
dpc-4246	73	7	count	count	NOUN
dpc-4246	73	8	was	be	AUX
dpc-4246	73	9	269.62	269.62	NUM
dpc-4246	73	10	,	,	PUNCT
dpc-4246	73	11	and	and	CCONJ
dpc-4246	73	12	the	the	DET
dpc-4246	73	13	mpv	mpv	PROPN
dpc-4246	73	14	was	be	AUX
dpc-4246	73	15	10.31	10.31	NUM
dpc-4246	73	16	.	.	PUNCT
dpc-4246	74	1	at	at	ADP
dpc-4246	74	2	the	the	DET
dpc-4246	74	3	third	third	ADJ
dpc-4246	74	4	month	month	NOUN
dpc-4246	74	5	of	of	ADP
dpc-4246	74	6	treatment	treatment	NOUN
dpc-4246	74	7	,	,	PUNCT
dpc-4246	74	8	the	the	DET
dpc-4246	74	9	average	average	ADJ
dpc-4246	74	10	platelet	platelet	NOUN
dpc-4246	74	11	count	count	NOUN
dpc-4246	74	12	was	be	AUX
dpc-4246	74	13	258.17	258.17	NUM
dpc-4246	74	14	,	,	PUNCT
dpc-4246	74	15	and	and	CCONJ
dpc-4246	74	16	the	the	DET
dpc-4246	74	17	mpv	mpv	PROPN
dpc-4246	74	18	was	be	AUX
dpc-4246	74	19	9.89	9.89	NUM
dpc-4246	74	20	.	.	PUNCT
dpc-4246	75	1	the	the	DET
dpc-4246	75	2	decrease	decrease	NOUN
dpc-4246	75	3	observed	observe	VERB
dpc-4246	75	4	in	in	ADP
dpc-4246	75	5	the	the	DET
dpc-4246	75	6	average	average	ADJ
dpc-4246	75	7	platelet	platelet	NOUN
dpc-4246	75	8	count	count	NOUN
dpc-4246	75	9	and	and	CCONJ
dpc-4246	75	10	mpv	mpv	PROPN
dpc-4246	75	11	values	value	NOUN
dpc-4246	75	12	was	be	AUX
dpc-4246	75	13	found	find	VERB
dpc-4246	75	14	to	to	PART
dpc-4246	75	15	be	be	AUX
dpc-4246	75	16	statistically	statistically	ADV
dpc-4246	75	17	significant	significant	ADJ
dpc-4246	75	18	(	(	PUNCT
dpc-4246	75	19	p	p	X
dpc-4246	75	20	:	:	PUNCT
dpc-4246	75	21	0.005	0.005	NUM
dpc-4246	75	22	,	,	PUNCT
dpc-4246	75	23	p	p	X
dpc-4246	75	24	:	:	PUNCT
dpc-4246	75	25	0.001	0.001	NUM
dpc-4246	75	26	;	;	PUNCT
dpc-4246	75	27	p	p	X
dpc-4246	75	28	<	<	X
dpc-4246	75	29	0.05	0.05	NUM
dpc-4246	75	30	)	)	PUNCT
dpc-4246	75	31	.	.	PUNCT
dpc-4246	76	1	no	no	DET
dpc-4246	76	2	statistically	statistically	ADV
dpc-4246	76	3	significant	significant	ADJ
dpc-4246	76	4	4	4	NUM
dpc-4246	76	5	original	original	ADJ
dpc-4246	76	6	article	article	NOUN
dpc-4246	76	7	|	|	ADV
dpc-4246	76	8	dermatol	dermatol	ADJ
dpc-4246	76	9	pract	pract	NOUN
dpc-4246	76	10	concept	concept	NOUN
dpc-4246	76	11	.	.	PUNCT
dpc-4246	77	1	2024;14(3):e2024193	2024;14(3):e2024193	NUM
dpc-4246	77	2	ophiasis	ophiasis	NOUN
dpc-4246	77	3	,	,	PUNCT
dpc-4246	77	4	diffuse	diffuse	ADJ
dpc-4246	77	5	,	,	PUNCT
dpc-4246	77	6	reticular	reticular	ADJ
dpc-4246	77	7	,	,	PUNCT
dpc-4246	77	8	and	and	CCONJ
dpc-4246	77	9	perinevoid	perinevoid	NOUN
dpc-4246	77	10	types	type	NOUN
dpc-4246	78	1	[	[	X
dpc-4246	78	2	7	7	NUM
dpc-4246	78	3	]	]	PUNCT
dpc-4246	78	4	.	.	PUNCT
dpc-4246	79	1	in	in	ADP
dpc-4246	79	2	daily	daily	ADJ
dpc-4246	79	3	practice	practice	NOUN
dpc-4246	79	4	,	,	PUNCT
dpc-4246	79	5	the	the	DET
dpc-4246	79	6	most	most	ADV
dpc-4246	79	7	common	common	ADJ
dpc-4246	79	8	clinical	clinical	ADJ
dpc-4246	79	9	presentation	presentation	NOUN
dpc-4246	79	10	is	be	AUX
dpc-4246	79	11	localized	localize	VERB
dpc-4246	79	12	,	,	PUNCT
dpc-4246	79	13	round	round	ADJ
dpc-4246	79	14	,	,	PUNCT
dpc-4246	79	15	or	or	CCONJ
dpc-4246	79	16	oval	oval	NOUN
dpc-4246	79	17	alopecic	alopecic	NOUN
dpc-4246	79	18	patches	patch	VERB
dpc-4246	79	19	on	on	ADP
dpc-4246	79	20	the	the	DET
dpc-4246	79	21	scalp	scalp	NOUN
dpc-4246	79	22	.	.	PUNCT
dpc-4246	80	1	the	the	DET
dpc-4246	80	2	course	course	NOUN
dpc-4246	80	3	of	of	ADP
dpc-4246	80	4	the	the	DET
dpc-4246	80	5	disease	disease	NOUN
dpc-4246	80	6	is	be	AUX
dpc-4246	80	7	unpredictable	unpredictable	ADJ
dpc-4246	80	8	,	,	PUNCT
dpc-4246	80	9	with	with	ADP
dpc-4246	80	10	spontaneous	spontaneous	ADJ
dpc-4246	80	11	remissions	remission	NOUN
dpc-4246	80	12	and	and	CCONJ
dpc-4246	80	13	relapses	relapse	NOUN
dpc-4246	80	14	occurring	occur	VERB
dpc-4246	80	15	in	in	ADP
dpc-4246	80	16	approximately	approximately	ADV
dpc-4246	80	17	80	80	NUM
dpc-4246	80	18	%	%	NOUN
dpc-4246	80	19	of	of	ADP
dpc-4246	80	20	patients	patient	NOUN
dpc-4246	80	21	.	.	PUNCT
dpc-4246	81	1	aa	aa	NOUN
dpc-4246	81	2	affects	affect	VERB
dpc-4246	81	3	both	both	DET
dpc-4246	81	4	males	male	NOUN
dpc-4246	81	5	and	and	CCONJ
dpc-4246	81	6	females	female	NOUN
dpc-4246	81	7	,	,	PUNCT
dpc-4246	81	8	with	with	ADP
dpc-4246	81	9	no	no	DET
dpc-4246	81	10	significant	significant	ADJ
dpc-4246	81	11	sex	sex	NOUN
dpc-4246	81	12	-	-	PUNCT
dpc-4246	81	13	based	base	VERB
dpc-4246	81	14	difference	difference	NOUN
dpc-4246	81	15	in	in	ADP
dpc-4246	81	16	prevalence	prevalence	NOUN
dpc-4246	81	17	.	.	PUNCT
dpc-4246	82	1	in	in	ADP
dpc-4246	82	2	a	a	DET
dpc-4246	82	3	study	study	NOUN
dpc-4246	82	4	by	by	ADP
dpc-4246	82	5	lundin	lundin	PROPN
dpc-4246	82	6	et	et	PROPN
dpc-4246	82	7	al	al	PROPN
dpc-4246	82	8	.	.	PROPN
dpc-4246	82	9	,	,	PUNCT
dpc-4246	82	10	female	female	NOUN
dpc-4246	82	11	:	:	PUNCT
dpc-4246	82	12	male	male	ADJ
dpc-4246	82	13	ratio	ratio	NOUN
dpc-4246	82	14	was	be	AUX
dpc-4246	82	15	found	find	VERB
dpc-4246	82	16	to	to	PART
dpc-4246	82	17	be	be	AUX
dpc-4246	82	18	2.3:1	2.3:1	NUM
dpc-4246	82	19	[	[	X
dpc-4246	82	20	8	8	NUM
dpc-4246	82	21	]	]	PUNCT
dpc-4246	82	22	.	.	PUNCT
dpc-4246	83	1	the	the	DET
dpc-4246	83	2	higher	high	ADJ
dpc-4246	83	3	incidence	incidence	NOUN
dpc-4246	83	4	of	of	ADP
dpc-4246	83	5	aa	aa	NOUN
dpc-4246	83	6	in	in	ADP
dpc-4246	83	7	women	woman	NOUN
dpc-4246	83	8	is	be	AUX
dpc-4246	83	9	attributed	attribute	VERB
dpc-4246	83	10	to	to	ADP
dpc-4246	83	11	their	their	PRON
dpc-4246	83	12	increased	increase	VERB
dpc-4246	83	13	sensitivity	sensitivity	NOUN
dpc-4246	83	14	to	to	ADP
dpc-4246	83	15	hair	hair	NOUN
dpc-4246	83	16	loss	loss	NOUN
dpc-4246	83	17	.	.	PUNCT
dpc-4246	84	1	in	in	ADP
dpc-4246	84	2	a	a	DET
dpc-4246	84	3	retrospective	retrospective	ADJ
dpc-4246	84	4	study	study	NOUN
dpc-4246	84	5	by	by	ADP
dpc-4246	84	6	uzuncakmak	uzuncakmak	PROPN
dpc-4246	84	7	et	et	PROPN
dpc-4246	84	8	al	al	PROPN
dpc-4246	84	9	.	.	PROPN
dpc-4246	84	10	,	,	PUNCT
dpc-4246	84	11	including	include	VERB
dpc-4246	84	12	a	a	DET
dpc-4246	84	13	total	total	NOUN
dpc-4246	84	14	of	of	ADP
dpc-4246	84	15	1,641	1,641	NUM
dpc-4246	84	16	patients	patient	NOUN
dpc-4246	84	17	,	,	PUNCT
dpc-4246	84	18	the	the	DET
dpc-4246	84	19	female	female	NOUN
dpc-4246	84	20	:	:	PUNCT
dpc-4246	84	21	male	male	ADJ
dpc-4246	84	22	ratio	ratio	NOUN
dpc-4246	84	23	was	be	AUX
dpc-4246	84	24	found	find	VERB
dpc-4246	84	25	to	to	PART
dpc-4246	84	26	be	be	AUX
dpc-4246	84	27	1.15:1	1.15:1	NUM
dpc-4246	85	1	[	[	X
dpc-4246	85	2	9	9	NUM
dpc-4246	85	3	]	]	PUNCT
dpc-4246	85	4	.	.	PUNCT
dpc-4246	86	1	another	another	DET
dpc-4246	86	2	retrospective	retrospective	ADJ
dpc-4246	86	3	cohort	cohort	NOUN
dpc-4246	86	4	study	study	NOUN
dpc-4246	86	5	by	by	ADP
dpc-4246	86	6	lyakhovitsky	lyakhovitsky	NOUN
dpc-4246	86	7	and	and	CCONJ
dpc-4246	86	8	colleagues	colleague	NOUN
dpc-4246	86	9	involving	involve	VERB
dpc-4246	86	10	29	29	NUM
dpc-4246	86	11	aa	aa	PROPN
dpc-4246	86	12	patients	patient	NOUN
dpc-4246	86	13	reported	report	VERB
dpc-4246	86	14	that	that	SCONJ
dpc-4246	86	15	86.2	86.2	NUM
dpc-4246	86	16	%	%	NOUN
dpc-4246	86	17	of	of	ADP
dpc-4246	86	18	the	the	DET
dpc-4246	86	19	patients	patient	NOUN
dpc-4246	86	20	were	be	AUX
dpc-4246	86	21	female	female	ADJ
dpc-4246	86	22	,	,	PUNCT
dpc-4246	86	23	resulting	result	VERB
dpc-4246	86	24	in	in	ADP
dpc-4246	86	25	a	a	DET
dpc-4246	86	26	female	female	NOUN
dpc-4246	86	27	:	:	PUNCT
dpc-4246	86	28	male	male	ADJ
dpc-4246	86	29	ratio	ratio	NOUN
dpc-4246	86	30	of	of	ADP
dpc-4246	86	31	6.2:1	6.2:1	NUM
dpc-4246	87	1	[	[	X
dpc-4246	87	2	10	10	NUM
dpc-4246	87	3	]	]	PUNCT
dpc-4246	87	4	.	.	PUNCT
dpc-4246	88	1	on	on	ADP
dpc-4246	88	2	the	the	DET
dpc-4246	88	3	contrary	contrary	NOUN
dpc-4246	88	4	,	,	PUNCT
dpc-4246	88	5	kavak	kavak	NOUN
dpc-4246	88	6	and	and	CCONJ
dpc-4246	88	7	colleagues	colleague	NOUN
dpc-4246	88	8	suggested	suggest	VERB
dpc-4246	88	9	a	a	DET
dpc-4246	88	10	higher	high	ADJ
dpc-4246	88	11	incidence	incidence	NOUN
dpc-4246	88	12	of	of	ADP
dpc-4246	88	13	aa	aa	NOUN
dpc-4246	88	14	in	in	ADP
dpc-4246	88	15	males	male	NOUN
dpc-4246	88	16	,	,	PUNCT
dpc-4246	88	17	with	with	ADP
dpc-4246	88	18	a	a	DET
dpc-4246	88	19	female	female	NOUN
dpc-4246	88	20	:	:	PUNCT
dpc-4246	88	21	male	male	ADJ
dpc-4246	88	22	ratio	ratio	NOUN
dpc-4246	88	23	of	of	ADP
dpc-4246	88	24	1:1.6	1:1.6	NUM
dpc-4246	89	1	[	[	X
dpc-4246	89	2	11	11	NUM
dpc-4246	89	3	]	]	PUNCT
dpc-4246	89	4	.	.	PUNCT
dpc-4246	90	1	in	in	ADP
dpc-4246	90	2	this	this	DET
dpc-4246	90	3	study	study	NOUN
dpc-4246	90	4	,	,	PUNCT
dpc-4246	90	5	the	the	DET
dpc-4246	90	6	female	female	NOUN
dpc-4246	90	7	:	:	PUNCT
dpc-4246	90	8	male	male	ADJ
dpc-4246	90	9	ratio	ratio	NOUN
dpc-4246	90	10	for	for	ADP
dpc-4246	90	11	aa	aa	PROPN
dpc-4246	90	12	patients	patient	NOUN
dpc-4246	90	13	was	be	AUX
dpc-4246	90	14	found	find	VERB
dpc-4246	90	15	to	to	PART
dpc-4246	90	16	be	be	AUX
dpc-4246	90	17	1:1.4	1:1.4	NUM
dpc-4246	90	18	.	.	PUNCT
dpc-4246	91	1	it	it	PRON
dpc-4246	91	2	has	have	AUX
dpc-4246	91	3	been	be	AUX
dpc-4246	91	4	demonstrated	demonstrate	VERB
dpc-4246	91	5	that	that	SCONJ
dpc-4246	91	6	several	several	ADJ
dpc-4246	91	7	other	other	ADJ
dpc-4246	91	8	diseases	disease	NOUN
dpc-4246	91	9	can	can	AUX
dpc-4246	91	10	coexist	coexist	VERB
dpc-4246	91	11	with	with	ADP
dpc-4246	91	12	aa	aa	NOUN
dpc-4246	91	13	.	.	PUNCT
dpc-4246	92	1	the	the	DET
dpc-4246	92	2	results	result	NOUN
dpc-4246	92	3	of	of	ADP
dpc-4246	92	4	a	a	DET
dpc-4246	92	5	meta	meta	ADJ
dpc-4246	92	6	-	-	PUNCT
dpc-4246	92	7	analysis	analysis	NOUN
dpc-4246	92	8	showed	show	VERB
dpc-4246	92	9	a	a	DET
dpc-4246	92	10	frequent	frequent	ADJ
dpc-4246	92	11	association	association	NOUN
dpc-4246	92	12	of	of	ADP
dpc-4246	92	13	aa	aa	PROPN
dpc-4246	92	14	with	with	ADP
dpc-4246	92	15	thyroid	thyroid	NOUN
dpc-4246	92	16	disease	disease	NOUN
dpc-4246	92	17	,	,	PUNCT
dpc-4246	92	18	iron	iron	NOUN
dpc-4246	92	19	deficiency	deficiency	NOUN
dpc-4246	92	20	anemia	anemia	NOUN
dpc-4246	92	21	,	,	PUNCT
dpc-4246	92	22	vitamin	vitamin	NOUN
dpc-4246	92	23	d	d	NOUN
dpc-4246	92	24	deficiency	deficiency	NOUN
dpc-4246	92	25	,	,	PUNCT
dpc-4246	92	26	systemic	systemic	ADJ
dpc-4246	92	27	lupus	lupus	PROPN
dpc-4246	92	28	erythematosus	erythematosus	NOUN
dpc-4246	92	29	,	,	PUNCT
dpc-4246	92	30	atopic	atopic	NOUN
dpc-4246	92	31	dermatitis	dermatitis	NOUN
dpc-4246	92	32	,	,	PUNCT
dpc-4246	92	33	allergic	allergic	ADJ
dpc-4246	92	34	rhinitis	rhinitis	NOUN
dpc-4246	92	35	,	,	PUNCT
dpc-4246	92	36	metabolic	metabolic	NOUN
dpc-4246	92	37	syndrome	syndrome	NOUN
dpc-4246	92	38	,	,	PUNCT
dpc-4246	92	39	and	and	CCONJ
dpc-4246	92	40	psychiatric	psychiatric	ADJ
dpc-4246	92	41	disorders	disorder	NOUN
dpc-4246	92	42	[	[	X
dpc-4246	92	43	12	12	NUM
dpc-4246	92	44	]	]	PUNCT
dpc-4246	92	45	.	.	PUNCT
dpc-4246	93	1	in	in	ADP
dpc-4246	93	2	a	a	DET
dpc-4246	93	3	retrospective	retrospective	ADJ
dpc-4246	93	4	study	study	NOUN
dpc-4246	93	5	by	by	ADP
dpc-4246	93	6	laitinen	laitinen	PROPN
dpc-4246	93	7	et	et	PROPN
dpc-4246	93	8	al	al	PROPN
dpc-4246	93	9	.	.	PROPN
dpc-4246	93	10	including	include	VERB
dpc-4246	93	11	a	a	DET
dpc-4246	93	12	total	total	NOUN
dpc-4246	93	13	of	of	ADP
dpc-4246	93	14	176	176	NUM
dpc-4246	93	15	aa	aa	NOUN
dpc-4246	93	16	patients	patient	NOUN
dpc-4246	93	17	,	,	PUNCT
dpc-4246	93	18	it	it	PRON
dpc-4246	93	19	was	be	AUX
dpc-4246	93	20	found	find	VERB
dpc-4246	93	21	that	that	SCONJ
dpc-4246	93	22	27.3	27.3	NUM
dpc-4246	93	23	%	%	NOUN
dpc-4246	93	24	of	of	ADP
dpc-4246	93	25	patients	patient	NOUN
dpc-4246	93	26	had	have	VERB
dpc-4246	93	27	atopic	atopic	NOUN
dpc-4246	93	28	dermatitis	dermatitis	NOUN
dpc-4246	93	29	,	,	PUNCT
dpc-4246	93	30	17	17	NUM
dpc-4246	93	31	%	%	NOUN
dpc-4246	93	32	had	have	VERB
dpc-4246	93	33	thyroid	thyroid	NOUN
dpc-4246	93	34	disease	disease	NOUN
dpc-4246	93	35	,	,	PUNCT
dpc-4246	93	36	and	and	CCONJ
dpc-4246	93	37	13.1	13.1	NUM
dpc-4246	93	38	%	%	NOUN
dpc-4246	93	39	had	have	VERB
dpc-4246	93	40	cardiovascular	cardiovascular	ADJ
dpc-4246	93	41	disease	disease	NOUN
dpc-4246	93	42	[	[	X
dpc-4246	93	43	13	13	NUM
dpc-4246	93	44	]	]	PUNCT
dpc-4246	93	45	.	.	PUNCT
dpc-4246	94	1	a	a	DET
dpc-4246	94	2	systematic	systematic	ADJ
dpc-4246	94	3	review	review	NOUN
dpc-4246	94	4	by	by	ADP
dpc-4246	94	5	fricke	fricke	PROPN
dpc-4246	94	6	et	et	PROPN
dpc-4246	94	7	al	al	PROPN
dpc-4246	94	8	.	.	PROPN
dpc-4246	94	9	reported	report	VERB
dpc-4246	94	10	the	the	DET
dpc-4246	94	11	rates	rate	NOUN
dpc-4246	94	12	of	of	ADP
dpc-4246	94	13	atopic	atopic	NOUN
dpc-4246	94	14	dermatitis	dermatitis	NOUN
dpc-4246	94	15	,	,	PUNCT
dpc-4246	94	16	thyroid	thyroid	NOUN
dpc-4246	94	17	diseases	disease	NOUN
dpc-4246	94	18	,	,	PUNCT
dpc-4246	94	19	and	and	CCONJ
dpc-4246	94	20	diabetes	diabetes	NOUN
dpc-4246	94	21	in	in	ADP
dpc-4246	94	22	aa	aa	PROPN
dpc-4246	94	23	patients	patient	NOUN
dpc-4246	94	24	as	as	ADP
dpc-4246	94	25	15.6	15.6	NUM
dpc-4246	94	26	%	%	NOUN
dpc-4246	94	27	,	,	PUNCT
dpc-4246	94	28	8.9	8.9	NUM
dpc-4246	94	29	%	%	NOUN
dpc-4246	94	30	,	,	PUNCT
dpc-4246	94	31	and	and	CCONJ
dpc-4246	94	32	11.1	11.1	NUM
dpc-4246	94	33	%	%	NOUN
dpc-4246	94	34	,	,	PUNCT
dpc-4246	94	35	respectively	respectively	ADV
dpc-4246	94	36	[	[	X
dpc-4246	94	37	14	14	NUM
dpc-4246	94	38	]	]	PUNCT
dpc-4246	94	39	.	.	PUNCT
dpc-4246	95	1	in	in	ADP
dpc-4246	95	2	this	this	DET
dpc-4246	95	3	study	study	NOUN
dpc-4246	95	4	,	,	PUNCT
dpc-4246	95	5	10	10	NUM
dpc-4246	95	6	%	%	NOUN
dpc-4246	95	7	of	of	ADP
dpc-4246	95	8	aa	aa	PROPN
dpc-4246	95	9	patients	patient	NOUN
dpc-4246	95	10	had	have	VERB
dpc-4246	95	11	coexisting	coexist	VERB
dpc-4246	95	12	diseases	disease	NOUN
dpc-4246	95	13	,	,	PUNCT
dpc-4246	95	14	including	include	VERB
dpc-4246	95	15	hypercholesterolemia	hypercholesterolemia	NOUN
dpc-4246	95	16	,	,	PUNCT
dpc-4246	95	17	pyelonephritis	pyelonephritis	NOUN
dpc-4246	95	18	,	,	PUNCT
dpc-4246	95	19	hypothyroidism	hypothyroidism	NOUN
dpc-4246	95	20	,	,	PUNCT
dpc-4246	95	21	diabetes	diabetes	NOUN
dpc-4246	95	22	,	,	PUNCT
dpc-4246	95	23	hypertension	hypertension	NOUN
dpc-4246	95	24	,	,	PUNCT
dpc-4246	95	25	hashimoto	hashimoto	NOUN
dpc-4246	95	26	thyroiditis	thyroiditis	NOUN
dpc-4246	95	27	,	,	PUNCT
dpc-4246	95	28	and	and	CCONJ
dpc-4246	95	29	iron	iron	NOUN
dpc-4246	95	30	deficiency	deficiency	NOUN
dpc-4246	95	31	anemia	anemia	NOUN
dpc-4246	95	32	.	.	PUNCT
dpc-4246	96	1	changes	change	NOUN
dpc-4246	96	2	were	be	AUX
dpc-4246	96	3	observed	observe	VERB
dpc-4246	96	4	in	in	ADP
dpc-4246	96	5	neutrophil	neutrophil	ADJ
dpc-4246	96	6	and	and	CCONJ
dpc-4246	96	7	lymphocyte	lymphocyte	ADJ
dpc-4246	96	8	count	count	NOUN
dpc-4246	96	9	,	,	PUNCT
dpc-4246	96	10	mlr	mlr	PROPN
dpc-4246	96	11	,	,	PUNCT
dpc-4246	96	12	nlr	nlr	PROPN
dpc-4246	96	13	,	,	PUNCT
dpc-4246	96	14	and	and	CCONJ
dpc-4246	96	15	sii	sii	ADV
dpc-4246	96	16	at	at	ADP
dpc-4246	96	17	the	the	DET
dpc-4246	96	18	third	third	ADJ
dpc-4246	96	19	month	month	NOUN
dpc-4246	96	20	of	of	ADP
dpc-4246	96	21	treatment	treatment	NOUN
dpc-4246	96	22	compared	compare	VERB
dpc-4246	96	23	to	to	ADP
dpc-4246	96	24	pre	pre	ADJ
dpc-4246	96	25	-	-	ADJ
dpc-4246	96	26	treatment	treatment	ADJ
dpc-4246	96	27	values	value	NOUN
dpc-4246	96	28	(	(	PUNCT
dpc-4246	96	29	table	table	NOUN
dpc-4246	96	30	1	1	NUM
dpc-4246	96	31	)	)	PUNCT
dpc-4246	96	32	.	.	PUNCT
dpc-4246	97	1	in	in	ADP
dpc-4246	97	2	the	the	DET
dpc-4246	97	3	aa	aa	PROPN
dpc-4246	97	4	group	group	NOUN
dpc-4246	97	5	,	,	PUNCT
dpc-4246	97	6	a	a	DET
dpc-4246	97	7	statistically	statistically	ADV
dpc-4246	97	8	significant	significant	ADJ
dpc-4246	97	9	relationship	relationship	NOUN
dpc-4246	97	10	was	be	AUX
dpc-4246	97	11	observed	observe	VERB
dpc-4246	97	12	between	between	ADP
dpc-4246	97	13	the	the	DET
dpc-4246	97	14	salt	salt	NOUN
dpc-4246	97	15	score	score	NOUN
dpc-4246	97	16	,	,	PUNCT
dpc-4246	97	17	indicative	indicative	ADJ
dpc-4246	97	18	of	of	ADP
dpc-4246	97	19	disease	disease	NOUN
dpc-4246	97	20	severity	severity	NOUN
dpc-4246	97	21	,	,	PUNCT
dpc-4246	97	22	and	and	CCONJ
dpc-4246	97	23	sii	sii	PROPN
dpc-4246	97	24	(	(	PUNCT
dpc-4246	97	25	p	p	X
dpc-4246	97	26	:	:	PUNCT
dpc-4246	97	27	0.002	0.002	NUM
dpc-4246	97	28	;	;	PUNCT
dpc-4246	97	29	p	p	X
dpc-4246	97	30	<	<	X
dpc-4246	97	31	0.05	0.05	NUM
dpc-4246	97	32	)	)	PUNCT
dpc-4246	97	33	(	(	PUNCT
dpc-4246	97	34	figure	figure	NOUN
dpc-4246	97	35	1	1	NUM
dpc-4246	97	36	)	)	PUNCT
dpc-4246	97	37	.	.	PUNCT
dpc-4246	98	1	after	after	ADP
dpc-4246	98	2	three	three	NUM
dpc-4246	98	3	months	month	NOUN
dpc-4246	98	4	of	of	ADP
dpc-4246	98	5	treatment	treatment	NOUN
dpc-4246	98	6	,	,	PUNCT
dpc-4246	98	7	salt	salt	NOUN
dpc-4246	98	8	scores	score	NOUN
dpc-4246	98	9	of	of	ADP
dpc-4246	98	10	aa	aa	NOUN
dpc-4246	98	11	patients	patient	NOUN
dpc-4246	98	12	were	be	AUX
dpc-4246	98	13	compared	compare	VERB
dpc-4246	98	14	to	to	ADP
dpc-4246	98	15	their	their	PRON
dpc-4246	98	16	pre	pre	ADJ
dpc-4246	98	17	-	-	ADJ
dpc-4246	98	18	treatment	treatment	ADJ
dpc-4246	98	19	values	value	NOUN
dpc-4246	98	20	.	.	PUNCT
dpc-4246	99	1	seventeen	seventeen	NUM
dpc-4246	99	2	patients	patient	NOUN
dpc-4246	99	3	(	(	PUNCT
dpc-4246	99	4	28.3	28.3	NUM
dpc-4246	99	5	%	%	NOUN
dpc-4246	99	6	)	)	PUNCT
dpc-4246	99	7	achieved	achieve	VERB
dpc-4246	99	8	a	a	DET
dpc-4246	99	9	salt	salt	NOUN
dpc-4246	99	10	score	score	NOUN
dpc-4246	99	11	of	of	ADP
dpc-4246	99	12	“	"	PUNCT
dpc-4246	99	13	0	0	NUM
dpc-4246	99	14	,	,	PUNCT
dpc-4246	99	15	”	"	PUNCT
dpc-4246	99	16	while	while	SCONJ
dpc-4246	99	17	37	37	NUM
dpc-4246	99	18	patients	patient	NOUN
dpc-4246	99	19	(	(	PUNCT
dpc-4246	99	20	61.7	61.7	NUM
dpc-4246	99	21	%	%	NOUN
dpc-4246	99	22	)	)	PUNCT
dpc-4246	99	23	experienced	experience	VERB
dpc-4246	99	24	a	a	DET
dpc-4246	99	25	reduction	reduction	NOUN
dpc-4246	99	26	in	in	ADP
dpc-4246	99	27	their	their	PRON
dpc-4246	99	28	salt	salt	NOUN
dpc-4246	99	29	scores	score	NOUN
dpc-4246	99	30	,	,	PUNCT
dpc-4246	99	31	and	and	CCONJ
dpc-4246	99	32	six	six	NUM
dpc-4246	99	33	patients	patient	NOUN
dpc-4246	99	34	(	(	PUNCT
dpc-4246	99	35	10	10	NUM
dpc-4246	99	36	%	%	NOUN
dpc-4246	99	37	)	)	PUNCT
dpc-4246	99	38	maintained	maintain	VERB
dpc-4246	99	39	unchanged	unchanged	ADJ
dpc-4246	99	40	salt	salt	NOUN
dpc-4246	99	41	scores	score	NOUN
dpc-4246	99	42	.	.	PUNCT
dpc-4246	100	1	six	six	NUM
dpc-4246	100	2	patients	patient	NOUN
dpc-4246	100	3	,	,	PUNCT
dpc-4246	100	4	who	who	PRON
dpc-4246	100	5	maintained	maintain	VERB
dpc-4246	100	6	unaltered	unaltered	ADJ
dpc-4246	100	7	salt	salt	NOUN
dpc-4246	100	8	scores	score	NOUN
dpc-4246	100	9	,	,	PUNCT
dpc-4246	100	10	exhibited	exhibit	VERB
dpc-4246	100	11	an	an	DET
dpc-4246	100	12	increase	increase	NOUN
dpc-4246	100	13	in	in	ADP
dpc-4246	100	14	sii	sii	ADJ
dpc-4246	100	15	values	value	NOUN
dpc-4246	100	16	at	at	ADP
dpc-4246	100	17	the	the	DET
dpc-4246	100	18	third	third	ADJ
dpc-4246	100	19	month	month	NOUN
dpc-4246	100	20	of	of	ADP
dpc-4246	100	21	treatment	treatment	NOUN
dpc-4246	100	22	.	.	PUNCT
dpc-4246	101	1	patients	patient	NOUN
dpc-4246	101	2	who	who	PRON
dpc-4246	101	3	achieved	achieve	VERB
dpc-4246	101	4	a	a	DET
dpc-4246	101	5	salt	salt	NOUN
dpc-4246	101	6	score	score	NOUN
dpc-4246	101	7	of	of	ADP
dpc-4246	101	8	“	"	PUNCT
dpc-4246	101	9	0	0	NUM
dpc-4246	101	10	”	"	PUNCT
dpc-4246	101	11	or	or	CCONJ
dpc-4246	101	12	experienced	experience	VERB
dpc-4246	101	13	a	a	DET
dpc-4246	101	14	reduction	reduction	NOUN
dpc-4246	101	15	in	in	ADP
dpc-4246	101	16	salt	salt	NOUN
dpc-4246	101	17	scores	score	NOUN
dpc-4246	101	18	showed	show	VERB
dpc-4246	101	19	lower	low	ADJ
dpc-4246	101	20	sii	sii	ADJ
dpc-4246	101	21	values	value	NOUN
dpc-4246	101	22	in	in	ADP
dpc-4246	101	23	comparison	comparison	NOUN
dpc-4246	101	24	to	to	ADP
dpc-4246	101	25	their	their	PRON
dpc-4246	101	26	pre	pre	ADJ
dpc-4246	101	27	-	-	ADJ
dpc-4246	101	28	treatment	treatment	ADJ
dpc-4246	101	29	values	value	NOUN
dpc-4246	101	30	.	.	PUNCT
dpc-4246	102	1	there	there	PRON
dpc-4246	102	2	was	be	VERB
dpc-4246	102	3	a	a	DET
dpc-4246	102	4	statistically	statistically	ADV
dpc-4246	102	5	significant	significant	ADJ
dpc-4246	102	6	difference	difference	NOUN
dpc-4246	102	7	between	between	ADP
dpc-4246	102	8	pre	pre	ADJ
dpc-4246	102	9	-	-	ADJ
dpc-4246	102	10	and	and	CCONJ
dpc-4246	102	11	post	post	ADJ
dpc-4246	102	12	-	-	ADJ
dpc-4246	102	13	treatment	treatment	ADJ
dpc-4246	102	14	values	value	NOUN
dpc-4246	102	15	(	(	PUNCT
dpc-4246	102	16	p	p	X
dpc-4246	102	17	<	<	X
dpc-4246	102	18	0.05	0.05	NUM
dpc-4246	102	19	)	)	PUNCT
dpc-4246	102	20	.	.	PUNCT
dpc-4246	103	1	the	the	DET
dpc-4246	103	2	roc	roc	PROPN
dpc-4246	103	3	curve	curve	NOUN
dpc-4246	103	4	was	be	AUX
dpc-4246	103	5	plotted	plot	VERB
dpc-4246	103	6	to	to	PART
dpc-4246	103	7	assess	assess	VERB
dpc-4246	103	8	the	the	DET
dpc-4246	103	9	performance	performance	NOUN
dpc-4246	103	10	of	of	ADP
dpc-4246	103	11	sii	sii	PROPN
dpc-4246	103	12	(	(	PUNCT
dpc-4246	103	13	auc	auc	NOUN
dpc-4246	103	14	:	:	PUNCT
dpc-4246	103	15	0.625	0.625	NUM
dpc-4246	103	16	)	)	PUNCT
dpc-4246	103	17	.	.	PUNCT
dpc-4246	104	1	it	it	PRON
dpc-4246	104	2	was	be	AUX
dpc-4246	104	3	found	find	VERB
dpc-4246	104	4	that	that	SCONJ
dpc-4246	104	5	sii	sii	PROPN
dpc-4246	104	6	can	can	AUX
dpc-4246	104	7	discriminate	discriminate	VERB
dpc-4246	104	8	aa	aa	NOUN
dpc-4246	104	9	patients	patient	NOUN
dpc-4246	104	10	from	from	ADP
dpc-4246	104	11	healthy	healthy	ADJ
dpc-4246	104	12	individuals	individual	NOUN
dpc-4246	104	13	at	at	ADP
dpc-4246	104	14	a	a	DET
dpc-4246	104	15	rate	rate	NOUN
dpc-4246	104	16	of	of	ADP
dpc-4246	104	17	62.5	62.5	NUM
dpc-4246	104	18	%	%	NOUN
dpc-4246	104	19	(	(	PUNCT
dpc-4246	104	20	moderate	moderate	ADJ
dpc-4246	104	21	level	level	NOUN
dpc-4246	104	22	)	)	PUNCT
dpc-4246	104	23	.	.	PUNCT
dpc-4246	105	1	the	the	DET
dpc-4246	105	2	threshold	threshold	NOUN
dpc-4246	105	3	value	value	NOUN
dpc-4246	105	4	for	for	ADP
dpc-4246	105	5	sii	sii	PROPN
dpc-4246	105	6	was	be	AUX
dpc-4246	105	7	determined	determine	VERB
dpc-4246	105	8	as	as	ADP
dpc-4246	105	9	368.67	368.67	NUM
dpc-4246	105	10	,	,	PUNCT
dpc-4246	105	11	with	with	ADP
dpc-4246	105	12	a	a	DET
dpc-4246	105	13	sensitivity	sensitivity	NOUN
dpc-4246	105	14	of	of	ADP
dpc-4246	105	15	85	85	NUM
dpc-4246	105	16	%	%	NOUN
dpc-4246	105	17	and	and	CCONJ
dpc-4246	105	18	specificity	specificity	NOUN
dpc-4246	105	19	of	of	ADP
dpc-4246	105	20	57.5	57.5	NUM
dpc-4246	105	21	%	%	NOUN
dpc-4246	105	22	.	.	PUNCT
dpc-4246	106	1	using	use	VERB
dpc-4246	106	2	this	this	DET
dpc-4246	106	3	threshold	threshold	NOUN
dpc-4246	106	4	value	value	NOUN
dpc-4246	106	5	,	,	PUNCT
dpc-4246	106	6	sii	sii	PROPN
dpc-4246	106	7	can	can	AUX
dpc-4246	106	8	identify	identify	VERB
dpc-4246	106	9	aa	aa	NOUN
dpc-4246	106	10	patients	patient	NOUN
dpc-4246	106	11	at	at	ADP
dpc-4246	106	12	a	a	DET
dpc-4246	106	13	rate	rate	NOUN
dpc-4246	106	14	of	of	ADP
dpc-4246	106	15	85	85	NUM
dpc-4246	106	16	%	%	NOUN
dpc-4246	106	17	and	and	CCONJ
dpc-4246	106	18	healthy	healthy	ADJ
dpc-4246	106	19	individuals	individual	NOUN
dpc-4246	106	20	at	at	ADP
dpc-4246	106	21	a	a	DET
dpc-4246	106	22	rate	rate	NOUN
dpc-4246	106	23	of	of	ADP
dpc-4246	106	24	57.5	57.5	NUM
dpc-4246	106	25	%	%	NOUN
dpc-4246	106	26	.	.	PUNCT
dpc-4246	107	1	sii	sii	PROPN
dpc-4246	107	2	can	can	AUX
dpc-4246	107	3	correctly	correctly	ADV
dpc-4246	107	4	classify	classify	VERB
dpc-4246	107	5	individuals	individual	NOUN
dpc-4246	107	6	with	with	ADP
dpc-4246	107	7	aa	aa	NOUN
dpc-4246	107	8	with	with	ADP
dpc-4246	107	9	a	a	DET
dpc-4246	107	10	probability	probability	NOUN
dpc-4246	107	11	of	of	ADP
dpc-4246	107	12	95	95	NUM
dpc-4246	107	13	%	%	NOUN
dpc-4246	107	14	,	,	PUNCT
dpc-4246	107	15	ranging	range	VERB
dpc-4246	107	16	from	from	ADP
dpc-4246	107	17	at	at	ADV
dpc-4246	107	18	least	least	ADV
dpc-4246	107	19	52.2	52.2	NUM
dpc-4246	107	20	%	%	NOUN
dpc-4246	107	21	to	to	ADP
dpc-4246	107	22	a	a	DET
dpc-4246	107	23	maximum	maximum	NOUN
dpc-4246	107	24	of	of	ADP
dpc-4246	107	25	71.9	71.9	NUM
dpc-4246	107	26	%	%	NOUN
dpc-4246	107	27	(	(	PUNCT
dpc-4246	107	28	auc	auc	NOUN
dpc-4246	107	29	:	:	PUNCT
dpc-4246	107	30	0.625	0.625	NUM
dpc-4246	107	31	;	;	PUNCT
dpc-4246	107	32	95	95	NUM
dpc-4246	107	33	%	%	NOUN
dpc-4246	107	34	ci	ci	NOUN
dpc-4246	107	35	:	:	PUNCT
dpc-4246	107	36	0.522–0.719	0.522–0.719	NOUN
dpc-4246	107	37	;	;	PUNCT
dpc-4246	107	38	p	p	X
dpc-4246	107	39	:	:	PUNCT
dpc-4246	107	40	0.030	0.030	NUM
dpc-4246	107	41	;	;	PUNCT
dpc-4246	107	42	p	p	X
dpc-4246	107	43	<	<	X
dpc-4246	107	44	0.05	0.05	NUM
dpc-4246	107	45	)	)	PUNCT
dpc-4246	107	46	(	(	PUNCT
dpc-4246	107	47	figure	figure	NOUN
dpc-4246	107	48	2	2	NUM
dpc-4246	107	49	)	)	PUNCT
dpc-4246	107	50	.	.	PUNCT
dpc-4246	108	1	discussion	discussion	NOUN
dpc-4246	108	2	aa	aa	NOUN
dpc-4246	108	3	is	be	AUX
dpc-4246	108	4	an	an	DET
dpc-4246	108	5	autoimmune	autoimmune	ADJ
dpc-4246	108	6	disease	disease	NOUN
dpc-4246	108	7	characterized	characterize	VERB
dpc-4246	108	8	by	by	ADP
dpc-4246	108	9	hair	hair	NOUN
dpc-4246	108	10	loss	loss	NOUN
dpc-4246	108	11	on	on	ADP
dpc-4246	108	12	the	the	DET
dpc-4246	108	13	scalp	scalp	NOUN
dpc-4246	108	14	,	,	PUNCT
dpc-4246	108	15	beard	beard	NOUN
dpc-4246	108	16	,	,	PUNCT
dpc-4246	108	17	eyebrows	eyebrow	NOUN
dpc-4246	108	18	/	/	SYM
dpc-4246	108	19	eyelashes	eyelash	NOUN
dpc-4246	108	20	,	,	PUNCT
dpc-4246	108	21	and/or	and/or	CCONJ
dpc-4246	108	22	body	body	NOUN
dpc-4246	108	23	hair	hair	NOUN
dpc-4246	108	24	.	.	PUNCT
dpc-4246	109	1	various	various	ADJ
dpc-4246	109	2	clinical	clinical	ADJ
dpc-4246	109	3	variants	variant	NOUN
dpc-4246	109	4	of	of	ADP
dpc-4246	109	5	aa	aa	PROPN
dpc-4246	109	6	exist	exist	VERB
dpc-4246	109	7	,	,	PUNCT
dpc-4246	109	8	including	include	VERB
dpc-4246	109	9	ophiasis	ophiasis	NOUN
dpc-4246	109	10	,	,	PUNCT
dpc-4246	109	11	inverse	inverse	ADJ
dpc-4246	109	12	figure	figure	NOUN
dpc-4246	109	13	1	1	NUM
dpc-4246	109	14	.	.	PUNCT
dpc-4246	109	15	correlation	correlation	NOUN
dpc-4246	109	16	graph	graph	NOUN
dpc-4246	109	17	depicting	depict	VERB
dpc-4246	109	18	the	the	DET
dpc-4246	109	19	relationship	relationship	NOUN
dpc-4246	109	20	between	between	ADP
dpc-4246	109	21	severity	severity	NOUN
dpc-4246	109	22	of	of	ADP
dpc-4246	109	23	alopecia	alopecia	NOUN
dpc-4246	109	24	tool	tool	NOUN
dpc-4246	109	25	(	(	PUNCT
dpc-4246	109	26	salt	salt	NOUN
dpc-4246	109	27	)	)	PUNCT
dpc-4246	109	28	score	score	NOUN
dpc-4246	109	29	and	and	CCONJ
dpc-4246	109	30	systemic	systemic	ADJ
dpc-4246	109	31	immune	immune	ADJ
dpc-4246	109	32	inflammation	inflammation	NOUN
dpc-4246	109	33	index	index	NOUN
dpc-4246	109	34	(	(	PUNCT
dpc-4246	109	35	sii	sii	PROPN
dpc-4246	109	36	)	)	PUNCT
dpc-4246	109	37	in	in	ADP
dpc-4246	109	38	the	the	DET
dpc-4246	109	39	alopecia	alopecia	NOUN
dpc-4246	109	40	areata	areata	ADJ
dpc-4246	109	41	(	(	PUNCT
dpc-4246	109	42	aa	aa	NOUN
dpc-4246	109	43	)	)	PUNCT
dpc-4246	109	44	patient	patient	NOUN
dpc-4246	109	45	group	group	NOUN
dpc-4246	109	46	.	.	PUNCT
dpc-4246	110	1	figure	figure	NOUN
dpc-4246	110	2	2	2	NUM
dpc-4246	110	3	.	.	PUNCT
dpc-4246	111	1	roc	roc	PROPN
dpc-4246	111	2	curve	curve	NOUN
dpc-4246	111	3	for	for	ADP
dpc-4246	111	4	systemic	systemic	ADJ
dpc-4246	111	5	immune	immune	ADJ
dpc-4246	111	6	-	-	PUNCT
dpc-4246	111	7	inflammation	inflammation	NOUN
dpc-4246	111	8	index	index	NOUN
dpc-4246	111	9	(	(	PUNCT
dpc-4246	111	10	sii	sii	PROPN
dpc-4246	111	11	)	)	PUNCT
dpc-4246	111	12	.	.	PUNCT
dpc-4246	112	1	original	original	ADJ
dpc-4246	112	2	article	article	NOUN
dpc-4246	112	3	|	|	ADV
dpc-4246	112	4	dermatol	dermatol	ADJ
dpc-4246	112	5	pract	pract	NOUN
dpc-4246	112	6	concept	concept	NOUN
dpc-4246	112	7	.	.	PUNCT
dpc-4246	113	1	2024;14(3):e2024193	2024;14(3):e2024193	NUM
dpc-4246	113	2	5	5	NUM
dpc-4246	113	3	mild	mild	ADJ
dpc-4246	113	4	psoriatic	psoriatic	ADJ
dpc-4246	113	5	arthritis	arthritis	NOUN
dpc-4246	113	6	[	[	X
dpc-4246	113	7	23	23	NUM
dpc-4246	113	8	]	]	PUNCT
dpc-4246	113	9	.	.	PUNCT
dpc-4246	114	1	in	in	ADP
dpc-4246	114	2	a	a	DET
dpc-4246	114	3	retrospective	retrospective	ADJ
dpc-4246	114	4	cohort	cohort	NOUN
dpc-4246	114	5	study	study	NOUN
dpc-4246	114	6	involving	involve	VERB
dpc-4246	114	7	patients	patient	NOUN
dpc-4246	114	8	with	with	ADP
dpc-4246	114	9	recurrent	recurrent	ADJ
dpc-4246	114	10	aphthous	aphthous	ADJ
dpc-4246	114	11	stomatitis	stomatitis	NOUN
dpc-4246	114	12	,	,	PUNCT
dpc-4246	114	13	a	a	DET
dpc-4246	114	14	positive	positive	ADJ
dpc-4246	114	15	correlation	correlation	NOUN
dpc-4246	114	16	was	be	AUX
dpc-4246	114	17	observed	observe	VERB
dpc-4246	114	18	between	between	ADP
dpc-4246	114	19	sii	sii	PROPN
dpc-4246	114	20	and	and	CCONJ
dpc-4246	114	21	the	the	DET
dpc-4246	114	22	disease	disease	NOUN
dpc-4246	114	23	severity	severity	NOUN
dpc-4246	114	24	(	(	PUNCT
dpc-4246	114	25	24	24	NUM
dpc-4246	114	26	)	)	PUNCT
dpc-4246	114	27	.	.	PUNCT
dpc-4246	115	1	in	in	ADP
dpc-4246	115	2	this	this	DET
dpc-4246	115	3	study	study	NOUN
dpc-4246	115	4	,	,	PUNCT
dpc-4246	115	5	a	a	DET
dpc-4246	115	6	positive	positive	ADJ
dpc-4246	115	7	correlation	correlation	NOUN
dpc-4246	115	8	between	between	ADP
dpc-4246	115	9	the	the	DET
dpc-4246	115	10	sii	sii	PROPN
dpc-4246	115	11	and	and	CCONJ
dpc-4246	115	12	the	the	DET
dpc-4246	115	13	salt	salt	NOUN
dpc-4246	115	14	score	score	NOUN
dpc-4246	115	15	suggests	suggest	VERB
dpc-4246	115	16	that	that	SCONJ
dpc-4246	115	17	sii	sii	PROPN
dpc-4246	115	18	could	could	AUX
dpc-4246	115	19	be	be	AUX
dpc-4246	115	20	used	use	VERB
dpc-4246	115	21	to	to	PART
dpc-4246	115	22	assess	assess	VERB
dpc-4246	115	23	the	the	DET
dpc-4246	115	24	severity	severity	NOUN
dpc-4246	115	25	of	of	ADP
dpc-4246	115	26	aa	aa	PROPN
dpc-4246	115	27	.	.	PUNCT
dpc-4246	116	1	limitations	limitation	NOUN
dpc-4246	116	2	this	this	DET
dpc-4246	116	3	study	study	NOUN
dpc-4246	116	4	has	have	VERB
dpc-4246	116	5	some	some	DET
dpc-4246	116	6	limitations	limitation	NOUN
dpc-4246	116	7	.	.	PUNCT
dpc-4246	117	1	a	a	DET
dpc-4246	117	2	longer	long	ADV
dpc-4246	117	3	follow	follow	NOUN
dpc-4246	117	4	-	-	PUNCT
dpc-4246	117	5	up	up	NOUN
dpc-4246	117	6	including	include	VERB
dpc-4246	117	7	a	a	DET
dpc-4246	117	8	period	period	NOUN
dpc-4246	117	9	of	of	ADP
dpc-4246	117	10	6	6	NUM
dpc-4246	117	11	-	-	SYM
dpc-4246	117	12	12	12	NUM
dpc-4246	117	13	months	month	NOUN
dpc-4246	117	14	could	could	AUX
dpc-4246	117	15	be	be	AUX
dpc-4246	117	16	carried	carry	VERB
dpc-4246	117	17	out	out	ADP
dpc-4246	117	18	.	.	PUNCT
dpc-4246	118	1	the	the	DET
dpc-4246	118	2	single	single	ADJ
dpc-4246	118	3	-	-	PUNCT
dpc-4246	118	4	center	center	NOUN
dpc-4246	118	5	nature	nature	NOUN
dpc-4246	118	6	of	of	ADP
dpc-4246	118	7	the	the	DET
dpc-4246	118	8	study	study	NOUN
dpc-4246	118	9	and	and	CCONJ
dpc-4246	118	10	the	the	DET
dpc-4246	118	11	relatively	relatively	ADV
dpc-4246	118	12	small	small	ADJ
dpc-4246	118	13	number	number	NOUN
dpc-4246	118	14	of	of	ADP
dpc-4246	118	15	patients	patient	NOUN
dpc-4246	118	16	and	and	CCONJ
dpc-4246	118	17	controls	control	NOUN
dpc-4246	118	18	can	can	AUX
dpc-4246	118	19	be	be	AUX
dpc-4246	118	20	considered	consider	VERB
dpc-4246	118	21	as	as	ADP
dpc-4246	118	22	other	other	ADJ
dpc-4246	118	23	limitations	limitation	NOUN
dpc-4246	118	24	.	.	PUNCT
dpc-4246	119	1	additionally	additionally	ADV
dpc-4246	119	2	,	,	PUNCT
dpc-4246	119	3	the	the	DET
dpc-4246	119	4	hematological	hematological	ADJ
dpc-4246	119	5	markers	marker	NOUN
dpc-4246	119	6	examined	examine	VERB
dpc-4246	119	7	in	in	ADP
dpc-4246	119	8	the	the	DET
dpc-4246	119	9	study	study	NOUN
dpc-4246	119	10	may	may	AUX
dpc-4246	119	11	show	show	VERB
dpc-4246	119	12	an	an	DET
dpc-4246	119	13	increase	increase	NOUN
dpc-4246	119	14	in	in	ADP
dpc-4246	119	15	existing	exist	VERB
dpc-4246	119	16	inflammatory	inflammatory	ADJ
dpc-4246	119	17	conditions	condition	NOUN
dpc-4246	119	18	including	include	VERB
dpc-4246	119	19	active	active	ADJ
dpc-4246	119	20	infections	infection	NOUN
dpc-4246	119	21	,	,	PUNCT
dpc-4246	119	22	rheumatoid	rheumatoid	NOUN
dpc-4246	119	23	arthritis	arthritis	NOUN
dpc-4246	119	24	,	,	PUNCT
dpc-4246	119	25	ankylosing	ankylose	VERB
dpc-4246	119	26	spondylitis	spondylitis	NOUN
dpc-4246	119	27	,	,	PUNCT
dpc-4246	119	28	autoimmune	autoimmune	ADJ
dpc-4246	119	29	diseases	disease	NOUN
dpc-4246	119	30	,	,	PUNCT
dpc-4246	119	31	inflammatory	inflammatory	ADJ
dpc-4246	119	32	bowel	bowel	NOUN
dpc-4246	119	33	diseases	disease	NOUN
dpc-4246	119	34	,	,	PUNCT
dpc-4246	119	35	and	and	CCONJ
dpc-4246	119	36	internal	internal	ADJ
dpc-4246	119	37	organ	organ	NOUN
dpc-4246	119	38	malignancies	malignancy	NOUN
dpc-4246	119	39	.	.	PUNCT
dpc-4246	120	1	therefore	therefore	ADV
dpc-4246	120	2	,	,	PUNCT
dpc-4246	120	3	active	active	ADJ
dpc-4246	120	4	infections	infection	NOUN
dpc-4246	120	5	or	or	CCONJ
dpc-4246	120	6	inflammatory	inflammatory	ADJ
dpc-4246	120	7	diseases	disease	NOUN
dpc-4246	120	8	may	may	AUX
dpc-4246	120	9	serve	serve	VERB
dpc-4246	120	10	as	as	ADP
dpc-4246	120	11	restrictive	restrictive	ADJ
dpc-4246	120	12	factors	factor	NOUN
dpc-4246	120	13	for	for	ADP
dpc-4246	120	14	the	the	DET
dpc-4246	120	15	use	use	NOUN
dpc-4246	120	16	of	of	ADP
dpc-4246	120	17	these	these	DET
dpc-4246	120	18	parameters	parameter	NOUN
dpc-4246	120	19	.	.	PUNCT
dpc-4246	121	1	in	in	ADP
dpc-4246	121	2	addition	addition	NOUN
dpc-4246	121	3	,	,	PUNCT
dpc-4246	121	4	it	it	PRON
dpc-4246	121	5	is	be	AUX
dpc-4246	121	6	crucial	crucial	ADJ
dpc-4246	121	7	to	to	PART
dpc-4246	121	8	consider	consider	VERB
dpc-4246	121	9	that	that	SCONJ
dpc-4246	121	10	the	the	DET
dpc-4246	121	11	positive	positive	ADJ
dpc-4246	121	12	correlation	correlation	NOUN
dpc-4246	121	13	between	between	ADP
dpc-4246	121	14	sii	sii	ADJ
dpc-4246	121	15	and	and	CCONJ
dpc-4246	121	16	salt	salt	NOUN
dpc-4246	121	17	scores	score	NOUN
dpc-4246	121	18	might	might	AUX
dpc-4246	121	19	not	not	PART
dpc-4246	121	20	be	be	AUX
dpc-4246	121	21	entirely	entirely	ADV
dpc-4246	121	22	accurate	accurate	ADJ
dpc-4246	121	23	.	.	PUNCT
dpc-4246	122	1	the	the	DET
dpc-4246	122	2	presence	presence	NOUN
dpc-4246	122	3	of	of	ADP
dpc-4246	122	4	preexisting	preexist	VERB
dpc-4246	122	5	inflammatory	inflammatory	ADJ
dpc-4246	122	6	conditions	condition	NOUN
dpc-4246	122	7	,	,	PUNCT
dpc-4246	122	8	as	as	SCONJ
dpc-4246	122	9	mentioned	mention	VERB
dpc-4246	122	10	earlier	early	ADV
dpc-4246	122	11	,	,	PUNCT
dpc-4246	122	12	could	could	AUX
dpc-4246	122	13	elevate	elevate	VERB
dpc-4246	122	14	sii	sii	PROPN
dpc-4246	122	15	,	,	PUNCT
dpc-4246	122	16	potentially	potentially	ADV
dpc-4246	122	17	introducing	introduce	VERB
dpc-4246	122	18	bias	bias	NOUN
dpc-4246	122	19	into	into	ADP
dpc-4246	122	20	its	its	PRON
dpc-4246	122	21	association	association	NOUN
dpc-4246	122	22	with	with	ADP
dpc-4246	122	23	the	the	DET
dpc-4246	122	24	salt	salt	NOUN
dpc-4246	122	25	score	score	NOUN
dpc-4246	122	26	.	.	PUNCT
dpc-4246	123	1	given	give	VERB
dpc-4246	123	2	the	the	DET
dpc-4246	123	3	potential	potential	NOUN
dpc-4246	123	4	for	for	ADP
dpc-4246	123	5	confounding	confound	VERB
dpc-4246	123	6	factors	factor	NOUN
dpc-4246	123	7	,	,	PUNCT
dpc-4246	123	8	further	further	ADJ
dpc-4246	123	9	research	research	NOUN
dpc-4246	123	10	is	be	AUX
dpc-4246	123	11	warranted	warrant	VERB
dpc-4246	123	12	to	to	PART
dpc-4246	123	13	clarify	clarify	VERB
dpc-4246	123	14	the	the	DET
dpc-4246	123	15	association	association	NOUN
dpc-4246	123	16	between	between	ADP
dpc-4246	123	17	sii	sii	PROPN
dpc-4246	123	18	and	and	CCONJ
dpc-4246	123	19	salt	salt	NOUN
dpc-4246	123	20	scores	score	NOUN
dpc-4246	123	21	.	.	PUNCT
dpc-4246	124	1	conclusion	conclusion	NOUN
dpc-4246	124	2	this	this	DET
dpc-4246	124	3	study	study	NOUN
dpc-4246	124	4	demonstrates	demonstrate	VERB
dpc-4246	124	5	that	that	SCONJ
dpc-4246	124	6	sii	sii	PROPN
dpc-4246	124	7	is	be	AUX
dpc-4246	124	8	a	a	DET
dpc-4246	124	9	useful	useful	ADJ
dpc-4246	124	10	marker	marker	NOUN
dpc-4246	124	11	for	for	ADP
dpc-4246	124	12	distinguishing	distinguish	VERB
dpc-4246	124	13	between	between	ADP
dpc-4246	124	14	patients	patient	NOUN
dpc-4246	124	15	with	with	ADP
dpc-4246	124	16	aa	aa	ADJ
dpc-4246	124	17	and	and	CCONJ
dpc-4246	124	18	healthy	healthy	ADJ
dpc-4246	124	19	controls	control	NOUN
dpc-4246	124	20	.	.	PUNCT
dpc-4246	125	1	furthermore	furthermore	ADV
dpc-4246	125	2	,	,	PUNCT
dpc-4246	125	3	it	it	PRON
dpc-4246	125	4	has	have	AUX
dpc-4246	125	5	been	be	AUX
dpc-4246	125	6	demonstrated	demonstrate	VERB
dpc-4246	125	7	that	that	SCONJ
dpc-4246	125	8	sii	sii	PROPN
dpc-4246	125	9	can	can	AUX
dpc-4246	125	10	be	be	AUX
dpc-4246	125	11	used	use	VERB
dpc-4246	125	12	to	to	PART
dpc-4246	125	13	evaluate	evaluate	VERB
dpc-4246	125	14	the	the	DET
dpc-4246	125	15	severity	severity	NOUN
dpc-4246	125	16	of	of	ADP
dpc-4246	125	17	aa	aa	NOUN
dpc-4246	125	18	and	and	CCONJ
dpc-4246	125	19	response	response	NOUN
dpc-4246	125	20	to	to	ADP
dpc-4246	125	21	treatment	treatment	NOUN
dpc-4246	125	22	.	.	PUNCT
dpc-4246	126	1	the	the	DET
dpc-4246	126	2	significant	significant	ADJ
dpc-4246	126	3	differences	difference	NOUN
dpc-4246	126	4	in	in	ADP
dpc-4246	126	5	mpv	mpv	PROPN
dpc-4246	126	6	,	,	PUNCT
dpc-4246	126	7	nlr	nlr	PROPN
dpc-4246	126	8	,	,	PUNCT
dpc-4246	126	9	sii	sii	PROPN
dpc-4246	126	10	,	,	PUNCT
dpc-4246	126	11	and	and	CCONJ
dpc-4246	126	12	hdl	hdl	PROPN
dpc-4246	126	13	values	value	NOUN
dpc-4246	126	14	in	in	ADP
dpc-4246	126	15	aa	aa	PROPN
dpc-4246	126	16	patients	patient	NOUN
dpc-4246	126	17	compared	compare	VERB
dpc-4246	126	18	to	to	ADP
dpc-4246	126	19	the	the	DET
dpc-4246	126	20	control	control	NOUN
dpc-4246	126	21	group	group	NOUN
dpc-4246	126	22	indicate	indicate	VERB
dpc-4246	126	23	that	that	SCONJ
dpc-4246	126	24	these	these	DET
dpc-4246	126	25	parameters	parameter	NOUN
dpc-4246	126	26	are	be	AUX
dpc-4246	126	27	useful	useful	ADJ
dpc-4246	126	28	in	in	ADP
dpc-4246	126	29	reflecting	reflect	VERB
dpc-4246	126	30	inflammation	inflammation	NOUN
dpc-4246	126	31	in	in	ADP
dpc-4246	126	32	aa	aa	NOUN
dpc-4246	126	33	.	.	PUNCT
dpc-4246	127	1	in	in	ADP
dpc-4246	127	2	this	this	DET
dpc-4246	127	3	regard	regard	NOUN
dpc-4246	127	4	,	,	PUNCT
dpc-4246	127	5	multicenter	multicenter	ADJ
dpc-4246	127	6	studies	study	NOUN
dpc-4246	127	7	involving	involve	VERB
dpc-4246	127	8	a	a	DET
dpc-4246	127	9	larger	large	ADJ
dpc-4246	127	10	patient	patient	ADJ
dpc-4246	127	11	population	population	NOUN
dpc-4246	127	12	are	be	AUX
dpc-4246	127	13	needed	need	VERB
dpc-4246	127	14	.	.	PUNCT
dpc-4246	128	1	references	reference	NOUN
dpc-4246	128	2	1	1	NUM
dpc-4246	128	3	.	.	PUNCT
dpc-4246	128	4	strazzulla	strazzulla	PROPN
dpc-4246	128	5	lc	lc	PROPN
dpc-4246	128	6	,	,	PUNCT
dpc-4246	128	7	wang	wang	PROPN
dpc-4246	128	8	ehc	ehc	PROPN
dpc-4246	128	9	,	,	PUNCT
dpc-4246	128	10	avila	avila	PROPN
dpc-4246	128	11	l	l	PROPN
dpc-4246	128	12	,	,	PUNCT
dpc-4246	128	13	et	et	PROPN
dpc-4246	128	14	al	al	PROPN
dpc-4246	128	15	.	.	PUNCT
dpc-4246	129	1	alopecia	alopecia	NOUN
dpc-4246	129	2	areata	areata	NOUN
dpc-4246	129	3	:	:	PUNCT
dpc-4246	129	4	disease	disease	NOUN
dpc-4246	129	5	characteristics	characteristic	NOUN
dpc-4246	129	6	,	,	PUNCT
dpc-4246	129	7	clinical	clinical	ADJ
dpc-4246	129	8	evaluation	evaluation	NOUN
dpc-4246	129	9	,	,	PUNCT
dpc-4246	129	10	and	and	CCONJ
dpc-4246	129	11	new	new	ADJ
dpc-4246	129	12	perspectives	perspective	NOUN
dpc-4246	129	13	on	on	ADP
dpc-4246	129	14	pathogenesis	pathogenesis	NOUN
dpc-4246	129	15	.	.	PUNCT
dpc-4246	130	1	j	j	PROPN
dpc-4246	130	2	am	be	AUX
dpc-4246	130	3	acad	acad	ADJ
dpc-4246	130	4	dermatol	dermatol	NOUN
dpc-4246	130	5	2018;78(1):1	2018;78(1):1	NUM
dpc-4246	130	6	-	-	SYM
dpc-4246	130	7	12	12	NUM
dpc-4246	130	8	.	.	PUNCT
dpc-4246	131	1	doi:10.1016	doi:10.1016	PROPN
dpc-4246	131	2	/	/	SYM
dpc-4246	131	3	j.jaad.2017.04.1141	j.jaad.2017.04.1141	PROPN
dpc-4246	131	4	2	2	NUM
dpc-4246	131	5	.	.	PUNCT
dpc-4246	132	1	zhou	zhou	PROPN
dpc-4246	132	2	c	c	PROPN
dpc-4246	132	3	,	,	PUNCT
dpc-4246	132	4	li	li	PROPN
dpc-4246	132	5	x	x	PROPN
dpc-4246	132	6	,	,	PUNCT
dpc-4246	132	7	wang	wang	PROPN
dpc-4246	132	8	c	c	PROPN
dpc-4246	132	9	,	,	PUNCT
dpc-4246	132	10	zhang	zhang	PROPN
dpc-4246	132	11	j.	j.	PROPN
dpc-4246	132	12	alopecia	alopecia	PROPN
dpc-4246	132	13	areata	areata	PROPN
dpc-4246	132	14	:	:	PUNCT
dpc-4246	132	15	an	an	DET
dpc-4246	132	16	update	update	NOUN
dpc-4246	132	17	on	on	ADP
dpc-4246	132	18	etiopathogenesis	etiopathogenesis	NOUN
dpc-4246	132	19	,	,	PUNCT
dpc-4246	132	20	diagnosis	diagnosis	NOUN
dpc-4246	132	21	,	,	PUNCT
dpc-4246	132	22	and	and	CCONJ
dpc-4246	132	23	management	management	NOUN
dpc-4246	132	24	.	.	PUNCT
dpc-4246	133	1	clin	clin	PROPN
dpc-4246	133	2	rev	rev	PROPN
dpc-4246	133	3	allergy	allergy	PROPN
dpc-4246	133	4	immunol	immunol	PROPN
dpc-4246	133	5	2021;61(3):403	2021;61(3):403	PROPN
dpc-4246	133	6	-	-	PUNCT
dpc-4246	133	7	423	423	NUM
dpc-4246	133	8	.	.	PUNCT
dpc-4246	134	1	doi:10.1007	doi:10.1007	VERB
dpc-4246	134	2	/	/	SYM
dpc-4246	135	1	s12016	s12016	PROPN
dpc-4246	135	2	-	-	PUNCT
dpc-4246	135	3	021	021	NUM
dpc-4246	135	4	-08883	-08883	NOUN
dpc-4246	135	5	-	-	PUNCT
dpc-4246	135	6	0	0	NUM
dpc-4246	135	7	3	3	NUM
dpc-4246	135	8	.	.	PUNCT
dpc-4246	135	9	dincer	dincer	PROPN
dpc-4246	135	10	rota	rota	PROPN
dpc-4246	135	11	d	d	PROPN
dpc-4246	135	12	,	,	PUNCT
dpc-4246	135	13	tanacan	tanacan	PROPN
dpc-4246	135	14	e.	e.	PROPN
dpc-4246	135	15	the	the	DET
dpc-4246	135	16	utility	utility	NOUN
dpc-4246	135	17	of	of	ADP
dpc-4246	135	18	systemic	systemic	ADJ
dpc-4246	135	19	-	-	PUNCT
dpc-4246	135	20	immune	immune	ADJ
dpc-4246	135	21	inflammation	inflammation	NOUN
dpc-4246	135	22	index	index	NOUN
dpc-4246	135	23	for	for	ADP
dpc-4246	135	24	predicting	predict	VERB
dpc-4246	135	25	the	the	DET
dpc-4246	135	26	disease	disease	NOUN
dpc-4246	135	27	activation	activation	NOUN
dpc-4246	135	28	in	in	ADP
dpc-4246	135	29	patients	patient	NOUN
dpc-4246	135	30	with	with	ADP
dpc-4246	135	31	psoriasis	psoriasis	NOUN
dpc-4246	135	32	.	.	PUNCT
dpc-4246	136	1	int	int	PROPN
dpc-4246	137	1	j	j	PROPN
dpc-4246	137	2	clin	clin	PROPN
dpc-4246	137	3	pract	pract	PROPN
dpc-4246	137	4	2021;75(6):e14101	2021;75(6):e14101	PROPN
dpc-4246	137	5	.	.	PUNCT
dpc-4246	138	1	doi:10.1111	doi:10.1111	NOUN
dpc-4246	138	2	/ijcp.14101	/ijcp.14101	PUNCT
dpc-4246	139	1	there	there	PRON
dpc-4246	139	2	are	be	VERB
dpc-4246	139	3	limited	limited	ADJ
dpc-4246	139	4	studies	study	NOUN
dpc-4246	139	5	investigating	investigate	VERB
dpc-4246	139	6	hematological	hematological	ADJ
dpc-4246	139	7	markers	marker	NOUN
dpc-4246	139	8	in	in	ADP
dpc-4246	139	9	aa	aa	PROPN
dpc-4246	139	10	patients	patient	NOUN
dpc-4246	139	11	.	.	PUNCT
dpc-4246	140	1	in	in	ADP
dpc-4246	140	2	a	a	DET
dpc-4246	140	3	case	case	NOUN
dpc-4246	140	4	-	-	PUNCT
dpc-4246	140	5	control	control	NOUN
dpc-4246	140	6	study	study	NOUN
dpc-4246	140	7	by	by	ADP
dpc-4246	140	8	saraç	saraç	PROPN
dpc-4246	140	9	et	et	PROPN
dpc-4246	140	10	al	al	PROPN
dpc-4246	140	11	.	.	PROPN
dpc-4246	140	12	,	,	PUNCT
dpc-4246	140	13	it	it	PRON
dpc-4246	140	14	was	be	AUX
dpc-4246	140	15	demonstrated	demonstrate	VERB
dpc-4246	140	16	that	that	SCONJ
dpc-4246	140	17	elevated	elevated	ADJ
dpc-4246	140	18	mhr	mhr	PROPN
dpc-4246	140	19	,	,	PUNCT
dpc-4246	140	20	mlr	mlr	NOUN
dpc-4246	140	21	,	,	PUNCT
dpc-4246	140	22	and	and	CCONJ
dpc-4246	140	23	platelet	platelet	ADJ
dpc-4246	140	24	-	-	PUNCT
dpc-4246	140	25	lymphocyte	lymphocyte	ADJ
dpc-4246	140	26	ratio	ratio	NOUN
dpc-4246	140	27	(	(	PUNCT
dpc-4246	140	28	plr	plr	NOUN
dpc-4246	140	29	)	)	PUNCT
dpc-4246	140	30	values	value	NOUN
dpc-4246	140	31	had	have	VERB
dpc-4246	140	32	diagnostic	diagnostic	ADJ
dpc-4246	140	33	importance	importance	NOUN
dpc-4246	140	34	and	and	CCONJ
dpc-4246	140	35	also	also	ADV
dpc-4246	140	36	increased	increase	VERB
dpc-4246	140	37	the	the	DET
dpc-4246	140	38	risk	risk	NOUN
dpc-4246	140	39	of	of	ADP
dpc-4246	140	40	developing	develop	VERB
dpc-4246	140	41	aa	aa	NOUN
dpc-4246	140	42	[	[	X
dpc-4246	140	43	15	15	NUM
dpc-4246	140	44	]	]	PUNCT
dpc-4246	140	45	.	.	PUNCT
dpc-4246	141	1	on	on	ADP
dpc-4246	141	2	the	the	DET
dpc-4246	141	3	other	other	ADJ
dpc-4246	141	4	hand	hand	NOUN
dpc-4246	141	5	,	,	PUNCT
dpc-4246	141	6	in	in	ADP
dpc-4246	141	7	a	a	DET
dpc-4246	141	8	retrospective	retrospective	ADJ
dpc-4246	141	9	study	study	NOUN
dpc-4246	141	10	by	by	ADP
dpc-4246	141	11	i̇slamoğlu	i̇slamoğlu	PROPN
dpc-4246	141	12	et	et	PROPN
dpc-4246	141	13	al	al	PROPN
dpc-4246	141	14	.	.	PROPN
dpc-4246	141	15	,	,	PUNCT
dpc-4246	141	16	no	no	DET
dpc-4246	141	17	significant	significant	ADJ
dpc-4246	141	18	relationship	relationship	NOUN
dpc-4246	141	19	was	be	AUX
dpc-4246	141	20	found	find	VERB
dpc-4246	141	21	between	between	ADP
dpc-4246	141	22	hematological	hematological	ADJ
dpc-4246	141	23	markers	marker	NOUN
dpc-4246	141	24	and	and	CCONJ
dpc-4246	141	25	aa	aa	NOUN
dpc-4246	141	26	in	in	ADP
dpc-4246	141	27	comparison	comparison	NOUN
dpc-4246	141	28	to	to	ADP
dpc-4246	141	29	the	the	DET
dpc-4246	141	30	control	control	NOUN
dpc-4246	141	31	group	group	NOUN
dpc-4246	141	32	,	,	PUNCT
dpc-4246	141	33	except	except	SCONJ
dpc-4246	141	34	for	for	ADP
dpc-4246	141	35	crp	crp	PROPN
dpc-4246	142	1	[	[	X
dpc-4246	142	2	16	16	NUM
dpc-4246	142	3	]	]	PUNCT
dpc-4246	142	4	.	.	PUNCT
dpc-4246	143	1	another	another	DET
dpc-4246	143	2	study	study	NOUN
dpc-4246	143	3	,	,	PUNCT
dpc-4246	143	4	by	by	ADP
dpc-4246	143	5	dere	dere	PROPN
dpc-4246	143	6	et	et	PROPN
dpc-4246	143	7	al	al	PROPN
dpc-4246	143	8	.	.	PROPN
dpc-4246	143	9	,	,	PUNCT
dpc-4246	143	10	suggested	suggest	VERB
dpc-4246	143	11	that	that	SCONJ
dpc-4246	143	12	plr	plr	NOUN
dpc-4246	143	13	,	,	PUNCT
dpc-4246	143	14	nlr	nlr	PROPN
dpc-4246	143	15	,	,	PUNCT
dpc-4246	143	16	and	and	CCONJ
dpc-4246	143	17	mpv	mpv	PROPN
dpc-4246	143	18	values	value	NOUN
dpc-4246	143	19	in	in	ADP
dpc-4246	143	20	aa	aa	PROPN
dpc-4246	143	21	patients	patient	NOUN
dpc-4246	143	22	were	be	AUX
dpc-4246	143	23	not	not	PART
dpc-4246	143	24	significantly	significantly	ADV
dpc-4246	143	25	different	different	ADJ
dpc-4246	143	26	from	from	ADP
dpc-4246	143	27	those	those	PRON
dpc-4246	143	28	in	in	ADP
dpc-4246	143	29	the	the	DET
dpc-4246	143	30	control	control	NOUN
dpc-4246	143	31	group	group	NOUN
dpc-4246	143	32	,	,	PUNCT
dpc-4246	143	33	and	and	CCONJ
dpc-4246	143	34	these	these	DET
dpc-4246	143	35	markers	marker	NOUN
dpc-4246	143	36	were	be	AUX
dpc-4246	143	37	not	not	PART
dpc-4246	143	38	useful	useful	ADJ
dpc-4246	143	39	in	in	ADP
dpc-4246	143	40	reflecting	reflect	VERB
dpc-4246	143	41	the	the	DET
dpc-4246	143	42	inflammatory	inflammatory	ADJ
dpc-4246	143	43	status	status	NOUN
dpc-4246	143	44	of	of	ADP
dpc-4246	143	45	the	the	DET
dpc-4246	143	46	patients	patient	NOUN
dpc-4246	143	47	[	[	X
dpc-4246	143	48	17	17	NUM
dpc-4246	143	49	]	]	PUNCT
dpc-4246	143	50	.	.	PUNCT
dpc-4246	144	1	this	this	DET
dpc-4246	144	2	study	study	NOUN
dpc-4246	144	3	revealed	reveal	VERB
dpc-4246	144	4	that	that	SCONJ
dpc-4246	144	5	aa	aa	PROPN
dpc-4246	144	6	patients	patient	NOUN
dpc-4246	144	7	exhibited	exhibit	VERB
dpc-4246	144	8	higher	high	ADJ
dpc-4246	144	9	levels	level	NOUN
dpc-4246	144	10	of	of	ADP
dpc-4246	144	11	nlr	nlr	PROPN
dpc-4246	144	12	,	,	PUNCT
dpc-4246	144	13	mpv	mpv	PROPN
dpc-4246	144	14	,	,	PUNCT
dpc-4246	144	15	and	and	CCONJ
dpc-4246	144	16	sii	sii	ADJ
dpc-4246	144	17	and	and	CCONJ
dpc-4246	144	18	lower	low	ADJ
dpc-4246	144	19	levels	level	NOUN
dpc-4246	144	20	of	of	ADP
dpc-4246	144	21	hdl	hdl	PROPN
dpc-4246	144	22	when	when	SCONJ
dpc-4246	144	23	compared	compare	VERB
dpc-4246	144	24	to	to	ADP
dpc-4246	144	25	the	the	DET
dpc-4246	144	26	control	control	NOUN
dpc-4246	144	27	group	group	NOUN
dpc-4246	144	28	.	.	PUNCT
dpc-4246	145	1	consequently	consequently	ADV
dpc-4246	145	2	,	,	PUNCT
dpc-4246	145	3	nlr	nlr	PROPN
dpc-4246	145	4	,	,	PUNCT
dpc-4246	145	5	mpv	mpv	PROPN
dpc-4246	145	6	,	,	PUNCT
dpc-4246	145	7	and	and	CCONJ
dpc-4246	145	8	sii	sii	PROPN
dpc-4246	145	9	were	be	AUX
dpc-4246	145	10	identified	identify	VERB
dpc-4246	145	11	as	as	ADP
dpc-4246	145	12	useful	useful	ADJ
dpc-4246	145	13	markers	marker	NOUN
dpc-4246	145	14	in	in	ADP
dpc-4246	145	15	indicating	indicate	VERB
dpc-4246	145	16	increased	increase	VERB
dpc-4246	145	17	inflammation	inflammation	NOUN
dpc-4246	145	18	in	in	ADP
dpc-4246	145	19	aa	aa	PROPN
dpc-4246	145	20	patients	patient	NOUN
dpc-4246	145	21	.	.	PUNCT
dpc-4246	146	1	the	the	DET
dpc-4246	146	2	marked	mark	VERB
dpc-4246	146	3	decrease	decrease	NOUN
dpc-4246	146	4	in	in	ADP
dpc-4246	146	5	hdl	hdl	PROPN
dpc-4246	146	6	,	,	PUNCT
dpc-4246	146	7	known	know	VERB
dpc-4246	146	8	for	for	ADP
dpc-4246	146	9	its	its	PRON
dpc-4246	146	10	anti	anti	ADJ
dpc-4246	146	11	-	-	ADJ
dpc-4246	146	12	inflammatory	inflammatory	ADJ
dpc-4246	146	13	and	and	CCONJ
dpc-4246	146	14	antioxidant	antioxidant	ADJ
dpc-4246	146	15	properties	property	NOUN
dpc-4246	146	16	,	,	PUNCT
dpc-4246	146	17	along	along	ADP
dpc-4246	146	18	with	with	ADP
dpc-4246	146	19	its	its	PRON
dpc-4246	146	20	rise	rise	NOUN
dpc-4246	146	21	after	after	ADP
dpc-4246	146	22	the	the	DET
dpc-4246	146	23	treatment	treatment	NOUN
dpc-4246	146	24	,	,	PUNCT
dpc-4246	146	25	indicates	indicate	VERB
dpc-4246	146	26	the	the	DET
dpc-4246	146	27	involvement	involvement	NOUN
dpc-4246	146	28	of	of	ADP
dpc-4246	146	29	inflammation	inflammation	NOUN
dpc-4246	146	30	and	and	CCONJ
dpc-4246	146	31	oxidative	oxidative	ADJ
dpc-4246	146	32	stress	stress	NOUN
dpc-4246	146	33	in	in	ADP
dpc-4246	146	34	the	the	DET
dpc-4246	146	35	pathogenesis	pathogenesis	NOUN
dpc-4246	146	36	of	of	ADP
dpc-4246	146	37	aa	aa	NOUN
dpc-4246	146	38	.	.	PUNCT
dpc-4246	147	1	the	the	DET
dpc-4246	147	2	sii	sii	PROPN
dpc-4246	147	3	(	(	PUNCT
dpc-4246	147	4	platelet	platelet	NOUN
dpc-4246	147	5	count	count	NOUN
dpc-4246	147	6	×	×	PROPN
dpc-4246	147	7	nlr	nlr	PROPN
dpc-4246	147	8	)	)	PUNCT
dpc-4246	147	9	is	be	AUX
dpc-4246	147	10	a	a	DET
dpc-4246	147	11	marker	marker	NOUN
dpc-4246	147	12	that	that	PRON
dpc-4246	147	13	has	have	AUX
dpc-4246	147	14	been	be	AUX
dpc-4246	147	15	used	use	VERB
dpc-4246	147	16	to	to	PART
dpc-4246	147	17	evaluate	evaluate	VERB
dpc-4246	147	18	the	the	DET
dpc-4246	147	19	disease	disease	NOUN
dpc-4246	147	20	activity	activity	NOUN
dpc-4246	147	21	of	of	ADP
dpc-4246	147	22	several	several	ADJ
dpc-4246	147	23	inflammatory	inflammatory	ADJ
dpc-4246	147	24	diseases	disease	NOUN
dpc-4246	147	25	.	.	PUNCT
dpc-4246	148	1	tanaçan	tanaçan	PROPN
dpc-4246	148	2	et	et	PROPN
dpc-4246	148	3	al	al	PROPN
dpc-4246	148	4	.	.	PROPN
dpc-4246	148	5	,	,	PUNCT
dpc-4246	148	6	demonstrated	demonstrate	VERB
dpc-4246	148	7	that	that	SCONJ
dpc-4246	148	8	patients	patient	NOUN
dpc-4246	148	9	with	with	ADP
dpc-4246	148	10	active	active	ADJ
dpc-4246	148	11	behçet	behçet	ADJ
dpc-4246	148	12	disease	disease	NOUN
dpc-4246	148	13	had	have	VERB
dpc-4246	148	14	significantly	significantly	ADV
dpc-4246	148	15	higher	high	ADJ
dpc-4246	148	16	sii	sii	ADJ
dpc-4246	148	17	values	value	NOUN
dpc-4246	148	18	compared	compare	VERB
dpc-4246	148	19	to	to	ADP
dpc-4246	148	20	those	those	PRON
dpc-4246	148	21	in	in	ADP
dpc-4246	148	22	remission	remission	NOUN
dpc-4246	148	23	.	.	PUNCT
dpc-4246	149	1	additionally	additionally	ADV
dpc-4246	149	2	,	,	PUNCT
dpc-4246	149	3	the	the	DET
dpc-4246	149	4	study	study	NOUN
dpc-4246	149	5	suggested	suggest	VERB
dpc-4246	149	6	that	that	SCONJ
dpc-4246	149	7	sii	sii	PROPN
dpc-4246	149	8	could	could	AUX
dpc-4246	149	9	be	be	AUX
dpc-4246	149	10	a	a	DET
dpc-4246	149	11	useful	useful	ADJ
dpc-4246	149	12	marker	marker	NOUN
dpc-4246	149	13	in	in	ADP
dpc-4246	149	14	assessing	assess	VERB
dpc-4246	149	15	the	the	DET
dpc-4246	149	16	severity	severity	NOUN
dpc-4246	149	17	of	of	ADP
dpc-4246	149	18	behçet	behçet	ADJ
dpc-4246	149	19	disease	disease	NOUN
dpc-4246	149	20	[	[	X
dpc-4246	149	21	4	4	NUM
dpc-4246	149	22	]	]	PUNCT
dpc-4246	149	23	.	.	PUNCT
dpc-4246	150	1	in	in	ADP
dpc-4246	150	2	a	a	DET
dpc-4246	150	3	case	case	NOUN
dpc-4246	150	4	-	-	PUNCT
dpc-4246	150	5	control	control	NOUN
dpc-4246	150	6	study	study	NOUN
dpc-4246	150	7	by	by	ADP
dpc-4246	150	8	karaosmanoğlu	karaosmanoğlu	PROPN
dpc-4246	150	9	et	et	PROPN
dpc-4246	150	10	al	al	PROPN
dpc-4246	150	11	.	.	PROPN
dpc-4246	150	12	,	,	PUNCT
dpc-4246	150	13	patients	patient	NOUN
dpc-4246	150	14	with	with	ADP
dpc-4246	150	15	rosacea	rosacea	NOUN
dpc-4246	150	16	were	be	AUX
dpc-4246	150	17	found	find	VERB
dpc-4246	150	18	to	to	PART
dpc-4246	150	19	have	have	VERB
dpc-4246	150	20	higher	high	ADJ
dpc-4246	150	21	sii	sii	ADJ
dpc-4246	150	22	values	value	NOUN
dpc-4246	150	23	compared	compare	VERB
dpc-4246	150	24	to	to	ADP
dpc-4246	150	25	healthy	healthy	ADJ
dpc-4246	150	26	controls	control	NOUN
dpc-4246	150	27	.	.	PUNCT
dpc-4246	151	1	however	however	ADV
dpc-4246	151	2	,	,	PUNCT
dpc-4246	151	3	there	there	PRON
dpc-4246	151	4	was	be	VERB
dpc-4246	151	5	no	no	DET
dpc-4246	151	6	significant	significant	ADJ
dpc-4246	151	7	relationship	relationship	NOUN
dpc-4246	151	8	between	between	ADP
dpc-4246	151	9	sii	sii	PROPN
dpc-4246	151	10	and	and	CCONJ
dpc-4246	151	11	the	the	DET
dpc-4246	151	12	severity	severity	NOUN
dpc-4246	151	13	of	of	ADP
dpc-4246	151	14	rosacea	rosacea	NOUN
dpc-4246	151	15	[	[	X
dpc-4246	151	16	18	18	NUM
dpc-4246	151	17	]	]	PUNCT
dpc-4246	151	18	.	.	PUNCT
dpc-4246	152	1	in	in	ADP
dpc-4246	152	2	a	a	DET
dpc-4246	152	3	study	study	NOUN
dpc-4246	152	4	by	by	ADP
dpc-4246	152	5	coşansu	coşansu	PROPN
dpc-4246	152	6	et	et	PROPN
dpc-4246	152	7	al	al	PROPN
dpc-4246	152	8	.	.	PROPN
dpc-4246	152	9	involving	involve	VERB
dpc-4246	152	10	patients	patient	NOUN
dpc-4246	152	11	with	with	ADP
dpc-4246	152	12	acne	acne	NOUN
dpc-4246	152	13	vulgaris	vulgaris	NOUN
dpc-4246	152	14	,	,	PUNCT
dpc-4246	152	15	sii	sii	ADJ
dpc-4246	152	16	values	value	NOUN
dpc-4246	152	17	calculated	calculate	VERB
dpc-4246	152	18	after	after	ADP
dpc-4246	152	19	three	three	NUM
dpc-4246	152	20	months	month	NOUN
dpc-4246	152	21	of	of	ADP
dpc-4246	152	22	systemic	systemic	ADJ
dpc-4246	152	23	isotretinoin	isotretinoin	PROPN
dpc-4246	152	24	treatment	treatment	NOUN
dpc-4246	152	25	were	be	AUX
dpc-4246	152	26	significantly	significantly	ADV
dpc-4246	152	27	lower	low	ADJ
dpc-4246	152	28	compared	compare	VERB
dpc-4246	152	29	to	to	ADP
dpc-4246	152	30	pre	pre	ADJ
dpc-4246	152	31	-	-	ADJ
dpc-4246	152	32	treatment	treatment	ADJ
dpc-4246	152	33	sii	sii	ADJ
dpc-4246	152	34	values	value	NOUN
dpc-4246	152	35	[	[	X
dpc-4246	152	36	19	19	NUM
dpc-4246	152	37	]	]	PUNCT
dpc-4246	152	38	.	.	PUNCT
dpc-4246	153	1	in	in	ADP
dpc-4246	153	2	another	another	DET
dpc-4246	153	3	study	study	NOUN
dpc-4246	153	4	including	include	VERB
dpc-4246	153	5	patients	patient	NOUN
dpc-4246	153	6	with	with	ADP
dpc-4246	153	7	acne	acne	NOUN
dpc-4246	153	8	vulgaris	vulgaris	NOUN
dpc-4246	153	9	,	,	PUNCT
dpc-4246	153	10	turan	turan	PROPN
dpc-4246	153	11	et	et	PROPN
dpc-4246	153	12	al	al	PROPN
dpc-4246	153	13	.	.	PROPN
dpc-4246	153	14	found	find	VERB
dpc-4246	153	15	that	that	SCONJ
dpc-4246	153	16	patients	patient	NOUN
dpc-4246	153	17	with	with	ADP
dpc-4246	153	18	nodulocystic	nodulocystic	ADJ
dpc-4246	153	19	acne	acne	NOUN
dpc-4246	153	20	exhibited	exhibit	VERB
dpc-4246	153	21	elevated	elevated	ADJ
dpc-4246	153	22	sii	sii	ADJ
dpc-4246	153	23	values	value	NOUN
dpc-4246	153	24	compared	compare	VERB
dpc-4246	153	25	to	to	ADP
dpc-4246	153	26	those	those	PRON
dpc-4246	153	27	with	with	ADP
dpc-4246	153	28	mild	mild	ADJ
dpc-4246	153	29	to	to	ADP
dpc-4246	153	30	moderate	moderate	ADJ
dpc-4246	153	31	acne	acne	NOUN
dpc-4246	153	32	.	.	PUNCT
dpc-4246	154	1	additionally	additionally	ADV
dpc-4246	154	2	,	,	PUNCT
dpc-4246	154	3	the	the	DET
dpc-4246	154	4	sii	sii	PROPN
dpc-4246	154	5	showed	show	VERB
dpc-4246	154	6	a	a	DET
dpc-4246	154	7	weak	weak	ADJ
dpc-4246	154	8	correlation	correlation	NOUN
dpc-4246	154	9	with	with	ADP
dpc-4246	154	10	the	the	DET
dpc-4246	154	11	number	number	NOUN
dpc-4246	154	12	of	of	ADP
dpc-4246	154	13	nodulocystic	nodulocystic	ADJ
dpc-4246	154	14	lesions	lesion	NOUN
dpc-4246	154	15	and	and	CCONJ
dpc-4246	154	16	acne	acne	NOUN
dpc-4246	154	17	severity	severity	NOUN
dpc-4246	154	18	[	[	X
dpc-4246	154	19	20	20	NUM
dpc-4246	154	20	]	]	PUNCT
dpc-4246	154	21	.	.	PUNCT
dpc-4246	155	1	yorulmaz	yorulmaz	INTJ
dpc-4246	155	2	et	et	PROPN
dpc-4246	155	3	al	al	PROPN
dpc-4246	155	4	.	.	PROPN
dpc-4246	155	5	observed	observe	VERB
dpc-4246	155	6	that	that	SCONJ
dpc-4246	155	7	sii	sii	PROPN
dpc-4246	155	8	values	value	NOUN
dpc-4246	155	9	were	be	AUX
dpc-4246	155	10	higher	high	ADJ
dpc-4246	155	11	in	in	ADP
dpc-4246	155	12	psoriasis	psoriasis	NOUN
dpc-4246	155	13	patients	patient	NOUN
dpc-4246	155	14	compared	compare	VERB
dpc-4246	155	15	to	to	ADP
dpc-4246	155	16	the	the	DET
dpc-4246	155	17	control	control	NOUN
dpc-4246	155	18	group	group	NOUN
dpc-4246	155	19	.	.	PUNCT
dpc-4246	156	1	moreover	moreover	ADV
dpc-4246	156	2	,	,	PUNCT
dpc-4246	156	3	the	the	DET
dpc-4246	156	4	study	study	NOUN
dpc-4246	156	5	found	find	VERB
dpc-4246	156	6	that	that	SCONJ
dpc-4246	156	7	sii	sii	PROPN
dpc-4246	156	8	values	value	NOUN
dpc-4246	156	9	were	be	AUX
dpc-4246	156	10	significantly	significantly	ADV
dpc-4246	156	11	higher	high	ADJ
dpc-4246	156	12	in	in	ADP
dpc-4246	156	13	patients	patient	NOUN
dpc-4246	156	14	with	with	ADP
dpc-4246	156	15	moderate	moderate	ADJ
dpc-4246	156	16	to	to	ADP
dpc-4246	156	17	severe	severe	ADJ
dpc-4246	156	18	psoriasis	psoriasis	NOUN
dpc-4246	156	19	compared	compare	VERB
dpc-4246	156	20	to	to	ADP
dpc-4246	156	21	those	those	PRON
dpc-4246	156	22	with	with	ADP
dpc-4246	156	23	mild	mild	ADJ
dpc-4246	156	24	psoriasis	psoriasis	NOUN
dpc-4246	156	25	[	[	X
dpc-4246	156	26	21	21	NUM
dpc-4246	156	27	]	]	PUNCT
dpc-4246	156	28	.	.	PUNCT
dpc-4246	157	1	in	in	ADP
dpc-4246	157	2	a	a	DET
dpc-4246	157	3	case	case	NOUN
dpc-4246	157	4	-	-	PUNCT
dpc-4246	157	5	control	control	NOUN
dpc-4246	157	6	study	study	NOUN
dpc-4246	157	7	by	by	ADP
dpc-4246	157	8	melikoğlu	melikoğlu	PROPN
dpc-4246	157	9	et	et	PROPN
dpc-4246	157	10	al	al	PROPN
dpc-4246	157	11	.	.	PROPN
dpc-4246	157	12	,	,	PUNCT
dpc-4246	157	13	it	it	PRON
dpc-4246	157	14	was	be	AUX
dpc-4246	157	15	demonstrated	demonstrate	VERB
dpc-4246	157	16	that	that	SCONJ
dpc-4246	157	17	psoriasis	psoriasis	NOUN
dpc-4246	157	18	patients	patient	NOUN
dpc-4246	157	19	had	have	VERB
dpc-4246	157	20	higher	high	ADJ
dpc-4246	157	21	sii	sii	ADJ
dpc-4246	157	22	values	value	NOUN
dpc-4246	157	23	compared	compare	VERB
dpc-4246	157	24	to	to	ADP
dpc-4246	157	25	healthy	healthy	ADJ
dpc-4246	157	26	controls	control	NOUN
dpc-4246	157	27	.	.	PUNCT
dpc-4246	158	1	however	however	ADV
dpc-4246	158	2	,	,	PUNCT
dpc-4246	158	3	no	no	DET
dpc-4246	158	4	statistically	statistically	ADV
dpc-4246	158	5	significant	significant	ADJ
dpc-4246	158	6	correlation	correlation	NOUN
dpc-4246	158	7	was	be	AUX
dpc-4246	158	8	found	find	VERB
dpc-4246	158	9	between	between	ADP
dpc-4246	158	10	sii	sii	ADJ
dpc-4246	158	11	and	and	CCONJ
dpc-4246	158	12	psoriasis	psoriasis	NOUN
dpc-4246	158	13	severity	severity	NOUN
dpc-4246	158	14	[	[	X
dpc-4246	158	15	22	22	NUM
dpc-4246	158	16	]	]	PUNCT
dpc-4246	158	17	.	.	PUNCT
dpc-4246	159	1	in	in	ADP
dpc-4246	159	2	a	a	DET
dpc-4246	159	3	study	study	NOUN
dpc-4246	159	4	by	by	ADP
dpc-4246	159	5	dinçer	dinçer	PROPN
dpc-4246	159	6	et	et	PROPN
dpc-4246	159	7	al	al	PROPN
dpc-4246	159	8	.	.	PROPN
dpc-4246	159	9	,	,	PUNCT
dpc-4246	159	10	sii	sii	PROPN
dpc-4246	159	11	values	value	NOUN
dpc-4246	159	12	were	be	AUX
dpc-4246	159	13	found	find	VERB
dpc-4246	159	14	to	to	PART
dpc-4246	159	15	be	be	AUX
dpc-4246	159	16	higher	high	ADJ
dpc-4246	159	17	in	in	ADP
dpc-4246	159	18	patients	patient	NOUN
dpc-4246	159	19	with	with	ADP
dpc-4246	159	20	moderate	moderate	ADJ
dpc-4246	159	21	to	to	ADP
dpc-4246	159	22	severe	severe	ADJ
dpc-4246	159	23	psoriatic	psoriatic	ADJ
dpc-4246	159	24	arthritis	arthritis	NOUN
dpc-4246	159	25	compared	compare	VERB
dpc-4246	159	26	to	to	ADP
dpc-4246	159	27	those	those	PRON
dpc-4246	159	28	with	with	ADP
dpc-4246	159	29	6	6	NUM
dpc-4246	159	30	original	original	ADJ
dpc-4246	159	31	article	article	NOUN
dpc-4246	159	32	|	|	ADV
dpc-4246	159	33	dermatol	dermatol	ADJ
dpc-4246	159	34	pract	pract	NOUN
dpc-4246	159	35	concept	concept	NOUN
dpc-4246	159	36	.	.	PUNCT
dpc-4246	160	1	2024;14(3):e2024193	2024;14(3):e2024193	NUM
dpc-4246	160	2	diagnosis	diagnosis	NOUN
dpc-4246	160	3	of	of	ADP
dpc-4246	160	4	alopecia	alopecia	NOUN
dpc-4246	160	5	areata	areata	ADJ
dpc-4246	160	6	.	.	PUNCT
dpc-4246	161	1	dermatol	dermatol	NOUN
dpc-4246	161	2	pract	pract	PROPN
dpc-4246	161	3	concept	concept	NOUN
dpc-4246	161	4	2023;13(2):e2023118	2023;13(2):e2023118	NUM
dpc-4246	161	5	.	.	PUNCT
dpc-4246	161	6	doi:10.5826	doi:10.5826	PROPN
dpc-4246	161	7	/	/	SYM
dpc-4246	162	1	dpc.1302a118	dpc.1302a118	VERB
dpc-4246	162	2	16	16	NUM
dpc-4246	162	3	.	.	PUNCT
dpc-4246	163	1	i̇slamoğlu	i̇slamoğlu	PROPN
dpc-4246	163	2	zgk	zgk	PROPN
dpc-4246	163	3	,	,	PUNCT
dpc-4246	163	4	demirbaş	demirbaş	VERB
dpc-4246	163	5	a.	a.	NOUN
dpc-4246	163	6	evaluation	evaluation	NOUN
dpc-4246	163	7	of	of	ADP
dpc-4246	163	8	complete	complete	ADJ
dpc-4246	163	9	blood	blood	NOUN
dpc-4246	163	10	cell	cell	NOUN
dpc-4246	163	11	and	and	CCONJ
dpc-4246	163	12	inflammatory	inflammatory	ADJ
dpc-4246	163	13	parameters	parameter	NOUN
dpc-4246	163	14	in	in	ADP
dpc-4246	163	15	patients	patient	NOUN
dpc-4246	163	16	with	with	ADP
dpc-4246	163	17	alopecia	alopecia	NOUN
dpc-4246	163	18	areata	areata	NOUN
dpc-4246	163	19	:	:	PUNCT
dpc-4246	163	20	their	their	PRON
dpc-4246	163	21	association	association	NOUN
dpc-4246	163	22	with	with	ADP
dpc-4246	163	23	disease	disease	NOUN
dpc-4246	163	24	severity	severity	NOUN
dpc-4246	163	25	.	.	PUNCT
dpc-4246	164	1	j	j	PROPN
dpc-4246	164	2	cosmet	cosmet	VERB
dpc-4246	164	3	dermatol	dermatol	NOUN
dpc-4246	164	4	2020;19(5):1239	2020;19(5):1239	NUM
dpc-4246	164	5	-	-	SYM
dpc-4246	164	6	1245	1245	NUM
dpc-4246	164	7	.	.	PUNCT
dpc-4246	165	1	doi:10.1111	doi:10.1111	PROPN
dpc-4246	165	2	/	/	SYM
dpc-4246	165	3	jocd.13131	jocd.13131	PROPN
dpc-4246	165	4	17	17	NUM
dpc-4246	165	5	.	.	PUNCT
dpc-4246	166	1	dere	dere	VERB
dpc-4246	166	2	g	g	PROPN
dpc-4246	166	3	,	,	PUNCT
dpc-4246	166	4	gündoğdu	gündoğdu	PROPN
dpc-4246	166	5	m.	m.	NOUN
dpc-4246	166	6	investigation	investigation	NOUN
dpc-4246	166	7	of	of	ADP
dpc-4246	166	8	the	the	DET
dpc-4246	166	9	relationship	relationship	NOUN
dpc-4246	166	10	between	between	ADP
dpc-4246	166	11	alopecia	alopecia	NOUN
dpc-4246	166	12	areata	areata	ADJ
dpc-4246	166	13	and	and	CCONJ
dpc-4246	166	14	inflammatory	inflammatory	ADJ
dpc-4246	166	15	blood	blood	NOUN
dpc-4246	166	16	parameters	parameter	NOUN
dpc-4246	166	17	.	.	PUNCT
dpc-4246	167	1	j	j	PROPN
dpc-4246	167	2	cosmet	cosmet	VERB
dpc-4246	167	3	dermatol	dermatol	NOUN
dpc-4246	167	4	2021;20(12):4048	2021;20(12):4048	NUM
dpc-4246	167	5	-	-	SYM
dpc-4246	167	6	4051	4051	NUM
dpc-4246	167	7	.	.	PUNCT
dpc-4246	168	1	doi:10.1111	doi:10.1111	ADJ
dpc-4246	168	2	/	/	SYM
dpc-4246	168	3	jocd.14048	jocd.14048	PROPN
dpc-4246	168	4	18	18	NUM
dpc-4246	168	5	.	.	PUNCT
dpc-4246	168	6	karaosmanoglu	karaosmanoglu	PROPN
dpc-4246	168	7	n	n	CCONJ
dpc-4246	168	8	,	,	PUNCT
dpc-4246	168	9	ozdemir	ozdemir	PROPN
dpc-4246	168	10	cetinkaya	cetinkaya	PROPN
dpc-4246	168	11	p	p	NOUN
dpc-4246	168	12	,	,	PUNCT
dpc-4246	168	13	orenay	orenay	NOUN
dpc-4246	168	14	om	om	NOUN
dpc-4246	168	15	.	.	PUNCT
dpc-4246	168	16	evaluation	evaluation	NOUN
dpc-4246	168	17	of	of	ADP
dpc-4246	168	18	inflammatory	inflammatory	ADJ
dpc-4246	168	19	status	status	NOUN
dpc-4246	168	20	in	in	ADP
dpc-4246	168	21	blood	blood	NOUN
dpc-4246	168	22	in	in	ADP
dpc-4246	168	23	patients	patient	NOUN
dpc-4246	168	24	with	with	ADP
dpc-4246	168	25	rosacea	rosacea	NOUN
dpc-4246	168	26	.	.	PUNCT
dpc-4246	169	1	sci	sci	PROPN
dpc-4246	169	2	rep	rep	PROPN
dpc-4246	169	3	2023;13(1):9068	2023;13(1):9068	PROPN
dpc-4246	169	4	.	.	PUNCT
dpc-4246	170	1	doi:10.1038	doi:10.1038	NOUN
dpc-4246	170	2	/	/	SYM
dpc-4246	170	3	s41598	s41598	NOUN
dpc-4246	170	4	-	-	PUNCT
dpc-4246	170	5	023	023	NUM
dpc-4246	170	6	-	-	PUNCT
dpc-4246	170	7	36247	36247	NUM
dpc-4246	170	8	-	-	SYM
dpc-4246	170	9	5	5	NUM
dpc-4246	170	10	19	19	NUM
dpc-4246	170	11	.	.	PUNCT
dpc-4246	171	1	cosansu	cosansu	PROPN
dpc-4246	171	2	nc	nc	PROPN
dpc-4246	171	3	,	,	PUNCT
dpc-4246	171	4	yuksekal	yuksekal	PROPN
dpc-4246	171	5	g	g	PROPN
dpc-4246	171	6	,	,	PUNCT
dpc-4246	171	7	turan	turan	PROPN
dpc-4246	171	8	u	u	NOUN
dpc-4246	171	9	,	,	PUNCT
dpc-4246	171	10	umitfer	umitfer	VERB
dpc-4246	171	11	f	f	PROPN
dpc-4246	171	12	,	,	PUNCT
dpc-4246	171	13	yaldiz	yaldiz	PROPN
dpc-4246	171	14	m	m	PROPN
dpc-4246	171	15	,	,	PUNCT
dpc-4246	171	16	sevimli	sevimli	PROPN
dpc-4246	171	17	dikicier	dikicier	PROPN
dpc-4246	171	18	b.	b.	PROPN
dpc-4246	171	19	investigation	investigation	NOUN
dpc-4246	171	20	of	of	ADP
dpc-4246	171	21	systemic	systemic	ADJ
dpc-4246	171	22	immune	immune	ADJ
dpc-4246	171	23	-	-	PUNCT
dpc-4246	171	24	inflammation	inflammation	NOUN
dpc-4246	171	25	index	index	NOUN
dpc-4246	171	26	and	and	CCONJ
dpc-4246	171	27	systemic	systemic	ADJ
dpc-4246	171	28	inflammation	inflammation	ADJ
dpc-4246	171	29	response	response	NOUN
dpc-4246	171	30	index	index	NOUN
dpc-4246	171	31	as	as	ADP
dpc-4246	171	32	an	an	DET
dpc-4246	171	33	indicator	indicator	NOUN
dpc-4246	171	34	of	of	ADP
dpc-4246	171	35	the	the	DET
dpc-4246	171	36	anti	anti	ADJ
dpc-4246	171	37	-	-	ADJ
dpc-4246	171	38	inflammatuary	inflammatuary	ADJ
dpc-4246	171	39	effect	effect	NOUN
dpc-4246	171	40	of	of	ADP
dpc-4246	171	41	isotretinoin	isotretinoin	PROPN
dpc-4246	171	42	in	in	ADP
dpc-4246	171	43	patients	patient	NOUN
dpc-4246	171	44	with	with	ADP
dpc-4246	171	45	acne	acne	NOUN
dpc-4246	171	46	vulgaris	vulgaris	NOUN
dpc-4246	171	47	.	.	PUNCT
dpc-4246	172	1	cutanocultoxicol2022;41(2):174	cutanocultoxicol2022;41(2):174	PROPN
dpc-4246	172	2	-	-	PUNCT
dpc-4246	172	3	178	178	NUM
dpc-4246	172	4	.	.	PUNCT
dpc-4246	173	1	doi:10.10	doi:10.10	NOUN
dpc-4246	173	2	80/15569527.2022.2081700	80/15569527.2022.2081700	NUM
dpc-4246	173	3	20	20	NUM
dpc-4246	173	4	.	.	PUNCT
dpc-4246	174	1	turan	turan	PROPN
dpc-4246	174	2	ç	ç	PROPN
dpc-4246	174	3	,	,	PUNCT
dpc-4246	174	4	coşansu	coşansu	PROPN
dpc-4246	174	5	nc	nc	PROPN
dpc-4246	174	6	,	,	PUNCT
dpc-4246	174	7	yüksekal	yüksekal	PROPN
dpc-4246	174	8	g.	g.	PROPN
dpc-4246	174	9	the	the	DET
dpc-4246	174	10	sii	sii	PROPN
dpc-4246	174	11	reflects	reflect	VERB
dpc-4246	174	12	inflammation	inflammation	NOUN
dpc-4246	174	13	in	in	ADP
dpc-4246	174	14	acne	acne	NOUN
dpc-4246	174	15	vulgaris	vulgaris	NOUN
dpc-4246	174	16	,	,	PUNCT
dpc-4246	174	17	but	but	CCONJ
dpc-4246	174	18	fails	fail	VERB
dpc-4246	174	19	to	to	PART
dpc-4246	174	20	determine	determine	VERB
dpc-4246	174	21	categorical	categorical	ADJ
dpc-4246	174	22	severity	severity	NOUN
dpc-4246	174	23	.	.	PUNCT
dpc-4246	175	1	j	j	PROPN
dpc-4246	175	2	cosmet	cosmet	VERB
dpc-4246	175	3	dermatol	dermatol	NOUN
dpc-4246	175	4	2022;21(11):63856392	2022;21(11):63856392	NUM
dpc-4246	175	5	.	.	PUNCT
dpc-4246	175	6	doi:10.1111	doi:10.1111	NOUN
dpc-4246	175	7	/jocd.15301	/jocd.15301	PUNCT
dpc-4246	176	1	21	21	X
dpc-4246	176	2	.	.	PUNCT
dpc-4246	177	1	yorulmaz	yorulmaz	INTJ
dpc-4246	177	2	a	a	PRON
dpc-4246	177	3	,	,	PUNCT
dpc-4246	177	4	hayran	hayran	NOUN
dpc-4246	177	5	y	y	PROPN
dpc-4246	177	6	,	,	PUNCT
dpc-4246	177	7	akpinar	akpinar	NOUN
dpc-4246	177	8	u	u	PROPN
dpc-4246	177	9	,	,	PUNCT
dpc-4246	177	10	yalcin	yalcin	PROPN
dpc-4246	177	11	b.	b.	PROPN
dpc-4246	177	12	systemic	systemic	ADJ
dpc-4246	177	13	immuneinflammation	immuneinflammation	NOUN
dpc-4246	177	14	index	index	NOUN
dpc-4246	177	15	(	(	PUNCT
dpc-4246	177	16	sii	sii	PROPN
dpc-4246	177	17	)	)	PUNCT
dpc-4246	177	18	predicts	predict	NOUN
dpc-4246	177	19	increased	increase	VERB
dpc-4246	177	20	severity	severity	NOUN
dpc-4246	177	21	in	in	ADP
dpc-4246	177	22	psoriasis	psoriasis	NOUN
dpc-4246	177	23	and	and	CCONJ
dpc-4246	177	24	psoriatic	psoriatic	ADJ
dpc-4246	177	25	arthritis	arthritis	NOUN
dpc-4246	177	26	.	.	PUNCT
dpc-4246	178	1	curr	curr	PROPN
dpc-4246	178	2	health	health	PROPN
dpc-4246	178	3	sci	sci	PROPN
dpc-4246	178	4	j	j	PROPN
dpc-4246	178	5	2020	2020	NUM
dpc-4246	178	6	;	;	PUNCT
dpc-4246	178	7	46(4):352	46(4):352	PROPN
dpc-4246	178	8	-	-	SYM
dpc-4246	178	9	357	357	NUM
dpc-4246	178	10	.	.	PUNCT
dpc-4246	179	1	doi:10.12865	doi:10.12865	PROPN
dpc-4246	179	2	/	/	SYM
dpc-4246	179	3	chsj.46.04.05	chsj.46.04.05	PROPN
dpc-4246	179	4	22	22	NUM
dpc-4246	179	5	.	.	PUNCT
dpc-4246	180	1	melikoglu	melikoglu	PROPN
dpc-4246	180	2	m	m	PROPN
dpc-4246	180	3	,	,	PUNCT
dpc-4246	180	4	pala	pala	PROPN
dpc-4246	180	5	e.	e.	PROPN
dpc-4246	180	6	systemic	systemic	PROPN
dpc-4246	180	7	immune	immune	PROPN
dpc-4246	180	8	-	-	PUNCT
dpc-4246	180	9	inflammation	inflammation	NOUN
dpc-4246	180	10	index	index	NOUN
dpc-4246	180	11	as	as	ADP
dpc-4246	180	12	a	a	DET
dpc-4246	180	13	biomarker	biomarker	NOUN
dpc-4246	180	14	of	of	ADP
dpc-4246	180	15	psoriasis	psoriasis	NOUN
dpc-4246	180	16	severity	severity	NOUN
dpc-4246	180	17	.	.	PUNCT
dpc-4246	181	1	arch	arch	ADJ
dpc-4246	181	2	basic	basic	ADJ
dpc-4246	181	3	clin	clin	PROPN
dpc-4246	181	4	res	re	VERB
dpc-4246	181	5	2023;5(2):291	2023;5(2):291	NOUN
dpc-4246	181	6	-	-	SYM
dpc-4246	181	7	295	295	NUM
dpc-4246	181	8	.	.	PUNCT
dpc-4246	182	1	23	23	NUM
dpc-4246	182	2	.	.	PUNCT
dpc-4246	183	1	kelesoglu	kelesoglu	PROPN
dpc-4246	183	2	dincer	dincer	PROPN
dpc-4246	183	3	ab	ab	PROPN
dpc-4246	183	4	,	,	PUNCT
dpc-4246	183	5	sezer	sezer	PROPN
dpc-4246	183	6	s.	s.	PROPN
dpc-4246	183	7	systemic	systemic	ADJ
dpc-4246	183	8	immune	immune	ADJ
dpc-4246	183	9	inflammation	inflammation	ADJ
dpc-4246	183	10	index	index	NOUN
dpc-4246	183	11	as	as	ADP
dpc-4246	183	12	a	a	DET
dpc-4246	183	13	reliable	reliable	ADJ
dpc-4246	183	14	disease	disease	NOUN
dpc-4246	183	15	activity	activity	NOUN
dpc-4246	183	16	marker	marker	NOUN
dpc-4246	183	17	in	in	ADP
dpc-4246	183	18	psoriatic	psoriatic	ADJ
dpc-4246	183	19	arthritis	arthritis	NOUN
dpc-4246	183	20	.	.	PUNCT
dpc-4246	184	1	j	j	PROPN
dpc-4246	184	2	coll	coll	PROPN
dpc-4246	184	3	physicians	physicians	PROPN
dpc-4246	184	4	surg	surg	PROPN
dpc-4246	184	5	pak	pak	PROPN
dpc-4246	184	6	2022;32(6):773	2022;32(6):773	PROPN
dpc-4246	184	7	-	-	PUNCT
dpc-4246	184	8	778	778	PROPN
dpc-4246	184	9	.	.	PUNCT
dpc-4246	185	1	doi:10.29271	doi:10.29271	PROPN
dpc-4246	185	2	/jcpsp.2022.06.773	/jcpsp.2022.06.773	PROPN
dpc-4246	186	1	24	24	NUM
dpc-4246	186	2	.	.	PUNCT
dpc-4246	187	1	tanacan	tanacan	PROPN
dpc-4246	187	2	e	e	PROPN
dpc-4246	187	3	,	,	PUNCT
dpc-4246	187	4	dinçer	dinçer	VERB
dpc-4246	187	5	rota	rota	PROPN
dpc-4246	187	6	d	d	PROPN
dpc-4246	187	7	,	,	PUNCT
dpc-4246	187	8	oktem	oktem	ADJ
dpc-4246	187	9	r	r	NOUN
dpc-4246	187	10	,	,	PUNCT
dpc-4246	187	11	erdogan	erdogan	VERB
dpc-4246	187	12	fg	fg	PRON
dpc-4246	187	13	.	.	PUNCT
dpc-4246	188	1	the	the	DET
dpc-4246	188	2	correlation	correlation	NOUN
dpc-4246	188	3	of	of	ADP
dpc-4246	188	4	systemic	systemic	ADJ
dpc-4246	188	5	immune	immune	ADJ
dpc-4246	188	6	-	-	PUNCT
dpc-4246	188	7	inflammation	inflammation	NOUN
dpc-4246	188	8	index	index	NOUN
dpc-4246	188	9	,	,	PUNCT
dpc-4246	188	10	neutrophil	neutrophil	NOUN
dpc-4246	188	11	-	-	PUNCT
dpc-4246	188	12	to	to	ADP
dpc-4246	188	13	lymphocyte	lymphocyte	ADJ
dpc-4246	188	14	ratio	ratio	NOUN
dpc-4246	188	15	,	,	PUNCT
dpc-4246	188	16	derived	derive	VERB
dpc-4246	188	17	neutrophil	neutrophil	ADJ
dpc-4246	188	18	-	-	PUNCT
dpc-4246	188	19	tolymphocyte	tolymphocyte	NOUN
dpc-4246	188	20	ratio	ratio	NOUN
dpc-4246	188	21	,	,	PUNCT
dpc-4246	188	22	and	and	CCONJ
dpc-4246	188	23	platelet	platelet	NOUN
dpc-4246	188	24	-	-	PUNCT
dpc-4246	188	25	to	to	ADP
dpc-4246	188	26	-	-	PUNCT
dpc-4246	188	27	lymphocyte	lymphocyte	ADJ
dpc-4246	188	28	ratio	ratio	NOUN
dpc-4246	188	29	with	with	ADP
dpc-4246	188	30	disease	disease	NOUN
dpc-4246	188	31	severity	severity	NOUN
dpc-4246	188	32	in	in	ADP
dpc-4246	188	33	recurrent	recurrent	ADJ
dpc-4246	188	34	aphthous	aphthous	ADJ
dpc-4246	188	35	stomatitis	stomatitis	NOUN
dpc-4246	188	36	.	.	PUNCT
dpc-4246	189	1	j	j	PROPN
dpc-4246	189	2	cosmet	cosmet	VERB
dpc-4246	189	3	dermatol	dermatol	NOUN
dpc-4246	189	4	2022;21(10	2022;21(10	NUM
dpc-4246	189	5	):	):	PUNCT
dpc-4246	189	6	48584863	48584863	NUM
dpc-4246	189	7	.	.	PUNCT
dpc-4246	190	1	doi:10.1111	doi:10.1111	ADJ
dpc-4246	190	2	/	/	SYM
dpc-4246	190	3	jocd.14838	jocd.14838	VERB
dpc-4246	190	4	4	4	NUM
dpc-4246	190	5	.	.	X
dpc-4246	190	6	tanacan	tanacan	PROPN
dpc-4246	190	7	e	e	PROPN
dpc-4246	190	8	,	,	PUNCT
dpc-4246	190	9	dincer	dincer	NOUN
dpc-4246	190	10	d	d	PROPN
dpc-4246	190	11	,	,	PUNCT
dpc-4246	190	12	erdogan	erdogan	ADJ
dpc-4246	190	13	fg	fg	ADP
dpc-4246	190	14	,	,	PUNCT
dpc-4246	190	15	gurler	gurler	PROPN
dpc-4246	190	16	a.	a.	NOUN
dpc-4246	190	17	a	a	DET
dpc-4246	190	18	cutoff	cutoff	NOUN
dpc-4246	190	19	value	value	NOUN
dpc-4246	190	20	for	for	ADP
dpc-4246	190	21	the	the	DET
dpc-4246	190	22	systemic	systemic	ADJ
dpc-4246	190	23	immune	immune	ADJ
dpc-4246	190	24	-	-	PUNCT
dpc-4246	190	25	inflammation	inflammation	NOUN
dpc-4246	190	26	index	index	NOUN
dpc-4246	190	27	in	in	ADP
dpc-4246	190	28	determining	determine	VERB
dpc-4246	190	29	activity	activity	NOUN
dpc-4246	190	30	of	of	ADP
dpc-4246	190	31	behçet	behçet	NOUN
dpc-4246	190	32	disease	disease	NOUN
dpc-4246	190	33	.	.	PUNCT
dpc-4246	191	1	clin	clin	PROPN
dpc-4246	191	2	exp	exp	NOUN
dpc-4246	191	3	dermatol2021;46(2):286	dermatol2021;46(2):286	PROPN
dpc-4246	191	4	-	-	PUNCT
dpc-4246	191	5	291	291	NUM
dpc-4246	191	6	.	.	PUNCT
dpc-4246	192	1	doi:10.1111	doi:10.1111	NOUN
dpc-4246	192	2	/	/	SYM
dpc-4246	192	3	ced.14432	ced.14432	SYM
dpc-4246	192	4	5	5	NUM
dpc-4246	192	5	.	.	PUNCT
dpc-4246	192	6	turan	turan	PROPN
dpc-4246	192	7	ç	ç	PROPN
dpc-4246	192	8	,	,	PUNCT
dpc-4246	192	9	metin	metin	PROPN
dpc-4246	192	10	n.	n.	PROPN
dpc-4246	192	11	a	a	DET
dpc-4246	192	12	novel	novel	ADJ
dpc-4246	192	13	inflammatory	inflammatory	ADJ
dpc-4246	192	14	marker	marker	NOUN
dpc-4246	192	15	in	in	ADP
dpc-4246	192	16	the	the	DET
dpc-4246	192	17	follow	follow	NOUN
dpc-4246	192	18	-	-	PUNCT
dpc-4246	192	19	up	up	NOUN
dpc-4246	192	20	of	of	ADP
dpc-4246	192	21	moderate	moderate	ADJ
dpc-4246	192	22	-	-	PUNCT
dpc-4246	192	23	to	to	ADP
dpc-4246	192	24	-	-	PUNCT
dpc-4246	192	25	severe	severe	ADJ
dpc-4246	192	26	acne	acne	NOUN
dpc-4246	192	27	vulgaris	vulgaris	NOUN
dpc-4246	192	28	administered	administer	VERB
dpc-4246	192	29	isotretinoin	isotretinoin	PROPN
dpc-4246	192	30	:	:	PUNCT
dpc-4246	192	31	systemic	systemic	ADJ
dpc-4246	192	32	immune	immune	ADJ
dpc-4246	192	33	-	-	PUNCT
dpc-4246	192	34	inflammation	inflammation	NOUN
dpc-4246	192	35	index	index	NOUN
dpc-4246	192	36	(	(	PUNCT
dpc-4246	192	37	sii	sii	PROPN
dpc-4246	192	38	)	)	PUNCT
dpc-4246	192	39	.	.	PUNCT
dpc-4246	193	1	curr	curr	PROPN
dpc-4246	193	2	health	health	PROPN
dpc-4246	193	3	sci	sci	PROPN
dpc-4246	193	4	j	j	PROPN
dpc-4246	193	5	2022;48(1):63	2022;48(1):63	PROPN
dpc-4246	193	6	-	-	PUNCT
dpc-4246	193	7	67	67	NUM
dpc-4246	193	8	.	.	PUNCT
dpc-4246	194	1	doi:10.12865	doi:10.12865	PROPN
dpc-4246	194	2	/	/	SYM
dpc-4246	194	3	chsj.48.01.09	chsj.48.01.09	PROPN
dpc-4246	194	4	6	6	NUM
dpc-4246	194	5	.	.	PUNCT
dpc-4246	195	1	özkur	özkur	PROPN
dpc-4246	195	2	e	e	NOUN
dpc-4246	195	3	,	,	PUNCT
dpc-4246	195	4	şeremet	şeremet	PROPN
dpc-4246	195	5	s	s	PART
dpc-4246	195	6	,	,	PUNCT
dpc-4246	195	7	afşar	afşar	VERB
dpc-4246	195	8	fş	fş	ADP
dpc-4246	195	9	,	,	PUNCT
dpc-4246	195	10	altunay	altunay	NOUN
dpc-4246	195	11	i̇k	i̇k	NOUN
dpc-4246	195	12	,	,	PUNCT
dpc-4246	196	1	çalıkoğlu	çalıkoğlu	NOUN
dpc-4246	196	2	ee	ee	PROPN
dpc-4246	196	3	.	.	PUNCT
dpc-4246	196	4	platelet	platelet	NOUN
dpc-4246	196	5	count	count	NOUN
dpc-4246	196	6	and	and	CCONJ
dpc-4246	196	7	mean	mean	VERB
dpc-4246	196	8	platelet	platelet	NOUN
dpc-4246	196	9	volume	volume	NOUN
dpc-4246	196	10	in	in	ADP
dpc-4246	196	11	psoriasis	psoriasis	NOUN
dpc-4246	196	12	patients	patient	NOUN
dpc-4246	196	13	.	.	PUNCT
dpc-4246	197	1	sislietfalhastan	sislietfalhastan	PROPN
dpc-4246	197	2	tip	tip	PROPN
dpc-4246	197	3	bul	bul	PROPN
dpc-4246	197	4	2018;54(1):58	2018;54(1):58	PROPN
dpc-4246	197	5	-	-	PUNCT
dpc-4246	197	6	61	61	NUM
dpc-4246	197	7	.	.	PUNCT
dpc-4246	198	1	published	publish	VERB
dpc-4246	198	2	2018	2018	NUM
dpc-4246	198	3	dec	dec	PROPN
dpc-4246	198	4	19	19	NUM
dpc-4246	198	5	.	.	PUNCT
dpc-4246	198	6	doi:10.14744	doi:10.14744	PROPN
dpc-4246	198	7	/	/	SYM
dpc-4246	198	8	semb.2018.69370	semb.2018.69370	PROPN
dpc-4246	198	9	7	7	NUM
dpc-4246	198	10	.	.	PUNCT
dpc-4246	198	11	olayinka	olayinka	PROPN
dpc-4246	198	12	jjt	jjt	PROPN
dpc-4246	198	13	,	,	PUNCT
dpc-4246	198	14	richmond	richmond	PROPN
dpc-4246	198	15	jm	jm	PROPN
dpc-4246	198	16	.	.	PROPN
dpc-4246	198	17	immunopathogenesis	immunopathogenesis	NOUN
dpc-4246	198	18	of	of	ADP
dpc-4246	198	19	alopecia	alopecia	NOUN
dpc-4246	198	20	areata	areata	ADJ
dpc-4246	198	21	.	.	PUNCT
dpc-4246	199	1	curr	curr	PROPN
dpc-4246	199	2	res	res	PROPN
dpc-4246	199	3	immunol	immunol	NOUN
dpc-4246	199	4	2021	2021	NUM
dpc-4246	199	5	;	;	PUNCT
dpc-4246	199	6	2:7	2:7	NUM
dpc-4246	199	7	-	-	SYM
dpc-4246	199	8	11	11	NUM
dpc-4246	199	9	.	.	PUNCT
dpc-4246	200	1	doi:10.1016	doi:10.1016	PROPN
dpc-4246	200	2	/	/	SYM
dpc-4246	200	3	j	j	PROPN
dpc-4246	200	4	.crimmu.2021.02.001	.crimmu.2021.02.001	NOUN
dpc-4246	201	1	8	8	X
dpc-4246	201	2	.	.	PUNCT
dpc-4246	202	1	lundin	lundin	PROPN
dpc-4246	202	2	m	m	PROPN
dpc-4246	202	3	,	,	PUNCT
dpc-4246	202	4	chawa	chawa	PROPN
dpc-4246	202	5	s	s	PROPN
dpc-4246	202	6	,	,	PUNCT
dpc-4246	202	7	sachdev	sachdev	PROPN
dpc-4246	202	8	a	a	PRON
dpc-4246	202	9	,	,	PUNCT
dpc-4246	202	10	bhanusali	bhanusali	ADJ
dpc-4246	202	11	d	d	NOUN
dpc-4246	202	12	,	,	PUNCT
dpc-4246	202	13	seiffert	seiffert	PROPN
dpc-4246	202	14	-	-	PUNCT
dpc-4246	202	15	sinha	sinha	NOUN
dpc-4246	202	16	k	k	PROPN
dpc-4246	202	17	,	,	PUNCT
dpc-4246	202	18	sinha	sinha	PROPN
dpc-4246	202	19	aa	aa	PROPN
dpc-4246	202	20	.	.	PUNCT
dpc-4246	203	1	gender	gender	NOUN
dpc-4246	203	2	differences	difference	NOUN
dpc-4246	203	3	in	in	ADP
dpc-4246	203	4	alopecia	alopecia	NOUN
dpc-4246	203	5	areata	areata	NOUN
dpc-4246	203	6	.	.	PUNCT
dpc-4246	204	1	j	j	PROPN
dpc-4246	204	2	drugs	drug	NOUN
dpc-4246	204	3	dermatol	dermatol	NOUN
dpc-4246	204	4	2014;13(4):409	2014;13(4):409	NOUN
dpc-4246	204	5	-	-	SYM
dpc-4246	204	6	413	413	NUM
dpc-4246	204	7	9	9	NUM
dpc-4246	204	8	.	.	PUNCT
dpc-4246	205	1	uzuncakmak	uzuncakmak	PROPN
dpc-4246	205	2	tk	tk	PROPN
dpc-4246	205	3	,	,	PUNCT
dpc-4246	205	4	engin	engin	PROPN
dpc-4246	205	5	b	b	PROPN
dpc-4246	205	6	,	,	PUNCT
dpc-4246	205	7	serdaroglu	serdaroglu	PROPN
dpc-4246	205	8	s	s	NOUN
dpc-4246	205	9	,	,	PUNCT
dpc-4246	205	10	tuzun	tuzun	ADV
dpc-4246	205	11	y.	y.	PROPN
dpc-4246	205	12	demographic	demographic	ADJ
dpc-4246	205	13	and	and	CCONJ
dpc-4246	205	14	clinical	clinical	ADJ
dpc-4246	205	15	features	feature	NOUN
dpc-4246	205	16	of	of	ADP
dpc-4246	205	17	1,641	1,641	NUM
dpc-4246	205	18	patients	patient	NOUN
dpc-4246	205	19	with	with	ADP
dpc-4246	205	20	alopecia	alopecia	NOUN
dpc-4246	205	21	areata	areata	NOUN
dpc-4246	205	22	,	,	PUNCT
dpc-4246	205	23	alopecia	alopecia	NOUN
dpc-4246	205	24	totalis	totalis	PROPN
dpc-4246	205	25	,	,	PUNCT
dpc-4246	205	26	and	and	CCONJ
dpc-4246	205	27	alopecia	alopecia	NOUN
dpc-4246	205	28	universalis	universali	VERB
dpc-4246	205	29	:	:	PUNCT
dpc-4246	205	30	a	a	DET
dpc-4246	205	31	single	single	ADJ
dpc-4246	205	32	-	-	PUNCT
dpc-4246	205	33	center	center	NOUN
dpc-4246	205	34	retrospective	retrospective	ADJ
dpc-4246	205	35	study	study	NOUN
dpc-4246	205	36	.	.	PUNCT
dpc-4246	206	1	skin	skin	NOUN
dpc-4246	206	2	appendage	appendage	NOUN
dpc-4246	206	3	disord	disord	NOUN
dpc-4246	206	4	2021;7(1):8	2021;7(1):8	PROPN
dpc-4246	206	5	-	-	SYM
dpc-4246	206	6	12	12	NUM
dpc-4246	206	7	.	.	PUNCT
dpc-4246	206	8	doi:10.1159/000510880	doi:10.1159/000510880	VERB
dpc-4246	206	9	10	10	NUM
dpc-4246	206	10	.	.	PUNCT
dpc-4246	207	1	lyakhovitsky	lyakhovitsky	PROPN
dpc-4246	207	2	a	a	PROPN
dpc-4246	207	3	,	,	PUNCT
dpc-4246	207	4	gilboa	gilboa	PROPN
dpc-4246	207	5	s	s	PROPN
dpc-4246	207	6	,	,	PUNCT
dpc-4246	207	7	eshkol	eshkol	PROPN
dpc-4246	207	8	a	a	PRON
dpc-4246	207	9	,	,	PUNCT
dpc-4246	207	10	barzilai	barzilai	PROPN
dpc-4246	207	11	a	a	PROPN
dpc-4246	207	12	,	,	PUNCT
dpc-4246	207	13	baum	baum	PROPN
dpc-4246	207	14	s.	s.	PROPN
dpc-4246	207	15	late	late	PROPN
dpc-4246	207	16	onset	onset	VERB
dpc-4246	207	17	alopecia	alopecia	NOUN
dpc-4246	207	18	areata	areata	NOUN
dpc-4246	207	19	:	:	PUNCT
dpc-4246	207	20	a	a	DET
dpc-4246	207	21	retrospective	retrospective	ADJ
dpc-4246	207	22	cohort	cohort	NOUN
dpc-4246	207	23	study	study	NOUN
dpc-4246	207	24	.	.	PUNCT
dpc-4246	208	1	dermatology	dermatology	NOUN
dpc-4246	208	2	2017;233(4):289	2017;233(4):289	NUM
dpc-4246	208	3	-	-	SYM
dpc-4246	208	4	294	294	NUM
dpc-4246	208	5	.	.	PUNCT
dpc-4246	209	1	doi:10.1159/000481881	doi:10.1159/000481881	NOUN
dpc-4246	209	2	11	11	NUM
dpc-4246	209	3	.	.	PUNCT
dpc-4246	210	1	kavak	kavak	PROPN
dpc-4246	210	2	a	a	PRON
dpc-4246	210	3	,	,	PUNCT
dpc-4246	210	4	yeşildal	yeşildal	NOUN
dpc-4246	210	5	n	n	CCONJ
dpc-4246	210	6	,	,	PUNCT
dpc-4246	210	7	parlak	parlak	NOUN
dpc-4246	210	8	ah	ah	INTJ
dpc-4246	210	9	,	,	PUNCT
dpc-4246	210	10	et	et	PROPN
dpc-4246	210	11	al	al	PROPN
dpc-4246	210	12	.	.	PUNCT
dpc-4246	211	1	alopecia	alopecia	NOUN
dpc-4246	211	2	areata	areata	VERB
dpc-4246	211	3	in	in	ADP
dpc-4246	211	4	turkey	turkey	NOUN
dpc-4246	211	5	:	:	PUNCT
dpc-4246	211	6	demographic	demographic	ADJ
dpc-4246	211	7	and	and	CCONJ
dpc-4246	211	8	clinical	clinical	ADJ
dpc-4246	211	9	features	feature	NOUN
dpc-4246	211	10	.	.	PUNCT
dpc-4246	212	1	j	j	PROPN
dpc-4246	212	2	euracad	euracad	ADJ
dpc-4246	212	3	dermatol	dermatol	NOUN
dpc-4246	212	4	venereol	venereol	NOUN
dpc-4246	212	5	2008;22(8):977	2008;22(8):977	PROPN
dpc-4246	212	6	-	-	SYM
dpc-4246	212	7	981	981	NUM
dpc-4246	212	8	.	.	PUNCT
dpc-4246	213	1	doi:10.1111	doi:10.1111	ADJ
dpc-4246	213	2	/	/	SYM
dpc-4246	213	3	j.1468	j.1468	NOUN
dpc-4246	213	4	-	-	PUNCT
dpc-4246	213	5	3083.2008.02699.x	3083.2008.02699.x	NUM
dpc-4246	213	6	12	12	NUM
dpc-4246	213	7	.	.	PUNCT
dpc-4246	214	1	lee	lee	PROPN
dpc-4246	214	2	s	s	PROPN
dpc-4246	214	3	,	,	PUNCT
dpc-4246	214	4	lee	lee	PROPN
dpc-4246	214	5	h	h	PROPN
dpc-4246	214	6	,	,	PUNCT
dpc-4246	214	7	lee	lee	PROPN
dpc-4246	214	8	ch	ch	PROPN
dpc-4246	214	9	,	,	PUNCT
dpc-4246	214	10	lee	lee	PROPN
dpc-4246	214	11	ws	ws	PROPN
dpc-4246	214	12	.	.	PUNCT
dpc-4246	214	13	comorbidities	comorbiditie	NOUN
dpc-4246	214	14	in	in	ADP
dpc-4246	214	15	alopecia	alopecia	NOUN
dpc-4246	214	16	areata	areata	NOUN
dpc-4246	214	17	:	:	PUNCT
dpc-4246	214	18	a	a	DET
dpc-4246	214	19	systematic	systematic	ADJ
dpc-4246	214	20	review	review	NOUN
dpc-4246	214	21	and	and	CCONJ
dpc-4246	214	22	meta	meta	ADJ
dpc-4246	214	23	-	-	PUNCT
dpc-4246	214	24	analysis	analysis	NOUN
dpc-4246	214	25	.	.	PUNCT
dpc-4246	215	1	j	j	PROPN
dpc-4246	215	2	am	be	AUX
dpc-4246	215	3	acad	acad	ADJ
dpc-4246	215	4	dermatol	dermatol	NOUN
dpc-4246	215	5	2019;80(2):466	2019;80(2):466	NUM
dpc-4246	215	6	-	-	SYM
dpc-4246	215	7	477.e16	477.e16	PROPN
dpc-4246	215	8	.	.	PUNCT
dpc-4246	215	9	doi:10.1016	doi:10.1016	PROPN
dpc-4246	215	10	/	/	SYM
dpc-4246	215	11	j.jaad.2018.07.013	j.jaad.2018.07.013	PROPN
dpc-4246	215	12	13	13	NUM
dpc-4246	215	13	.	.	PUNCT
dpc-4246	216	1	laitinen	laitinen	PROPN
dpc-4246	216	2	i	i	PROPN
dpc-4246	216	3	,	,	PUNCT
dpc-4246	216	4	jokelainen	jokelainen	PROPN
dpc-4246	216	5	j	j	PROPN
dpc-4246	216	6	,	,	PUNCT
dpc-4246	216	7	tasanen	tasanen	PROPN
dpc-4246	216	8	k	k	PROPN
dpc-4246	216	9	,	,	PUNCT
dpc-4246	216	10	huilaja	huilaja	PROPN
dpc-4246	216	11	l.	l.	PROPN
dpc-4246	216	12	comorbidities	comorbiditie	NOUN
dpc-4246	216	13	of	of	ADP
dpc-4246	216	14	alopecia	alopecia	NOUN
dpc-4246	216	15	areata	areata	ADJ
dpc-4246	216	16	in	in	ADP
dpc-4246	216	17	finland	finland	PROPN
dpc-4246	216	18	between	between	ADP
dpc-4246	216	19	1987	1987	NUM
dpc-4246	216	20	and	and	CCONJ
dpc-4246	216	21	2016	2016	NUM
dpc-4246	216	22	.	.	PUNCT
dpc-4246	217	1	acta	acta	PROPN
dpc-4246	217	2	derm	derm	PROPN
dpc-4246	217	3	venereol	venereol	NOUN
dpc-4246	217	4	2020;100(4):adv00063	2020;100(4):adv00063	NUM
dpc-4246	217	5	.	.	PUNCT
dpc-4246	218	1	doi:10.2340/00015555	doi:10.2340/00015555	NOUN
dpc-4246	218	2	-	-	SYM
dpc-4246	218	3	3412	3412	NUM
dpc-4246	218	4	14	14	NUM
dpc-4246	218	5	.	.	PUNCT
dpc-4246	219	1	villasante	villasante	PROPN
dpc-4246	219	2	fricke	fricke	PROPN
dpc-4246	219	3	ac	ac	PROPN
dpc-4246	219	4	,	,	PUNCT
dpc-4246	219	5	miteva	miteva	PROPN
dpc-4246	219	6	m.	m.	NOUN
dpc-4246	219	7	epidemiology	epidemiology	NOUN
dpc-4246	219	8	and	and	CCONJ
dpc-4246	219	9	burden	burden	NOUN
dpc-4246	219	10	of	of	ADP
dpc-4246	219	11	alopecia	alopecia	NOUN
dpc-4246	219	12	areata	areata	NOUN
dpc-4246	219	13	:	:	PUNCT
dpc-4246	219	14	a	a	DET
dpc-4246	219	15	systematic	systematic	ADJ
dpc-4246	219	16	review	review	NOUN
dpc-4246	219	17	.	.	PUNCT
dpc-4246	220	1	clin	clin	PROPN
dpc-4246	220	2	cosmetinvestig	cosmetinvestig	PROPN
dpc-4246	220	3	dermatol2015;8:397	dermatol2015;8:397	PROPN
dpc-4246	220	4	-	-	PUNCT
dpc-4246	220	5	403	403	PROPN
dpc-4246	220	6	.	.	PUNCT
dpc-4246	221	1	doi:10.2147	doi:10.2147	NOUN
dpc-4246	221	2	/	/	SYM
dpc-4246	221	3	ccid.s53985	ccid.s53985	NOUN
dpc-4246	221	4	15	15	NUM
dpc-4246	221	5	.	.	PUNCT
dpc-4246	222	1	aksoy	aksoy	PROPN
dpc-4246	222	2	sarac	sarac	PROPN
dpc-4246	222	3	g	g	PROPN
dpc-4246	222	4	,	,	PUNCT
dpc-4246	222	5	acar	acar	ADJ
dpc-4246	222	6	o	o	NOUN
dpc-4246	222	7	,	,	PUNCT
dpc-4246	222	8	nayır	nayır	PROPN
dpc-4246	222	9	t	t	PROPN
dpc-4246	222	10	,	,	PUNCT
dpc-4246	222	11	hararcı	hararcı	PROPN
dpc-4246	222	12	yıldırım	yıldırım	PROPN
dpc-4246	222	13	p	p	PROPN
dpc-4246	222	14	,	,	PUNCT
dpc-4246	222	15	dinçer	dinçer	PROPN
dpc-4246	222	16	rota	rota	PROPN
dpc-4246	222	17	d.	d.	PROPN
dpc-4246	222	18	the	the	DET
dpc-4246	222	19	use	use	NOUN
dpc-4246	222	20	of	of	ADP
dpc-4246	222	21	new	new	ADJ
dpc-4246	222	22	hematological	hematological	ADJ
dpc-4246	222	23	markers	marker	NOUN
dpc-4246	222	24	in	in	ADP
dpc-4246	222	25	the	the	PRON